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Abstract. The synaptic communication between neuronal cells is based on the release and 
uptake of neurotransmitters. In the mammalian brain inhibitory signal transduction relies on 
the neurotransmitter γ-amino butyric acid (GABA) which is recognised by specific receptors 
in the post synaptic plasma membrane. These receptors experience high spatio-temporal 
fluctuations and thus need to be accumulated in direct opposition to the presynaptic active 
site to facilitate fast communication. Malfunctions in this process are origin of multiple 
neuronal diseases. A protein machinery composed of the cell adhesion protein neuroligin 2 
(NL2), the scaffolding protein gephyrin and the adaptor protein collybistin 2 (CB2), that 
interacts with phosphoinositides (PtdInsPs) in the plasma membrane, is assumed to be 
responsible for the receptor organisation in the postsynaptic specialisations. The complex has 
been examined only in vivo so far, yet to characterise each constituent in detail and to 
investigate their intermolecular interactions an in vitro system is required. Therefore, this work 
focusses on the preparation of a model system, based on membranes supported by SiO2 
substrates. In solid-supported lipid bilayers (SLBs) a heterogeneous distribution of the 
bisphosphorylated phosphoinositide (PtdIns[4,5]P2) was detected, thus solid-supported 
hybrid membranes (SHMs) prepared by spreading of small unilamellar vesicles (SUVs) on 
hydrophobically functionalised SiO2 were deployed to guarantee homogeneous distribution 
and comparability of all PtdInsPs (PtdIns[3]P, PtdIns[4,5]P2 and PtdIns[3,4,5]P3) tested. 
The adsorption of recombinantly expressed CB2 to SHMs containing the different PtdInsPs 
was examined by means of reflectometric interference spectroscopy (RIfS) and atomic force 
microscopy (AFM). In this way the isolated PH domain (CB2PH) and the point-mutated, active 
full-length isoform (CB2SH3/W24A-E262A) were characterised as unspecific, moderate PtdInsP 
interation partners, while the wild-type of CB2 (CB2SH3) was incapable of binding. 
Furthermore, it was shown that the height of the adsorbed protein is dictated by the C-terminal 
PH domain. 
The addition of a second receptor lipid (DGS), specific for a NL2 protein construct mimicking 
its intracellular domain (His-cytNL2) introduced a positive charge but did not affect the 
established membrane system. After fixation of His-cytNL2 to SHMs doped with DGS and 
PtdInsP also adsorption of CB2SH3 was detected. Thereby, the activation of the wild-type by 
interaction with the intracellular domain of NL2 was proven. Additionally, the activated wild-
type exhibited a higher specificity compared to that of CB2SH3/W24A-E262A.  




Zusammenfassung. Die Inhibition der Reizweiterleitung im Gehirn von Säugetieren beruht 
auf der Ausschüttung und Aufnahme von γ-Aminobuttersäure (GABA). Die Detektion dieses 
Neurotransmitters erfolgt durch spezifische Rezeptoren, die in der postsynaptischen 
Plasmamembran lokalisiert sind. Für eine schnelle und effiziente Inhibition ist die 
Akkumulation dieser Rezeptoren gegenüberliegend zur aktiven Zone der Präsynapse 
notwendig. Es wird angenommen, dass dieser Organisationsprozess auf den Proteinen 
Neuroligin 2 (NL2), Gephyrin und Collybistin 2 (CB2) beruht. Letzteres fungiert als 
Adapterprotein zwischen dem Proteinkomplex und Phosphatidylinositolphosphaten 
(PtdInsPs) in der Membrane. Zur genauen Characterisierung der einzelnen Bestandteile dieses 
Komplexes und ihrer Wechselwirkungen wurde im Rahmen dieser Arbeit ein in vitro Modell 
entwickelt. Dieses basiert auf festkörperunterstützten Lipidmonoschichten (SHMs), die durch 
das Spreiten von kleinen unilamellaren Vesikeln auf hydrophob funktionalisierten SiO2 
Oberflächen erzeugt wurden. Es konnte im Vergleich mit festkörperunterstützten 
Lipiddoppelschichten (SLBs) gezeigt werden, dass es in letzteren zu einer heterogenen 
Verteilung von PtdIns[4,5]P2 kommt. Diese äußerte sich in einer Verarmung an zugänglichen 
Rezeptorlipiden, die unter der Verwendung von Markerproteinen mittels reflektometrischer 
Interferenzspektroskopie (RIfS) und Rasterkraftmikroskopie (AFM) detektiert wurde. 
Auf Grund der ermittelten Vorteile wurden nochfolgend Adsorptionsstudien von CB2 auf 
SHMs durchgeführt, welche mit verschiedenen PtdInsPs dotiert waren. Dadurch konnte 
gezeigt werden, dass es sich bei allen CB2 Isoformen um unspezifische PtdInsP-
Interaktionspartner handelt. Lediglich der CB2 Wildtyp zeigte keine Bindungsaktivität. 
Desweiteren wurde die C-terminale PH Domäne als höhenbestimmendes Proteinmodul 
identifiziert. Zusätzlich konnte gezeigt werden, dass neben der Proteinhöhe auch die Größe 
der adsorbierten Proteinstrukturen unabhängig vom vorliegenden PtdInsP ist. 
Die Erweiterung des Modellsystems um NL2 in Form der C-terminalen intrazellulären 
Domäne, erforderte die Dotierung mit DGS als spezifisches Rezeptorlipid zusätzlich zu 
PtdInsP. Für SHMs, die beide Rezeptorlipide enthielten, wurden lediglich ein um die Hälfte 
reduzierte Diffussionskoeffizienten detektiert. Anhand von Co-Adsorptionsstudien von CB2 
nach vorheriger NL2-Injektion, konnte gezeigt werden, dass der Wildtyp durch NL2 aktiviert 
wird und somit in der Lage ist mit PtdInsPs zu interagieren. Somit konnte anhand des 
entwickelten System ein Nachweis für die Aktivierung von CB2 durch NL2 erbracht werden. 






The nervous system can be divided into the peripheral nervous system (PNS) and the central 
nervous system (CNS) in which neurons represent the principle building blocks. These cells 
were identified right before the turn from 19th to 20th century by CAJAL, who visualized their 
dendritic spines via various staining techniques, thereby proving the predominant reticular 
theory of that time to be wrong.1,2 Based on his results fundamental characteristics of neurons 
could be identified despite their large anatomical variations which is schematically shown in 
Figure 1.1. In most cases neurons consist of the central soma to which one or multiple dendrites 
and a unique axon are attached.3 Both, dendrites 
and axon can be ramified to a different degree.  
While the PNS mainly executes the transport of 
external sensory stimuli and corresponding mo-
toric responses, the CNS functions as the control-
ling unit, where information is integrated, pro-
cessed and afterwards transmitted to the PNS 
again. It is composed of the spinal cord and the 
brain. Due to its diverse functions the brain is pre-
sumed to be the most complex organ in the hu-
man body which is also reflected in the huge 
number of neurons inside. A rough estimation by 
WILLIAMS and HERRUP assumed 85 billion neurons to be contained in the adult human brain 
in addition to other cells like the glial cell, which do not participate in synaptic transition, yet, 
serve a supportive function and are essential in neuronal migration.4  
The inter-neuronal contact sites are called synapses. They constitute the neuronal network in 
which signal transduction is either obtained via chemical transmission or, less common, by 
electrical coupling. While at electrical synapses gap junctions connect the cytoplasm of pre- 
and postsynaptic neurons, chemical synapses are composed of a presynaptic axon that is in 
close apposition to a postsynaptic dendrite or dendritic spine. Both are separated by a small 
Figure 1.1: Variety in neuron morphology illus-
trated by schemes of a retinal ganglion cell, a retinal 
amacrine cell, a retinal bipolar cell, and a cortical py-
ramidal cell. Modified from PURVES et al.3  
1 INTRODUCTION   
2 
 
interval of extracellular space, the so-called synaptic cleft. To pass information across this ex-
tracellular area neurotransmitters are secreted via exocytosis of synaptic vesicles at the pre-
synaptic terminal and diffuse to specialisations inside the post synaptic membrane where they 
bind and activate specific receptors.5 
Two types of transmitter receptors are known. One class are the metabotropic, G-protein cou-
pled receptors and the other one are ionotropic neurotransmitter receptors. The latter are ion 
channels which open their pore upon ligand binding and selectively allow ions to flow along 
the electrochemical gradient. This ion transfer changes the membrane potential of the postsyn-
aptic dendrite. Spatiotemporal integration of all synaptic stimuli on the respective neuron re-
sults in an action potential that, in case a certain threshold value in potential is reached, prop-
agates down the axon. Thereby the firing behaviour of this neuron is determined via all syn-
aptic inputs and its activity in the neuronal network is controlled.6–8 
It has been estimated that each neuron in the human brain is connected via more than 10,000 
synapses to others.5 The accurate communication and its underlying mechanism are critical 
for the well-being of the whole organism as the exchange controls virtually all internal body 
processes and functions. The necessity of its accurate function is confirmed by diseases like 
Alzheimer’s and major depressions, shown to be a result of any malfunction in the information 
transmission process.3 Thus, understanding the details of the processes underlying synaptic 
transmission is a prerequisite to get further insights in complex brain functions and to inves-
tigate rational treatments for the aforementioned and all other diseases who originate from 
dysfunctions in neuronal communication. 
 
 
The signal transduction between neurons takes place at either chemical or electrical synapses. 
While at the latter gap junctions are used for signal transfer, at chemical synapses secretion of 
a great variety of neurotransmitters occurs via vesicle fusion at the exon terminal. All types of 
neurotransmitters experience a similar circuit of use with synthesis, transport to synaptic ves-
icles, exocytosis and release in the synaptic cleft, binding to specific postsynaptic receptors and 
finally fast removal or degradation. The binding and simultaneous activation of specific neu-
rotransmitter receptors lead to ionic permeability in the postsynaptic membrane determining 
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whether the actions at the dendrite are excitatory or inhibitory. The permeability of the den-
dritic membrane and a transmembrane ion concentration gradient, maintained for the most 
part via Na+/K+-ATPase, result in a negative membrane potential of circa -60 mV to -70 mV at 
rest.9 Upon binding of neurotransmitters like glutamate to excitatory ionotropic receptors, Na+ 
influx causes a depolarisation of the membrane potential resulting in an action potential if the 
threshold of approximately -40 mV is reached. Yet, the activity of neurons must be controlled. 
Therefore, an inhibition has to take place that is based on γ-amino butyric acid (GABA) and 
glycine release at synapses in the brain and the spinal cord, respectively.10 The specific recep-
tors for both neurotransmitters are ligand-gated Cl- channels, whose opening and the accom-
panying Cl- influx result in hyperpolarisation of postsynaptic membrane potentials. This hy-
perpolarisation antagonises the depolarisation of excitatory inputs and in this way leads to an 
inhibitory effect on the firing probability. 
GRAY studied cerebrocortical tissues of rats and identified two different types of synapses. The 
electron micrographs presented in Figure 1.2 A-C clearly indicate a thickening of the postsyn-
aptic membranes at synapses expressed 
between axons and dendrites or dendritic 
spines (type I) whereas no asymmetric 
thickening is detected in axosomatic syn-
apses (type II).11 Posterior studies showed 
that GRAY’s synaptic types I and II accord 
with excitatory and inhibitory synapses, 
respectively.12 Thus, there is also a struc-
tural difference between the two synaptic 
types. What was detected as a thickening 
of the postsynaptic membrane in excitatory synapses, later was identified as an electron-dense 
area composed of many proteins referred to as the postsynaptic density (PSD).13–15 Only 10 % 
of the great protein diversity in the PSD were ion channels and receptors.16,17 This small frac-
tion stresses the importance of other constituents in the receptor organisation process at the 
excitatory postsynaptic membranes. In contrast to the rigorously investigated principles of ex-
citatory synapses at the molecular and cell biological level, this information is lacking in most 
Figure 1.2: Electron micrographs of an axo-dendritic excita-
tory synapse (A) and an axo-somatic inhibitory synapse (B). 
Inset (C) highlights the reduced electron density in PSDs of 
inhibitory synapses in contrast to excitatory ones. “Pre” 
marks the axon while “den”/”post” labels the signal receiv-
ing neuron. Modified from GRAY.11 
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instances for inhibitory synapses relying on GABA as neurotransmitter, due to their challeng-
ing isolation and sparse character.18 For this reason, a detailed look in the basics of GABAergic 
synapse formation and its molecular processes seems to be reasonable. 
 
 
Chemical synapses are defined by the neurotransmitter that is released from the axon and 
detected on the other side of the synaptic cleft at the postsynaptic membrane. The inhibition 
of neurons in the brain is induced by GABA detection that leads to hyperpolarisation of the 
postsynaptic neuron. Based on these two facts, one class of neuronal communication sites is 
referred to as GABAergic inhibitory synapses. These synapses have shown to provide a brake 
to neural firing and are relevant in various other purposes like action potential pattern modu-
lation and synaptic strength modification.19–23 Moreover, the fidelity of GABA transmission 
directly depends on the number of postsynaptic GABA receptors (GABARs) as GABA satu-
rates them.24,25 Hence, even slight changes in GABAR expression or their concentration in the 
synaptic specialisations of the postsynaptic membrane influence the signal trafficking, leading 
to behavioural consequences and direct physiological effects.26,27 On these grounds a focus on 
this type of synapse is necessary. Despite the lack of information on them, in contrast to the 
excitatory PSD, former studies already identified potential proteins that contribute to the GA-
BAergic synapse formation. Ideally, their number ranges in an amount manageable in in vitro 
experiments by which basic characteristics for each constituent part and for all together can be 
determined. The assumed composition of the receptor organisation machinery and its opera-
tion mechanism is outlined in the following section. 
 
 
As mentioned before, it is necessary for fast signal transduction that the postsynaptic special-
isation is in direct apposition to the presynaptic terminal. This is ensured by the interaction of 
the cell adhesion molecules (CAMs) neurexin (presynaptic) and neuroligin (post synaptic) 
across the synaptic cleft. Additionally, the latter exhibits a gephyrin-binding site which is 
highly conserved in all its four isoforms, yet, only neuroligin 2 (NL2) holds a poly-proline 
segment (cf. Figure 1.5 A) being capable of interacting with collybistin 2 (CB2).28,29 Such an 
interaction is src homology 3 (SH3) domain-dependent and causes the dissipation of the auto-
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inhibition and opening of collybistin into an active conformation. In the open state the pleck-
strin homology (PH) domain can bind to phosphoinositides in the plasma membrane. It is 
known that inactive CB2 can still interact with gephyrin via its B-cell lymphoma (Dbl) homol-
ogy (DH) domain and forms cytosolic aggregates, though, after CB2 is switched in its active 
state these aggregates are adsorbed to the postsynaptic membrane (Figure 1.3 B) thereby, 
building the basis for the formation of gephyrin clusters underneath it (Figure 1.3 C).  
Because of the oligomerisation potentials of both terminal domains of gephyrin a hexagonal 
shape of the sub membraneous scaffold is hypothesized, that is formed in the area of the syn-
aptic specialisation and accumulates GABA receptors type A (GABAARs). With this organisa-
tion process a fast signal transduction can occur. Yet, no direct evidence for this mechanism in 
the in vivo systems has been detected so far. An indication for the proposed protein machinery 
Figure 1.3: Postulated three-protein two-step mechanism of GABAAR organisation in the post synaptic membrane 
of inhibitory synapses. (A) Cytosolic gephyrin-collybistin aggregates can interact with the C-terminal parts of a 
NL2 dimer via a specific gephyrin binding site and a poly proline sequence. (B) The interaction leads to an opening 
of CB2 and facilitates the adsorption of the aggregate to the plasma membrane via binding of the PH domain of 
CB2 to PtdInsPs. (C) Further gephyrin molecules adsorb to the anchored gephyrin-collybistin aggregate because of 
the high oligomerisation potential of gephyrin’s terminal G- and E-domains and thereby form a hexagonal scaffold 
which causes the accumulation of GABAARs at the synaptic specialisation. 
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and along with it the activation of collybistin via an interaction with NL2 was presented by 
POULOPOULOS et al. in co-expression experiments of all three proteins in COS7 cells.30 
 
 
The inhibition of neuronal signal trafficking is 
largely a result of γ-aminobutyric acid transmission. 
Its fast-inhibitory functions are mediated by activa-
tion of specific GABA receptors in the brain. The 
GABA-specific receptors are composed of a hetero-
pentameric stoichiometry of subunits (α1-6, β1-3, γ1-3, 
δ, ε1-3, π, θ)31 as shown in Figure 1.4 and belong to a 
ligand-gated ion channel superfamily, which as 
well includes nicotinic acetylcholine and glycine re-
ceptors.32,33 Correlating with their variety in subunit composition, these receptors exhibit dif-
ferent physiological and pharmacological properties, yet the most abundant ones at synapses 
consist of two α subunits, two β subunits and one γ subunit (cf. Figure 1.4). These types of 
GABARs referred to as GABAARs, are drug targets in clinical daily routine for anti-convulsant, 
anxiolytic and sedative-hypnotic agents. Furthermore, disease patterns like epilepsy34, Hun-
tington’s disease35, anxiety disorders36, schizophrenia37 and Autism spectrum disorders38 are 
provoked by deficits in the functional expression of them. 
After their formation in the endoplasmic reticulum and navigation through the secretory path-
way, GABAARs are inserted in the neuronal plasma membrane and can either access inhibitory 
postsynaptic specialisations or extra synaptic areas.32 Due to the large surface area of extrasyn-
aptic versus synaptic membrane the total number of extrasynaptic receptors is likely to be 
larger than that of synaptic ones.39 Thus, the accumulation mechanism of GABAARs in the ac-
tive areas of postsynaptic membranes is essential for fast synaptic transmission between neu-
rons, whilst a malfunction in this process can cause the aforementioned diseases. Therefore, 
the understanding of the organisation processes and their underlying molecular machinery 
has been in researchers’ focus within the last decades to identify possible treatment sites. 
GABAARs experience the omnipresent BROWNIAN motion in the form of lateral diffusion in 
plasma membranes,40 yet, the concerted spatial and temporary accumulation of the receptors 
Figure 1.4: Schematic image of the pentameric 
composition in a GABA-receptor. The receptor   
consists in variations of α1-6, β1-3, γ1-3, δ, ε1-3, π, and 
θ subunits. 
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cannot exclusively be obtained by this process.41 A further trapping of the receptors in the 
synaptic clusters is required, leading to an increase in this population due to reduced mobili-
ties, as most GABAARs are delivered to extra synaptic sites.42–44 Specialisation in excitatory post 
synapses form via receptor-associated proteins and cytoskeletal elements located in the 
PSD.15,45,46 In contrast to that, GABAAergic, inhibitory synapse formation is based on the tubulin 
binding protein gephyrin. It reduces the receptor diffusion velocity from high (10-1 -10-2 µm2s-
1), while moving between synaptic specialisations, to low (<10-3 µm2s-1) diffusion rates when 
interacting with scaffold aggregates.41 The interaction of GABAARs with gephyrin was also 
shown by in vivo experiments with gephyrin-deficient cortical neurons of mice by ESSRICH et 
al.47 However, this trapping mechanism for GABAARs is altered by collybistin and thus, must 
be composed of further components in addition to gephyrin.48  
 
 
For GABAARs organisation in postsynaptic specialisations, in direct apposition to presynaptic 
neurotransmitter release-sites, the interaction of cell adhesion molecules (CAMs) is among the 
earliest and most indispensable events of synaptogenesis to guarantee faithful information 
transmission across the synaptic cleft. CAMs are localized on both sides of the synapse and 
execute strong transsynaptical interactions which align pre- and postsynaptic specialisations 
even when biochemically copurified in the presence of detergents.13  
One brain-specific group of CAMs are neuroligins (NL) located at the postsynaptic site in neu-
rons.49,50 The group consists of four major members NL 1, 2, 3, and 4 which show great struc-
tural similarities and high homologies in their amino acid sequences as depicted in Figure 1.5 
A. 
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The structural similarities are based on the fact that each member has a single transmembrane 
region, that separates a highly conserved, extracellular esterase-like domain from a short in-
trinsically disordered cytoplasmic tail (cf. Figure 1.5 B).51–54 The different subtypes of NL are 
located each at unique membrane areas. While NL1 and NL2 are exclusively found at excita-
tory glutamatergic and inhibitory GABAergic synapses, respectively, NL3 is localised at both 
types of synapses.54,55 Nevertheless, the primary adhesion partner of neuroligins inside the 
presynaptic axon is the neurexin family with a vast number of splice variants.56 Furthermore, 
it has been shown that the primary species of NLs in the cell is a dimer and its formation is 
assumed to be a crucial step in NL trafficking.57,58 
At GABAergic synapses, NL2 was shown to recruit the scaffolding protein gephyrin via a spe-
cific binding motif in its C-terminus.55,59 Furthermore, the proline-rich area in the amino acid 
sequence of the cytosolic loop is a possible interaction site for the adaptor protein collybis-
tin.30,60 Based on these interactions, NL2 is believed to be the starting point of a two-step, three-
protein organisation machinery for GABAARs in postsynaptic specialisations during synapto-
genesis as presented in Figure 1.3.53 
  
Figure 1.5: (A) Alignment of amino acid sequences of NL1-4, where the sequences correspond to mouse NL1, rat 
NL2, and human NL3 and NL4.53 (B) Matrices representing the approximate percent identity of the different human 
neuroligin protein sequences separated by domains (extra- and intracellular).54 





The tubulin binding protein gephyrin is the most prominent scaffolding protein in inhibitory 
post synapses as it is crucial for the localisation of both glycine and GABA specific receptors 
at synaptic sites.47,61,62 Its interaction with the latter is based on binding to the 1-3 and 2-3 
subunits with lower affinities, however, it is not less important.63–67 Additional to its scaffold-
ing character, it also interacts with cell adhesion molecules, signalling molecules and motor 
protein complexes, all contributing during anchoring of GABAARs to synaptic specialisations 
of the neuronal membrane.68–70 Beyond its participation in receptor organisation gephyrin ca-
talyses the terminal steps of the molybdenum cofactor biosynthesis.71 Both gephyrin functions 
turned out to be essential as shown by FENG et al.72  
The protein itself is composed of a N-terminal G domain connected via a linker of ~150 amino 
acids to a C-terminal E domain.73 Several studies based on crystal structure analysis showed 
that the G domain is capable of trimerisation,74,75 while the E domain tends to form dimers.76,77 
This oligomerisation potential is essential for the synaptic clustering of gephyrin.78 Further-
more, successive publications postulated the formation of a so-called hexagonal lattice when 
all oligomerisation interfaces of both domains are utilised.79,80 Yet, structural analysis of holo-
gephyrin indicates a prevention of the E domain dimerisation in full-length gephyrin and sug-
gests different compact and extended states depending on the flexible linker region.81 SPECHT 
and co-workers used different single-molecule based imaging techniques to gain insights in 
the three-dimensional organisation of gephyrin and detected a two-dimensional lattice with 
different gephyrin densities in constant proximity to the neuronal membrane that can be ex-
plained with the aforementioned compact and extended linker region states.82 Notwithstand-
ing gephyrin’s spatial arrangement at synaptic sites, it was shown that the complexation of 
receptors with gephyrin per se is not sufficient for receptor cluster formation, as these com-
plexes were also detected in extrasynaptic membrane parts and cytosolic compartments.83,84 
Additional factors, influencing receptor clustering, were found by observation of trapped 
GABAARs at excitatory synapses and on the other hand trapped AMPA receptors at inhibitory 
synapses by RENNER et al.85 These hint at a higher complexity of the receptor organisation pro-
cess composed of further participants next to gephyrin like the aforementioned cytoskeleton 
and the adaptor protein collybistin, on which the following paragraph will focus on. 




The structure of collybistin (CB) consists of an N-terminal SH3 domain connected to a so-called 
tandem domain of a DH and a PH domain (cf. Figure 1.6), which classifies CB as a member of 
the Dbl protein-family. The DH-domain enables collybistin’s function as a guanine-nucleotide 
exchange factor (GEF) for small rat sarcoma homologue (Rho) GTPases. To be precise, CB reg-
ulates the small GTPase Cdc42 (cell division control protein 42 homologue) that is implicated 
in the control of the cytoskeleton and filopodia formation.86 As illustrated in Figure 1.6 there 
are three isoforms of collybistin, CB1-3, exhibiting high sequence homology except for differ-
ences in their C-termini. 
Furthermore, for CB2 a 
splice variant exists lack-
ing the N-terminal SH3 
domain (CB2-SH3).48 Figure 
1.6 schematically illus-
trates the structure of all 
collybistin isoforms. 
In its duty as a GEF, CB 
has a second small Rho 
GTPases, TC10, next to 
Cdc42 as a substrate. Both enzymes share 67.4 % of sequence identity and structural similari-
ties which are also represented in common cellular functions.87,88 Yet, in contrast to Cdc42, 
which is ubiquitously expressed in the brain, TC10 is located only in specific areas like the 
CA1 region of the hippocampus.89 Nevertheless, both GTPases are activated upon guanosine 
5´-triphosphate (GTP) binding and deactivated via its hydrolysis to guanosine 5´-diphosphate 
(GDP) in the presence of GTPase activating proteins (GAPs). Collybistin afterwards regener-
ates the enzymes’ activities by substitution of the nucleotides. Due to this function it was called 
collybistin from the ancient Greek word  for “exchange”.90 It is highly ex-
pressed throughout the brain and is specifically enriched in neuronal dendrites.91,92  
In 2000, KINS et al. first proved a connection between CB function and synaptic cluster for-
mation of gephyrin. They were able to detect two splice variants of collybistin (CB1 and CB2) 
Figure 1.6: Schematic illustration of the three splice variants of collybistin (CB1-
3) which vary in their C-termini only. All consist of a SH3 domain connected to a 
tandem domain made up from DH and PH domain except for a splice variant of 
CB2 that lacks the N-terminal SH3 domain. 
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and showed that the longer transcript variant CB1 co-expressed with gephyrin caused cyto-
solic aggregate formation in non-neuronal cells. In case of the shorter variant CB2 co-expres-
sion led to CB-gephyrin cluster formation underneath the plasma membrane.90 These results 
built the base for the assumption that collybistin functions as a molecular switch and is rele-
vant for neuronal receptor accumulation at inhibitory synaptic specialisations by regulating 
gephyrin clustering. This characteristic results from an intramolecular interaction between the 
N-terminal SH3 and the C-terminal PH domain that blocks the relevant binding sites necessary 
for fixation of CB to the plasma membrane via specific receptor lipids.60 In case of CB these 
receptor lipids are the phosphorylated metabolic products of phosphatidylinositol (PI), the 
so-called phosphatidylinositol phosphates or phosphoinositides (PtdInsPs).93 Additional stud-
ies determined that CB2-SH3 displays the strongest binding to PtdIns(3)P in a PH domain-de-
pendent manner, while the longer splice variant CB2SH3 expresses no specific preference for a 
particular phosphoinositide and lower affinities.60,94 The binding site for PtdInsPs is positioned 
in the loop between the 3- and 4-sheets of the PH-domain that is composed of seven anti-
parallel -sheets in total.93,95,96 Via its interaction with the different PtdInsPs, that are widely 
distributed in the cell,97 CB can be specifically localised in different cellular compartments. 
Even though, the potential activation of CB has been outlined, the exact interaction sites stay 
enigmatic and proof for the precise mechanism is missing. To focus this uncertainty in such a 
detail necessary for clarification a simplification or a model for the topic in question is reason-
able. This can be done by a transfer into in vitro systems in which control of all relevant pa-
rameters is possible. A widely distributed tool are model membrane systems that are used to 
broaden the understanding of processes occurring in or at the plasma membrane. Therefore, 
chapter 1.4 will deal with these specific in vitro systems in detail.  
 
 
The examination of processes and interaction in vivo has the advantage to present the object of 
study in its natural environment. However, in many cases investigations of protein-lipid or 
protein-protein interactions in their original environment and conditions are inappropriate for 
determinations of specific features or characterisations of these processes. This is based on 
difficulties like low abundance, high turnover or the molecular complexity of in vivo systems.98 
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Therefore, a plethora of studies focussing on a precise process or interaction have been per-
formed in in vitro systems. They are usually composed step-by-step in a bottom-up approach 
which allows the control of all parameters and constituents resulting in the exact determina-
tion of characteristics underlying the respective research object. It is e.g. possible to extract 
natural lipids and built up a membrane by mixing chemically defined lipid species. This leads 
to a complete control of the membrane composition. There is a wide range of model membrane 
systems available differing in their features. Some of these are schematically illustrated in Fig-
ure 1.7.  
The choice can be made between vesicles of different sizes and lamellarity,99 adhered or freely 
floating, and lipid nanodiscs.100 Furthermore, black lipid membranes, pore-spanning mem-
branes, tethered double bilayers, solid-supported bilayers, solid-supported monolayers or pol-
ymer-cushion tethered bilayers are possible option for a model system of the plasma mem-
brane.101–103 Hence, the choice depends on the properties required for experimentation. Poly-
mer-cushion tethered layers e.g. were used by TAMM and colleagues to perform reconstitution 
experiments with SNARE-proteins.104 However in most cases the model system of choice is the 
solid-supported lipid bilayer (SLB) due to its simple preparation via spontaneous spreading 
of small unilamellar vesicles (SUVs) on hydrophilic surfaces.105,106 This type of model mem-
Figure 1.7: Schematically illustrations of various model membrane systems (a unilamellar vesicle, a lipid nanodisc, 
a black lipid membrane and diverse forms of solid-supported membrane systems)100-102 that are arranged in an orbit 
around a scheme of the cellular plasma membrane modified from SEZGIN et al.103 
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brane system allows the use of surface sensitive methods to characterise interactions and pro-
cesses mentioned before in a label-free and time-resolved manner.107,108 Therefore, the solid-
supported lipid membrane represented by either the standard lipid bilayer or a hybrid lipid 
membrane on top of a hydrophobically functionalised substrate will represent the basis for the 
experimental work of this study. 
  








The mammalian nervous system is composed of a plethora of neuronal cells which communi-
cate via electrical or chemical synapses to guarantee proper signal transduction. In case of the 
second synapse type a differentiation between excitatory and inhibitory characteristics is fea-
sible, depending on the induced post synaptic potential that either forwards information or 
stops its transduction. While excitatory synapses have been investigated rigorously at the mo-
lecular and cell biological level, similar characterisation is missing for inhibitory synapses re-
lying on γ-amino butyric acid (GABA) which is a neurotransmitter prevalently used in the 
brain. This is owed to their challenging isolation and sparse character. 
Therefore, this work aims on the preparation of an in vitro model system for the organisation 
machinery of specific GABA receptors in the postsynaptic plasma membrane. The organisa-
tion complex is assumed to consist of the cell adhesion protein neuroligin 2 (NL2), the scaf-
folding protein gephyrin and the adaptor protein (CB2). The latter is capable to interact with 
phosphoinositides (PtdInsPs) present in the postsynaptic membrane. For this reason, a bot-
tom-up approach based on two different membrane systems, supported by silicon dioxide 
substrates with either hydrophilic or hydrophobic surface features, will be applied to charac-
terise the anchoring CB2-PtdInsP interaction. Moreover, the impact of the phosphorylation 
pattern of PtdInsP will be examined by deploying three exemplary variants (PtdIns[3]P, PtdIns 
[4,5]P2 and PtdIns[3,4,5]P3). The preparation of solid-supported lipid bilayers (SLBs) and solid-
supported hybrid membranes (SHMs) will facilitate their comparison and thus, examination 
of the support’s impact on the receptor lipid distribution and other membrane features. 
The investigation of CB2 adsorption to the PtdInsP containing model membranes by means of 
reflectometric interference spectroscopy (RIfS) and atomic force microscopy (AFM) will give 
insights in the adsorption behaviour of the adaptor protein and its organisation when attached 
to a membrane. 
After detailed characterisation of the protein-lipid interaction, the model system will be ex-
panded by an additional receptor lipid specific for a protein construct that mimics the intra-
cellular domain of NL2. When the expansion does not impede the established model, the 
NL2—CB2 interaction will be investigated in order to elucidate if this interaction induces a 
intramolecular cleavage in CB2 that renders the protein active.  











In this thesis artificial membrane systems were used to mimic the plasma membrane. The 
model membranes were composed of varying lipid mixtures to investigate their impact on the 
proteins involved in post synaptic GABAA receptor organisation. All mixtures were composed 




The matrix lipid represents the mayor part of all lipid compositions but should not have a 
significant interaction with the attached proteins. Dependent on the used technique and the 
physical properties required for the experimental setup, two different phospholipids were uti-
lised as matrix lipids in this work. On one hand, 1-palmitoyl-2-oleoyl-sn-glycero-phosphocho-
line (POPC) was used when fluid characteristic at room temperature were inevitable as it is 
the case for in situ membrane formation during reflectometric interference spectroscopy (RIfS, 
cf. Chapter 3.5). Alternatively, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), which is 
in the gel phase at room temperature, was employed to simplify protein imaging via atomic 
force microscopy because of reduced lateral motion inside the more rigid system. These lipids 
show different main transition temperatures TM (POPC: TM = -3 °C; DPPC: TM = 41 °C)109,110 due 
to variations in their fatty acid chains attached to their glycerol backbone with POPC having 
Scheme 3.1: Structures of the matrix lipids 1-palmitoyl-2-oleoyl-sn-glycero-phosphocholine (POPC) and 1,2-dipal-
mitoyl-sn-glycero-3-phosphocholine (DPPC) with their molecular formulas, molecular weights and main transition 
temperature. 
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a palmitic acid (16:0) esterified on position 1 and an oleic acid (18:1 Δ9-cis) on position 2 
whereas DPPC only carries two palmitic acid chains on both positions (cf. Scheme 3.1). None-
theless, both express a high structural similarity and provide no charge as glycerol is substi-
tuted with a phosphocholine headgroup at position 3. 
 
 
The artificial membrane systems contained in addition to the matrix lipids specific lipids 
which enabled an adsorption of the investigated proteins to the lipid layers. These lipids that 
are intended to affect the tested proteins are referred to as receptor lipids. While one class of 
them has been shown to be relevant physiological interaction partners inside the plasma mem-
brane for collybistin and N-ERMAD, the second class employed are synthetic lipids that were 
used for the fixation of the protein construct mimicking the intracellular domain of neuroligin. 
 
Phosphoinositides (PtdInsP) are the phosphorylated products of phosphoinositol (PI). They 
are generated by reversible phosphorylation of the inositol ring at positions 3, 4 and 5 yielding 
seven different phosphoinositides that are either mono-, bis- or tris-phosphorylated. In 
Scheme 3.2 the three phosphoinositides are shown which were employed in this work. While 
L-α-phosphatidylinositol-4,5-bisphosphate (PtdIns[4,5]P2) is the most abundant representative 
of this lipid group with 1 mol% of all phospholipids inside human erythrocytes,111,112 the mono-
phosphorylated PtdIns[3]P has been shown to express the highest binding affinity to collybis-
tin.113 To evaluate the influence of the degree of phosphorylation also the lipid PtdIns[3,4,5]P3 
was employed. All three share the characteristic of two palmitic acid chains that are esterified 
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at positions 1 and 2 of their glycerol backbone. Due to the phosphate groups of the inositol 
headgroup all PtdInsPs are negatively charged. 
 
In contrast to the aforementioned phosphoinositides with physiological relevance the second 
receptor lipid used is the synthetic 1,2-dioleoyl-sn-glycero-3-{[N-(5-amino-1-carboxypen-
tyl)iminodiacetic acid]succinyl} nickel salt (DGS). As shown in Scheme 3.3 it consists of two 
oleic acids (18:1 Δ9-cis) that are esterified to the central glycerol at position 1 and 2. Addition-
ally, nitrilotriacetic acid (NTA) is esterified via a linker to position 3 of the glycerol. 
The NTA headgroup is a tetra dental ligand and can coordinate cations in an octahedral fash-
ion leaving two coordination sites vacant. Therefore, further coordination of other ligands 
Scheme 3.2: Structural framework of the phosphoinositides PtdIns[3]P, PtdIns[4,5]P2 and PtdIns[3,4,5]P3 with their 
molecular formulas and weights.  
Scheme 3.3: Structures of the synthetic lipid 1,2-dioleoyl-sn-glycero-3-{N-5-amino-1-carboxypentyl)iminodiacetic 
acid]succinyl] nickel salt with its molecular formula and weight. 
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such as histidine-residues is possible and enables adsorption of proteins carrying a poly-histi-
dine tag.  
 
 
Fluorescent microscopy was used in this work to determine the quality of the artificial mem-
brane systems and to investigate the lateral mobility of the lipids therein. To do so different 
lipid coupled dyes were introduced in small amounts into the lipid compositions. 
 
The fluorophore Texas Red® (TxR) was used in this work to determine the homogeneity of the 
model lipid layers and to check for defect formation. For this reason, the fluorescent molecule 
TxR coupled to 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine (TxR-DHPE, cf. 
Scheme 3.4) was employed for detection. The excitation wavelength of this dye is λex = 561 nm 
and the emitted light was detected in a range of 585-630 nm. 
 
Furthermore, labelled receptor lipids are an interesting tool to investigate the lipid’s behaviour 
inside the model membrane under varying conditions. Therefore, all three phosphoinositides 
tested in this work were purchased with a fluorescent dye, BODIPY®-TMR, coupled to one of 
Scheme 3.4: Structure of the fluorescent probe TxR-DHPE with its molecular formula and weight. 
Scheme 3.5: Structure of BODIPY®-TMR PtdIns[4,5]P2 with its molecular formula and weight as an example for 
fluorescently labelled phosphoinositides. The dye is coupled to the fatty acid chain of the lipid molecule. 
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the fatty acid chains as exemplary shown in Scheme 3.5 for PtdIns[4,5]P2. While in position 1 
of the glycerol the palmitic acid is substituted by a caproic acid, in position 2 the fluorophore 
BODIPY®-TMR is esterified via a linker to the lipid. In analogy to this, labelled version of the 
mono- and tris-phosphorylated phosphoinositides were also employed in this work. 
 
 
In this work solid-supported model membrane systems were prepared on top of a silicon base. 
The silicon wafers used for this purpose were purchased from Silicon Materials Inc. (Glenshow, 
USA) and exhibited SiO2 layers with thickness of 100 nm or 5 µm on their surfaces. While the 
substrates with a thinner layer were applied for experimentation with atomic force microscopy 
(AFM) and fluorescence microscopy, the 5 µm layer of SiO2 was a prerequisite for the applica-
tion of RIfS (cf. Chapter 3.5). Furthermore, the Si-SiO2 substrate’s surface features can be ma-
nipulated via functionalisation which facilitates the employment of model membrane systems 
supported by either a hydrophilic or a hydrophobic base. 
 
 
The study of protein characteristics and their interaction with other partners such as lipids or 
other proteins consumes a high amount of resources in the sense of the proteins themselves. 
Therefore, a method of recombinant protein expression based on the application of bacteria is 
widely spread. In doing so Escherichia coli (E. coli) is the most frequently used prokaryotic ex-
pression system as it exhibits fast growth rates and a well-functioning protein biosynthesis.114 
Furthermore, E. coli is available in various mutated strains and can be combined with a pleth-
ora of cloning vectors.115 Nonetheless, there are also disadvantages like the formation of inclu-
sion bodies and the lack of post-translational modifications.116 However, all proteins investi-
gated within this thesis were expressed in E. coli, to be precise in the cells of the BL21(DE3) 
strain that contains the T7-RNA-polymerase promotor system. 
 
 
Under physiological conditions bacterial cells can take genetic material up with low efficien-
cies. Therefore, it is necessary to temporary enhance this process by increasing the permeabil-
ity of the cellular membrane for exogeneous uptake. For gram-negative bacteria such as E. coli 
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this can be achieved by electroporation or the use competent cells. For the later different meth-
ods of preparation are known of which the cell treatment with calcium chloride is the most 
prominent one. For the preparation of competent cells different E. coli strains can be used. This 
section will focus on the process with cell from the DH5α strain that are preferably employed 
for plasmid copying due to their high transformation efficiency.117  
First DH5α cells of a former preparation were placed on a LB (lysogeny broth) agar plate (for 
composition cf. Table 3.3) without any antibiotics contained and incubated at 37 °C in an in-
cubator hood (Edmund Bühler GmbH, Bodelshausen, Germany) overnight. Then a single col-
ony from the plate was selected and used for inoculation of an overnight culture (25 mL LB 
medium, cf. Table 3.3) which was subsequently incubated at 37 °C and 185 rpm overnight. 
1 mL of this culture was used on the next day to inoculate the main culture (100 mL LB me-
dium) that grew at 37 °C and 185 rpm till an optical density OD600 of 0.4 was reached. Growth 
was stopped by placing the culture on ice. Afterwards the cell suspension was centrifuged 
(2700 x g, 10 min, 4 °C), the resulting pellet was resuspended in 1.6 mL of CaCl2 solution (100 
mM) and stored on ice for 30 min. This process was repeated a second time and thereafter 
0.5 mL of glycerol were added to the cell suspension in CaCl2-solution followed by fractiona-




All plasmids (cf. Table 3.1) utilised within this work were reproduced in the DH5α cell system 
prior to transformation into the recombinant expression system.  
Table 3.1: Overview of the employed vectors with their affinity tags, cleavage sites and antibiotic resistance. 
Vector DNA-Sequence Affinity tag Cleavage site Resistance 
pET28a+ N-ERMAD His6 Thrombin 
Kanamycin, 
Chloramphenicol 










Intein (DTT induced) Ampicillin 
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The plasmids encoding collybistin and neuroligin were kindly provide by the group of Her-
mann Schindelin (Rudolph-Virchow-Zentrum, Würzburg, Germany). To achieve sufficient 
protein yields different E. coli strains were used that matched with the specific vectors (cf. 
Table 3.2) as some proteins show cell-toxic effects at critical concentrations.118,119  
Table 3.2: Overview of the different E. coli strains used for protein expression with their genotypes and distributors. 
Strain Genotype Expressed proteins Distributor 






BL21(DE3) pLysS F- ompT hsdSB(rB–mB–) gal dcm 
(DE3) pLysS (CamR) 
N-ERMAD Invitrogen 
BL21(DE3) Rosetta F- ompT hsdSB(rB- mB-) gal dcm 




A solution of plasmid in ultrapure H2O (5 µL) was added to an aliquot of competent cells 
(50 µL) on ice and incubated for at least 30 min. After this duration the cell solution was placed 
for 45 s in a 42 °C water bath to induce exogeneous uptake via heat shock. Subsequently the 
solution was again stored on ice for 4 min and then 250 µL of SOC medium (super optimal broth 
with catabolite repression, for composition cf. Table 3.3) were added. For fast cell growth the 
culture was incubated at 37 °C and 150 rpm for one hour. Afterwards the cells were distributed 
on LB-agar plates, containing the specific antibiotic to guarantee selective growth of only suc-
cessfully transformed bacterial cells, which were then incubated at 37 °C overnight. 
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Table 3.3: Composition of the nutrient solutions used for plasmid reproduction and protein expression. 
LB medium 
pH 7.0 or pH 
7.4 
1.0 %(w/v) tryptone 
1.0 %(w/v) NaCl 




pH 7.0 or pH 
7.4 
1.0 %(w/v) tryptone 
1.0 %(w/v) NaCl 
0.5 %(w/v) yeast extract 
1.5 %(w/v) Agar-agar 
SOC medium 
pH 7.0 
2.0 %(w/v) tryptone 
0.5 %(w/v) yeast extract 
10 mM NaCl 
2.5 mM KCl 
10 mM MgCl2 
10 mM MgSO4 
20 mM glucose 
 
 
The isolation of the plasmid DNA was essential to guarantee a sufficient stock as protein ex-
pression was only conducted with freshly transformed E. coli cells. The vector isolation was 
performed using a Nucleobond® Xtra Midi EF-Kit (Macherey-Nagel, Düren, Germany).120 A sin-
gle successfully transformed colony (as describe in Chapter 3.2.2) was picked from a LB-agar 
plate and used for inoculation of 100 mL LB medium at 37 °C and 185 rpm overnight. The cell 
suspension was then centrifuged (4500 rpm, 20 min, 4 °C) and the obtained pellet was resus-
pended in 8 mL RES-EF buffer which included RNase A. Further addition of 8 mL LYS-EF 
buffer induced the alkaline lysis of the cell that was followed by incubation at room tempera-
ture for 5 min. Meanwhile, a silica-based anion-exchange chromatography column was equil-
ibrated by rinsing with 15 mL EQU-EF buffer. The lysate was then diluted with 8 mL NEU-EF 
buffer to neutralise the solutions pH and incubated for 5 min on ice. The separation of cell 
debris and lysate was achieved by centrifugation (4500 rpm, 10 min, 20 °C). The later was ap-
plied to the equilibrated column which was subsequently washed with 5 mL FIL-EF buffer, 
35 mL ENDO-EF buffer and 15 mL WASH-EF buffer. After all impurities were removed the 
vector DNA was eluted with 5 mL ELU-EF buffer. A last purification step was performed by 
addition of 3.5 mL isopropyl alcohol to the plasmid solution and a further centrifugation 
(4500 rpm, 45 min, 4 °C). The resulting pellet was dissolved in endotoxin-free ethanol and 
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again centrifuged (13000 rpm, 5 min, 20 °C). After solvent removal the plasmid was solved in 
1.2 mL ultrapure water, divided in aliquots, frozen in liquid N2 and stored at -20 °C until fur-
ther use. All buffer solution mentioned in this Chapter were ingredients of the initially men-
tioned isolation kit which included no information on the buffers’ compositions. 
 
 
All plasmids were sequenced directly after their purification to avoid the use of any false DNA 
sequence that would impede the whole protein expression process. The sequencing of the vec-
tor DNA was implemented by the company SeqLab, Inc. (Göttingen, Germany). The primers 
(predominantly T7 promoter and T7 terminator, cf. Table 3.4) were directly provided by the 
sequencing company. 
Table 3.4: Primers used for plasmid sequencing. 
Name Sequence 
T7 promotor primer 5-TAATACGACTCACTATAGGG-3 
T7 terminator primer 5-GCTAGTTATTGCTCAGCGG-3 
 
 
As mentioned in Chapter 3.2.2 it is necessary to consider the combination of host system and 
vector when planning a heterologous protein expression because some proteins are toxic to 
the bacterial cells when expressed in higher concentrations. Therefore, the aim is to reduce 
basal expression to a minimum which was achieved by employment of E. coli strains contain-
ing the lysogen λDE3. This gen originates from bacteriophage T7 and encodes the T7-RNA 
polymerase which solely is capable of binding to the T7-promoter sequence of the vectors 
used, thus, transcribing the gen of the target proteins. Though, the expression of the T7 enzyme 
is initially inhibited by binding of the lac1-repressor to the lac-operon during growing period 
of the host system. Furthermore, the repressor binds to the lac-operon of the vector sequence 
hindering a transcription of the target protein’s DNA. This fact ensures no expression of target 
protein even in the presence of slight amounts of basal T7-RNA polymerase. 
With the addition of isopropyl-β-D-thiogalactopyranoside (IPTG), which is a molecular mimic 
of the lactose metabolite allolactose and binds to the lac1-repressor, interaction of the later with 
the lac-operon is cleaved and expression of the T7-RNA polymerase is induced. Additionally, 
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the expression of the target protein starts because of the accessibility of T7-promoter for the 
RNA polymerase.  
 
Experimental procedure 
At the beginning of every protein expression a fresh transformation (cf. Chapter 3.2.2) of the 
vector (cf. Table 3.1) in the appropriate E. coli strain as stated in Table 3.2 was performed. In 
the process the specific antibiotic (cf. see Table 3.5) was added to the LB-agar solution prior to 
plate preparation to guarantee selective cell growth. 
Table 3.5: Proteins with their corresponding antibiotic for selective growth including final concentrations. 
Protein N-ERMAD His-cytNL2 CB isoforms 
cAntibiotic per mL 
LB medium 
60 µg kanamycin 
34 µg chloramphenicol 
50 µg kanamycin 100 µg ampicillin 
A single culture from the LB agar plate was picked and used for inoculation of 50 mL LB me-
dium (incl. the appropriate antibiotics, cf. Table 3.5) at 37 °C and 185 rpm overnight. From this 
overnight culture a glycerol-stock was taken consisting of a 1:1 mixture of culture and glycerol 
(95 %). This stock was frozen in liquid N2 and stored as backup at –80 °C. 
For the main culture the overnight culture was diluted with antibiotic containing LB medium 
in a ratio of 1:50 to result in total volume of 250 mL. In doing so, it had to be considered that 
for N-ERMAD expression only kanamycin was added to the main culture. After inoculation 
the main culture was placed in an Innova® 44 orbital shaker (New Brunswick Scientific, Enfield, 
USA) at 37 °C and 185 rpm and growth of the E. coli cells was controlled via OD600 measure-
ments. While for His-cytNL2 and all CB2 isoforms cultivation took place until an OD600 of 0.8 
to 1.0 was reached, growth of cells transformed with pET28a+ (N-ERMAD) was already 
stopped at an OD600 of 0.5 to 0.6. The cultivation of cells was brought to a standstill via addition 
of IPTG (1 mM for N-ERMAD and 0.5 mM for His-cytNL2 and all CB2 isoforms) which induced 
the heterologous expression of the target proteins. For sufficient expression of the target pro-
teins different conditions that are described in Table 3.6 were required. 
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Table 3.6: Working conditions for expression of the target proteins 
Protein N-ERMAD His-cytNL2 CB isoforms 
Time (t) / h 4 ≥15 ≥15 
Temperature (T) / °C 37 4 4 
Panning / rpm 175 200 185 
 
After expression, the main culture was place on ice for 10 min to stop the expression machin-
ery, then was poured in sterile centrifuge tubes and the cells were harvested via centrifugation 
at 4 °C and 4000 rpm for 20 min. The obtain cell pellets were either directly used for cell lysis 
as described in the following Chapter or stored at -20 °C until use. 
 
 
The protein expression is performed within the cells, therefore it is necessary to overcome the 
plasma membrane which functions as a barrier. There are different approaches to break down 
the membrane which can be allocated to two subclasses, the mechanical and non-mechanical 
lysis techniques. Ultrasonic treatment and the use of high-pressure homogenisers among other 
belong to the first class. While the cells bump against each other and open during exposition 
to ultrasonic, the lysis in a high-pressure homogeniser relies upon strong shear forces by 
pumping the cell suspension under high pressure (up to 1.5 kbar) through capillary tubes of 
defined geometry. In contrast to that non-mechanical lysis methods are based on destabilisa-
tion of the cellular membrane by the utilisation of lysis agents like lysozymes and ethylenedi-
aminetetraacetic acid (EDTA). 
 
Experimental procedure 
The freshly harvested pellet or one stored at -20 °C was resuspended in lysis buffer (with spe-
cific compositions for the target proteins, cf. Table 3.7) and 80 mg of DNaseI (in DNaseI buffer, 
cf. Table 3.7) added in case of all collybistin isoforms. For those and the resuspensions of His-
cytNL2 containing cells a high homogeneity of the suspensions without any bigger pellet res-
idues was achieved by stirring for 1 h at 4 °C. These suspensions were afterwards lysed under 
high pressure in a homogeniser LM10 processor (Microfluidics, Westwood, USA). For lysis the 
suspensions were treated in three consecutive cycles at either 1 kbar or 1.5 kbar for collybistin 
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or His-cytNL2, respectively. In contrast to that cells containing N-ERMAD were lysed via five 
cycles of 30 s tip sonification pulses (Sonopuls, Bandelin electronic GmbH&Co. KG, Berlin; 60 % 
power) followed by 15 s resting phases on ice. All lysates then were clarified by centrifugation 
(100,000 × g, 45 min to 1 h, 4 °C) and afterwards applied to French press columns containing 
specific resins to which each target protein expressed high affinity enabling the purification of 
the target proteins. This process is described in detail in the following section. 




300 mM NaCl 
40 mM HEPES 
20 mM imidazole 
1 mM EDTA 





500 mM NaCl 
100 mM HEPES 
10 %(w/v) glycerol 
*5 mM β-mercaptoethanol 
*6 mM benzamidine 





250 mM NaCl 
20 mM TRIS 
10 %(w/v) glycerol 




20 mM TRIS 
50 %(w/v) glycerol 
1 mM MgCl2 
* addition of reagents directly prior to use 
 
 
The aim of protein purification processes is to obtain solely the target protein in solution to 
ensure experimentation on it without distortions by any contaminations. There is a great vari-
ety of fractioning techniques available that exploit the physical and chemical characteristics 
(charge, polarity, size, and specific affinity) of the desired protein to stepwise separate it from 
other substances like basal proteins present in the cell lysate. These separation methods are 
referred to as chromatography and are classified by the type of interaction with the protein 
and the employed stationary phase. 
 




This type of chromatography employs the capability of some protein parts to bind non-cova-
lently, yet specifically to ligand molecules that are coupled to a chromatography matrix in a 
reversible fashion. After adequate washing steps to erase contaminations that are not strongly 
attached to the chromatography column, the target protein can be eluted from the stationary 
phase by changing the buffer conditions e.g. via pH variation or addition of a competitive 
reagent. 
In the cases of N-ERMAD and His-cytNL2 a special variant of affinity chromatography, the 
immobilized metal ion affinity chromatography (IMAC) was applied for purification as both 
proteins exhibit an N-terminal fused hexa-histidine tag (His6 tag). This fusion tag is able to 
interact with divalent cations, especially Ni2+, and thereby can 
bind to a ligand in which this cation is chelated by NTA. These 
interaction partners build up a complex with an octahedral 
structure in which to binding sites are either occupied by water 
molecules or histidine residues of the fusion tag as shown in 
Figure 3.1. The association of the His is achieved via its free 
electron pair and can be disrupted by introducing imidazole to 
the system which expresses a high affinity to Ni2+. The isolation 
of the His6-tagged proteins is conducted with NTA(Ni2+)-
coupled agarose (Protino®, Macherey-Nagel, Düren, Germany) 
with a capacity of around 50 mg/mL. 
It has already been mentioned that the genes encoding the target proteins of this work were 
cloned into vector DNA which was well suited to the expression systems. In case of the colly-
bistin isoforms the used vectors also encoded an Intein tag which was fused either N- or C-
terminally for the pTXB1 or pTYB21 vector, respectively. This tag consists of a so-called Chitin 
binding domain (CBD) and can be used to adsorb the protein to a chitin resin (New England 
BioLabs Inc., Ipswich, USA). The resin used for all collybistin isolations exhibited a capacity of 
2 mg/mL. After adsorption as illustrated in Figure 3.2 an intramolecular N,S-acyl shift in the 
linker region between target protein and Intein tag takes place.121 This facilitates thiolysis of 
the target protein from the tag when a thiol is introduced to the system. While the Intein tag 
Figure 3.1: Schematic illustration of  
the interaction between the target 
protein containing a His6-tag and 
the NTA(Ni2+) functional group of 
an agarose matrix utilised in 
IMAC. 
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remains at the chitin matrix, the protein carries a 
thioester moiety which is directly hydrolysed to a 
carboxylic acid under aqueous conditions. Subse-
quently, the desired collybistin can be eluted.122 
 
Experimental procedure 
For the isolation of the target proteins from the 
lysates, each French press column was loaded 
with the specific resin. Thereby, the column vol-
ume (CV) depended on the capacity of the matrix 
material, its capacity and of course on the sched-
uled quantity. The resin was washed with lysis- 
(cf. Table 3.7) or equilibration buffer (10 CV, cf. 
Table 3.8) prior to loading with the clarified lysate 
(cf. Chapter 3.2.6). The matrix-lysate suspension 
was then incubated under constant swivelling for 
1 h at 4 °C. Subsequent, the column was placed in a vertical position and after the descent of 
the matrix particles the supernatant liquid (flow through, FT) was collected for posterior anal-
ysis. This was followed by a varying quantity of washing steps with wash buffers (15-20 CV) 
of specific compositions (cf. Table 3.8) which all were collected as washing fractions (WF). 
While CB2 isoforms were not eluted before the chitin resin was incubated in the second wash-
ing buffer (50 mM dithiothreitol, DTT) for on-column cleavage for at least 24 h at 4 °C the elu-
tion of both N-ERMAD and His-cytNL2 was conducted immediately after the washing steps. 
For protein elution buffers (10-15 CV) with compositions stated in detail in Table 3.8 were 
used. The eluted protein was finally collected in fractions (elution fractions, E) of either 1.5 mL 
or 10 mL volumes for N-ERMAD or His-cytNL2 and CB2, respectively. Storage of the proteins 
in elution buffer at 4 °C was possible for a duration of ca. three month. The success of this 
purification step was controlled by SDS-PAGE which is described in detail in Chapter 3.2.8. 
Though, the conditions of the elution buffers were incompatible with the prerequisites of fur-
ther experimentation. Therefore, a change of the buffer system prior to adsorption studies was 
Figure 3.2: Schematic illustration of the protein pu-
rification via a CBD carrying Intein-tag that is either 
C- or N-terminal fused to the target protein. 
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necessary in all cases. This was achieved either via dialysis or spin concentration as described 
in Chapter 3.2.10. 





300 mM NaCl 
40 mM HEPES 





250 mM Imidazol 
50 mM KCl 
20 mM Tris 
 
Wash buffer I 
N-ERMAD 
pH 7.4 
300 mM NaCl 
40 mM HEPES 
30 mM imidazole 
1 mM MgCl2 
*10 mM β-mercaptoethanol 
Wash buffer II 
N-ERMAD 
pH 7.4 
300 mM NaCl 
40 mM HEPES 
40 mM imidazole 
1 mM MgCl2 





500 mM NaCl 
100 mM HEPES 
10 %(w/v) glycerol 




250 mM NaCl 
250 mM imidazole 
50 mM HEPES 
*5 mM β-mercaptoethanol 
 
Wash buffer I 
CB2 
pH 8.0 
1 M NaCl 
20 mM HEPES 
2 mM EDTA 
Wash buffer II 
CB2 
pH 8.0 
250 mM NaCl 
*50 mM DTT 
20 mM HEPES 




250 mM NaCl 
*5 mM DTT 
20 mM HEPES 
2 mM EDTA 
 
  
* addition of reagents immediately before use 
 




The ion exchange chromatography (IEC) is divided into two classes either anion- or cation-
exchange chromatography based on the stationary phase utilised for immobilisation of 
charged molecules. While cation-exchange columns bind positively charge particles, the an-
ion-exchange is used for immobilisation of negatively charged ions. The binding capability of 
proteins depends on their net charge which in turn is influenced by the pH. Furthermore, the 
presence of other ions has an impact on the proteins’ binding affinities as they compete for 
binding sites of the ion exchanger. Therefore, the choice for the suitable stationary phase de-
pends on the isoelectric point (pI, is the pH at which a molecule exhibits no net charge) of the 
target protein. As the amino acids that make up proteins are zwitterionic containing both pos-
itively and negatively charged residues each protein has a specific pI. In general, a good esti-
mation is to use buffer conditions with pH values either at least 1 higher than the pI of the 
target protein or 1 lower than the specific pI when working with anion- or cation-exchangers, 
respectively. 
After the affinity chromatography of His-cytNL2, contaminations were still detected via SDS-
PAGE. Therefore, a subsequent anion-exchange chromatography was performed, although 
His-cytNL2 exhibits a relative neutral pI of 7.31. For this purpose, a Mono Q 5/50 GL column 
(GE Healthcare, Uppsala, Sweden) was used in combination with a ÄKTA purifier 10 system 
(GE Healthcare, Uppsala, Sweden). The stationary phase of the column consists of mono-dis-
perse, porous beads out of styrene-divinylbenzene copolymer carrying quaternary ammo-
nium ligands. The elution of the protein was achieved by a gradual increase of ion strength 
(cNaCl) within the mobile phase. 
 
Experimental procedure 
All solutions (cf. Table 3.9) were filtrated and degassed before being applied to the ÄKTA 
system. The column was rinsed with buffer A (5 CV), buffer B (5 CV) and again buffer A (5 CV) 
to guarantee the absence of potential contaminations caused by previous use. Afterwards the 
column was rinsed with a buffer mixture of A : B (97.5 : 2.5) matching the ionic strength of the 
His-cytNL2 solution which was first dialysed to pre-ÄKTA buffer (cf. Table 3.9), then diluted 
in a 1:1 ratio with ultrapure water and after that applied to the column at a flow velocity of 
2 mL/min. While the protein solution was loaded to the anion-exchanger the flow through was 
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collected to ensure no protein loss. The column was washed with aforementioned buffer ratio 
(2 CV) to get rid of weakly bound molecules. The purification of the protein was then con-
ducted via a linear gradient of buffer B (starting from 50 mM to 2 M NaCl) over a duration of 
25 CV with a flow velocity of 3 mL/min. The process of elution was controlled by UV/VIS ad-
sorption (λ = 280 nm) and conductivity detection. During elution fractions of 1 mL volume 
were collected by a sampler. Fractions that showed activity in the UV/VIS spectrum together 
with those collected during the loading and washing process were subsequently analysed by 
SDS-PAGE as described in the following paragraph. 




20 mM HEPES 
1 mM EDTA 




2 M NaCl 
25 mM HEPES 
1 mM EDTA 





50 mM NaCl 
25 mM HEPES 




The success of an isolation was determined by sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) which relies upon the movement of charged particles within an 
electric field and is well suited for molecular weight determination. The detergent sodium 
dodecyl sulfate (SDS) interacts with the non-polar parts of proteins via its hydrophobic resi-
dues, not only supporting the denaturing process but also inducing a linearization and intro-
ducing an anionic surplus charge to the proteins. By the latter effect SDS covers the intrinsic 
charge of the proteins and enables the separation based only on their mass as it guarantees a 
constant mass-to-charge ratio.123 Yet, SDS alone is not sufficient for complete denaturing of the 
proteins, therefore, all protein samples were diluted with sample buffer containing dithio-
threitol (DTT) which is a reducing agent and dissolves intramolecular disulfide bridges within 
proteins. 
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The separation during electrophoresis is carried out in porous polyacrylamide gels that consist 
of a stacking and a resolving gel. This differentiation is the reason why this method is also 
referred to as a discontinuous PAGE. The pore size differs between stacking and resolving gel 
due to varying ratios of acrylamide monomers (AA) to cross-linking N,N´-meth-
ylenebisacrylamide (Bis-AA) and has next to the constant mass-to-charge ratio the biggest in-
fluence on protein separation. The separation itself occurs in the close meshed resolving gel 
while a band focussing takes place in the stacking gel that also has a lower pH and contains 
chloride ions. These move with high velocity within the electric field due to their pH-inde-
pendent anionic character in contrast to the glycine-ions that are present in the running buffer 
and express a zwitterionic character at low pH values. Zwitterionic particles are effectively 
uncharged. This discrepancy in velocity generates an electric field gradient inside the stacking 
gel causing the aforementioned focussing of protein bands owing to their electrophoretic mo-
bility. When the glycine-ions are transferred from the stacking to the resolving gel they lose 
their zwitterionic character because of deprotonation and pass the protein bands whose veloc-
ities are reduced due to the smaller pore size in the resolving gel. These processes result in a 
high separation with sharp signals for the individual protein bands. In addition to the protein 
sample a mass standard (PageRuler Plus Prestained Protein Ladder, Thermo Fisher Scientific, 
Waltham, USA) has to be present in the gel to allow molecular weight estimations of the re-
sulting protein bands. These fundamentals of the SDS-PAGE were first presented by U. K. 
LAEMMLI in 1970, however, a slightly changed method was utilised in this work.123 By follow-
ing the modifications of SCHÄGGER and VON JAGOW who used tricine instead of glycine result-
ing in a reduced electrophoretic mobility and thereby caused an increased separation for pro-
teins with masses varying in the range of 1 to 100 kDa better results for the proteins in focus 
of this work were expected.124,125 
 
Experimental procedure 
The polyacrylamide gels were prepared under the use of the vertical gel electrophoresis kit 
Mini-PROTEAN® Tetra Cell (Bio-Rad Laboratories Inc., Hercules, USA). The glass panels mak-
ing up the preparation chambers were cleaned with ultrapure H2O and ethanol p.a. and after-
wards mounted in the gear. Initially the resolving gel solution (10 %, cf. Table 3.10) was in-
jected into the chamber and covered during polymerisation with isopropyl alcohol for 1 h. The 
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polymerisation of the gels is initialised by ammonium peroxydisulfate (APS, 10 %(w/v)) and is 
catalysed by N,N,N´,N´-tetramethyl ethylenediamine (TEMED). After removal of the alcohol 
the stacking gel (4 %, cf. Table 3.10) was added and a comb was inserted that functioned as 
space holder for sample pockets. The polymerisation reaction was finished after 1 h. The pol-
yacrylamide gel was then mounted into the electrophoresis chamber and the comb removed. 
Adjacent the inside of the chamber was filled with cathode buffer (cf. Table 3.10) while anode 
buffer (cf. Table 3.10) was poured into the outer compartment.  
Table 3.10: Composition of stacking and resolving gel following the protocol of SCHÄGGER and VON JAGOW 
Stacking gel 
4 % 
570 µL ultrapure H2O 
1.06 mL glycerol 
(50 %(v/v)) 
1.68 mL gel buffer (pH 
8.45) 
*1.66 mL AA-mix 
25 µL APS (10 %(w/v)) 
3 µL TEMED 
Resolving gel 
10 % 
1.23 mL ultrapure H2O 
500 µL gel buffer (pH 8.45) 
267 µL AA-mix* 
13.4 µL APS (10 %(w/v)) 
2.65 µL TEMED 
* AA-mix contains AA and Bis-AA in the ratio of 37.5:1 
 
The protein samples (10 µL) that needed testing were merged with sample buffer (10 µL) and 
scalded to 85 °C for 5 min at 350 rpm. After complete denaturation the merges were pipetted 
into the sample pockets of the gel. The electrophoresis chamber was then connected to a power 
source applying a constant voltage of 210 V for ca. 90 min. Progress control of the electropho-
resis was possible because of the bromophenol blue dye (0.02 %(v/v)) inside the sample buffer 
highlighting the migration. The gel was washed with ultrapure water, heated up in a micro-
wave (800 W, 45 s) after electrophoresis and subsequently dyed with staining solution (cf. Ta-
ble 3.11) that contains Coomassie brilliant blue capable of binding to alkaline amino acid resi-
dues. After washing with ultrapure water, the gel was incubated in destaining solution (cf. 
Table 3.11) overnight.  
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175 mM Tris/HCl 
100 mM DTT 
15 %(w/v) SDS 
2 %(w/v) SDS 




3 M Tris 




100 mM Tris 
100 mM tricine 
0.1 %(w/v) SDS 
Anode buffer 
pH 8.9 
200 mM Tris 
Staining solu-
tion 
0.05 %(w/v) Coomassie 
brilliant blue G250 
45 %(v/v) methanol 
45 %(v/v) acetic acid 
Destaining so-
lution 
5 %(v/v) ethanol 
7.5 %(v/v) acetic acid 
 
Afterwards the gels were rinsed with ultrapure water, either photographs of the discoloured 
gels were taken with a Nikon D600 (Nikon Corporation, Minato, Japan) or they were imaged 
with an Azure c300 gel imaging system (Azure Biosystems, Inc., Dublin, USA). 
 
 
The Western blot (WB) is an additional and continuative method for the analysis of isolated 
proteins based on immune staining. For this type of immune blotting a previous electropho-
resis is inevitable to separate the protein sample based on their molecular weight as described 
in detail in Chapter 3.2.8. The separated protein bands are then transferred or blotted to a 
nitrocellulose membrane via electrophoresis in orthogonal direction of the prior step. The blot 
can be controlled by staining with the azo-dye Ponceau S that reversibly and unspecifically 
binds to proteins and therefore enables the detection of the weight standard. The visualisation 
for protein identification is conducted via a two-step labelling process with selective antibod-
ies. In this work the used antibodies varied depending on the protein that was analysed: 
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Table 3.12: Antibodies employed during Western blot for detection of the different proteins. 




Amino acids 826 
to 843 of mouse 
neuroligin1 
Goat Anti-Rabbit 







Amino acids 44 to 




















The second antibodies that were added after non bound primary antibodies have been re-
moved did not only bind selectively to the later but also carried a horse radish peroxidase 
(HRP). The enzyme catalyses in presence of H2O2 the oxidation of luminol whereupon an ex-
cited 3-aminophtalat-dianion is form. The electron transition in this molecule from the excited 




The protein samples were first separated by SDS-PAGE. In contrast to the process described 
in Chapter 3.2.8 no staining after electrophoresis took place since the gel was used for the sec-
ond orthogonal electrophoresis. Simultaneous to the SDS-PAGE two Whatman-paper and a 
nitrocellulose membrane (Bio-Rad Laboratories Inc., Hercules, USA) were cut to the size of the 
gel and incubated for 30 min in blotting buffer (for composition cf. Table 3.13). Afterwards the 
platin electrode of the blotting gear Trans-Blot® (Bio-Rad Laboratories Inc., Hercules, USA) was 
moistened with blotting buffer and the first soaked Whatman-paper was placed upon the elec-
trode. In this work the semidry method introduced by KYHSE-ANDERSEN was applied.126 On 
top of the Whatman-paper the nitrocellulose membrane was placed followed by the gel and 
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the second Whatman-paper. During 
the stacking process the enclosure of 
air was avoided. The blotting gear 
was closed with a stainless-steel elec-
trode above the pile (compare Figure 
3.3). By appling 180 mA for 45 min 
the blot was conducted.  
The success of the blot was con-
trolled after a 3 min incubation of the nitrocellulose membrane in Ponceau S solution (cf. Table 
3.13). Subsequently the membrane was washed with ultrapure H2O and then incubated in a 
suspension of low-fat dry milk (5 %(w/v)) in TBST buffer (tris buffer saline Tween-20, cf. Table 
3.13) for 1 h at room temperature. The proteins within the milk suspension block vacant bind-
ing sites on the nitrocellulose membrane which otherwise would have been used by the first 
antibody leading to no specific detection. Afterwards the interaction of the primary antibody 
with the proteins takes place during incubation of the membrane with a solution of the anti-
body in a suspension of low-fat dry milk (5 %(w/v)) in TBST buffer overnight at 4 °C under 
constant fluctuation. The concentration of the antibody varied in the range of 0.8 to 1.0 µg/mL. 
Rinsing the membrane three times with TBST buffer (50 mL for 10 min) removed the excess of 
antibody and was followed by incubation with the second antibody for 1 h at 4 °C with gentle 
agitation, again solved in a 5 %(w/v) dry milk suspension in TBST buffer (1:2500 (w/w)). Un-
bound secondary antibody was removed by rinsing with TBST buffer (50 mL for 20 min) fol-
lowed by incubation of the membrane for 2 min in a 1:1 mixture of enhanced chemilumines-
cence (ECL) solution 1 and 2 (for composition cf. Table 3.13). This initiated the oxidation of 
luminol and the resulting chemiluminescence was detected with imaging system Azure 300 
(azure biosystems, Dublin, USA). Additionally, a marker image (comparable to a normal image 
of the nitrocellulose membrane) was taken to enable a correlation or overlay of luminescence 
and marker image and by that simplifying the estimation of molecular weights. 
  
Figure 3.3: Schematic illustration of the layer order in the stack dur-
ing a semidry Western blot. 
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20 mM Tris 
150 mM glycine 
0.05 %(w/v) SDS 
20 %(v/v) methanol 
TBST buffer 
pH 7.4 
10 mM Tris 
150 mM NaCl 
0.2 %(w/v) Tween 20 
ECL 1 
 
100 mM Tris 
2.5 mM luminol 
0.4 mM p-coumaric acid 
ECL 2 
 
100 mM Tris 
0.02 %(w/v) H2O2 
Ponceau S so-
lution 
0.2 %(w/v) Ponceau S 




Since most proteins exhibit an intrinsically order structure dictated by their amino acid se-
quence and its capability to form intramolecular hydrogen bonds. To maintain these second-
ary structures a stabilization via appropriate buffer conditions is necessary. Furthermore, 
some buffers can contain reagents which are inevitable for their application areas, yet, these 
might perturb further experimentation as is the case for imidazole. Imidazole is used to sys-
tematically elute target proteins from an NTA(Ni2+)-matrix during IMAC (cf. Chapter 3.2.7.1) 
but its presence would impede adsorption experiments that rely on the interaction of His6-
tagged proteins to e.g. lipids like DGS (cf. Scheme 3.3). 
The change from one buffer system to another can be achieved in different ways which will be 
described in the next sections. 
 
 
Dialysis is used to exchange low molecular substances across a semipermeable membrane 
with a defined molecular weight cut-off (MWCO). By this transfer, which is based upon os-
motic pressure, generated through concentration gradients of two solutions, the composition 
of a protein-containing solution can be change to desired conditions. 
The elution fractions of the target protein (cf. Chapter 3.2.7) were combined in ZelluTrans® 
dialysis-tubes (MWCO = 14 kDa, Carl Roth GmbH+Co. KG, Karlsruhe, Germany) and dialyzed 
at 4 °C and constant stirring against a 50-fold excess of E1- or HEPES A-buffer (cf. Table 3.14) 
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for N-ERMAD or His-cytNL2, respectively. The buffer was exchanged at least two times while 
the 24 h duration. Afterwards the protein solution was collected, its concentration determined 
and stored at 4 °C until use. 
 
 
For the CB2 isoforms the protein stability was a critical factor as the protein exhibits a good 
lifetime in the elution buffer, but this buffer was not compatible with surface sensitive methods 
like reflectometric interference spectroscopy. Therefore, an empirical study was performed to 
identify buffer compositions combining a compatibility to the utilised techniques with a suffi-
cient lifetime of CB2. This search resulted in the HEPES- and its DTT-free modification HEPES-
A buffer (cf. Table 3.14). Dependent on the experimental setup both buffers were also used as 
EDTA-free versions. To reduce the duration of buffer exchange in case of CB2 an alternative 
to dialysis was used that obtains buffer exchange and an increase in protein concentration via 
centrifugation.  
A volume of 500 µL elution fractions of CB2 was injected in Vivaspin® 500 centrifugal concen-
trator (MWCO = 5 kDa, Sartorius GmbH, Göttingen, Germany) and centrifuged for 10 min at 
4 °C and 17,000 x g (Heraeus Fresco 17, Thermo Scientific, Darmstadt, Germany). Afterwards 
the flow-through was discharged, the volume within the concentrator adjusted to 500µL with 
the desired buffer and again centrifuged at similar conditions. This process was repeated a 
second time to ensure a complete buffer exchange. The protein solution was collected, and its 
concentrations determined by UV/VIS measurements as describe in the following chapter. 
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50 mM KCl 
20 mM Tris/HCl 
0.1 mM EDTA 




100 mM NaCl 
25 mM HEPES 
5 mM DTT 







100 mM NaCl 
25 mM HEPES 
*0.5 mM EDTA 
  
*when working with DGS containing membranes EDTA was left out 
 
 
It is necessary for the planning, the reproducibility, and the analysis of experiments to exactly 
know the concentration of protein within the experimental setup. This can only be guaranteed 
by knowing the amount of protein inside its stock solution. There are different ways to deter-
mine such concentration, in this work either the method based on light absorption of aromatic 
amino acids or the one developed by M. BRADFORD were applied. 
 
 
The determination of protein concentrations within a solution via UV/VIS spectroscopy relies 
upon the fact that aromatic amino acids like trypsin, tryptophan and phenylalanine absorbed 
light at a wavelength of 280 nm. Considering the law of LAMBERT and BEER (Equation 3.2) that 
describes the correlation of intensities before (I0) and after (I0) passing through an absorbing 
medium as the decadic logarithm of their proportion, concentration calculations for the ab-
sorbing species inside the medium is possible with Equation 3.3. 





= 𝜀 ∙ 𝑐 ∙ 𝑑 3.2 







Yet, to calculate the exact concentrations one has to know the specific extinction coefficients 
ε280 for the proteins under investigation. These characteristic values were computed with the 
PROTPARAM tool based on the amino acid sequence (cf. Appendix A.4) for each protein and 
are in Table 3.15. The absorption at a wavelength of 280 nm (A280) was detected in a photomet-
ric measurement in which the optical path length (d) was dictated to be 1 mm by the utilised 
instrument in this work. 
Table 3.15: Extinction coefficients of all proteins investigated calculated with the PROTPARAM tool. 
Protein N-ERMAD CB2SH3 CB2SH3/W24A-E262A CB2PH His-cytNL2 
ε [M-1·cm-1] 52,400 98,945 93,445 37,930 6,000 
 
 
The technique described in the preceding Chapter is a fast and easy way to determine concen-
trations of proteins solution. However, some small proteins or protein fragments do not con-
tain any aromatic amino acids, hence a concentration calculation based on the absorbance at 
280 nm results in imprecise values. This is the case for the protein construct mimicking the 
intracellular domain of neuroligin 2, therefore an alternative technique was applied first intro-
duced by MARION M. BRADFORD.127 It uses Coomassie Brilliant Blue G-250 dye that is able to 
bind to proteins via electrostatic interactions of its sulfonic acid residues together with VAN 
DER WAALS and hydrophobic interactions and thereby switches from its cationic to its anionic 
form. This change in charge results in an adsorption maximum shift from 465 nm for the cati-
onic form to 595 nm for the anionic one. Therefore, the amount of protein-dye complexes di-
rectly correlates with the absorbance at the latter wavelength. 
For concentration calculation a calibration curve was required that was generated with bovine 
serum albumin (BSA) in a concentration range from 0.1 to 0.8 mg/mL. The photometric meas-
urements were conducted in disposable cuvettes as the dye interacts with regular quartz cu-
vettes using a Cary 50 UV/VIS spectrometer (Agilent Technologies, Santa Clara, USA). 
 
 
The investigation of protein adsorption processes and their interactions with either lipids or 
other proteins is dependent on multiple factors. To characterise these a differentiation among 
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them is a prerequisite. Yet, such distinction is not possible in vivo because of the features al-
ready mentioned in the introductory section (cf. Chapter 1.4). Therefore, a common tool to 
study adsorption processes to e.g. receptor lipid molecules are solid-supported membrane sys-
tems. In this work two different types of supported model membrane were applied. On the 
one hand solid-supported lipid bilayers (SLBs) were prepared on hydrophilic silicon dioxide 
substrates while on the other hand supported lipid monolayers or hybrid membranes (SHMs) 
formed on hydrophobically functionalised SiO2 substrates. Different functionalisation strate-
gies were tested to obtain optimal conditions for SHM-formation. Both model membrane types 
formed by spreading of small unilamellar vesicles (SUVs), hence their preparation process will 
be described in the following part. 
 
 
Lipid molecules cluster in an aqueous environment due to their amphiphilic character and can 
arrange in aggregates of different shape.128 If the lipid concentration is beyond a critical point 
(critical micelle concentration, CMC) lipid bilayer formation is feasible in the form of lipid 
vesicles. These vesicles appear in a widely ranging size that depends, inter alia, on the solu-
tion’s composition and the preparation method.129–131 The smallest representatives of this ag-
gregate type are the SUVs that exhibit diameters of up to 100 nm and a high membrane cur-
vature. They can be formed by sonification of rehydrated lipid films and are often utilised to 
prepare supported lipid membranes. The application of lipid films as starting material for ves-
icle formation facilitates well defined compositions and known ratios of matrix to receptor 
lipids. Furthermore, not only the amount of lipid material can be adjusted to match the re-
quirements, but also additional components can be enclosed. In this work lipid films with ma-




Starting from stock solutions of the desired lipids with concentration ranging from 1.0 to 
15.0 mg/mL the particular volumes were added to a test tube filled with 100 µL chloroform in 
requested molar ratios. Furthermore, a small amount of methanol (10-15 µL) was added to 
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increase the mixture’s polarity, thus preventing lipid precipitation. The solvents were re-
moved under a steady N2 stream in a water bath at temperatures above TM of the employed 
matrix lipid (cf. Chapter 3.1.1.1). Afterwards the lipid films were dried in vacuum (T > TM) for 
at least 3 h to guarantee complete solvent removal and then stored at 4 °C until use. 
On purpose of vesicle preparation, the lipid films were rehydrated with 200-800 µL low pH 
buffers (Na-citrate buffer, cf. Table 3.16) while taking particular care that EDTA-free buffer 
was applied when working with DGS containing films. Afterwards the films were incubated 
for 30 min at T > TM and subsequently multilamellar vesicles (MLVs) were obtained by vortex-
ing 3 x 30 s at 5 min intervals. The MLV suspensions were transferred into Eppendorf cups 
and sonicated for 30 min at T > TM using a SONOPULS HD2070 ultrasonic homogeniser (Ban-
delin electronic GmbH & Co. KG, Berlin, Germany) to obtain SUVs. The SUV suspensions were 
used the same day for supported lipid membrane formation on either hydrophilic or hydro-
phobic SiO2 substrates. The procedures of substrate treatment prior to incubation with SUVs 
will be focussed in the following section. 




50 mM KCl 
20 mM Na citrate 
*0.1 mM EDTA 
0.1 mM NaN3 
  
*when working with DGS containing lipid films EDTA was left out 
 
 
Lipid bilayers were prepared on silicon substrates, that exhibited a SiO2 layer on their surfaces, 
because of the relatively low roughness. This layer had a thickness of either 100 nm or 5 µm 
dependent on the measuring technique subsequently applied. Due to uniform measurement 
chamber dimensions all substrates were cut into rectangle pieces (1.95 cm x 0.7 cm). They were 
rinsed with ethanol p.a. and ultrapure water prior to incubation in an ammoniacal solution 
(H2O : NH3 : H2O2, 5:1:1 (v/v/v)) at 70 °C for 20 min. After this treatment, the substrate’s surface 
was clean and rendered hydrophilic. A storage until utilisation was possible in ultrapure wa-
ter. Immediately before the experimental start the substrates were dried in N2 stream and 
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treated with O2 plasma in a Zepto LF PC (Diener electronic GmbH & Co. KG, Ebhausen, Ger-
many) at 60 % power for 30 s. 
 
 
In contrast to the simple preliminary cleaning steps 
prior to SLB formation, the SiO2 substrates that were 
used to support the SHMs had to be functionalised 
additionally to render their surfaces hydrophobic. 
The manipulation of surface characteristics is a 
commonly used way to obtain additional infor-
mation on surface-related subject of matter. There-
fore, different approaches like the functionalisation 
of gold surfaces with reagents containing reactive thiol groups or the reaction of silicon sub-
strates with chloro-, alkoxysilanes or silyl amines are widely distributed.132–134 As RIfS was one 
of the main techniques applied in the protein adsorption studies of this work and as it relies 
upon the interference of reflected and transmitted light, described in detail in section 3.5, sub-
strates with a high reflectivity such as gold or other metal surfaces were not suitable. There-
fore, the method of choice to obtain substrates with hydrophobic surface features was the 
treatment of Si-SiO2 wafers with silyl amine 1,1,1-trimethyl-N-(trimethylsilyl)silanamine 
(HMDS). Its reaction with accessible hydroxy groups of the SiO2 surface are illustrated in 
Scheme 3.6. Different functionalisation strategies, direct incubation with HMDS solution (cf. 
Chapter 3.3.3.1), plasma deposition (cf. Chapter 3.3.3.2) and vapour deposition (cf. Chapter 
3.3.3.3) were tested to ascertain a functionalisation strategy leading to low surface roughness 
and high hydrophobicity. In the beginning of all functionalisation pathways the silicon sub-
strates were cleaned by three cycles of sonification for 15 min during which the wafers were 
incubated in detergent solution (Hellmanex III, 0.5 %(v/v), 1st cycle) and two times in ultrapure 
water (2nd and 3rd cycle). Afterwards the wafers were dried in a N2-stream and treated with O2 
plasma (pO2 = 0.2 mbar) for 30 s at 60 % power. Subsequently the substrates could be function-
alised with HMDS. Independent of the followed functionalisation strategy all substrates were 
tested for their hydrophobic character via contact angle measurement after the functionalisa-
tion process (cf. Chapter 3.4). 
Scheme 3.6: Chemical equation of the surface 
functionalisation reaction of HMDS with the ac-
cessible hydroxyl groups of the SiO2 surface. 




The cleaned silicon wafers were mounted in a reaction chamber and HMDS solution was 
added directly on top of the substrates. The reaction chamber was closed and incubated over 




The substrates remained in the plasma cleaner after first treatment with oxygen plasma (cf. 
Chapter 3.3.3) and a HMDS-reservoir was attached via vacuum tubing directly to the gas inlet 
of the cleaner. Afterwards multiple evacuation and ventilation cycles below the desired pres-
sure of 0.2 mbar were conducted to rinse the reaction chamber, then HMDS deposition was 
started at 0.2 mbar for at least 120 s in a 100 % HMDS plasma at 60% power. 
 
 
The wafers were stored upright in a glass chamber together with a test tube filled with 65 µL 
HMDS. Afterwards the chamber was sealed and placed overnight in a VD 23 drying cabinet 
(Binder GmbH, Tuttlingen, Germany) at 120 °C under reduced pressure. The next day the sub-
strates were slowly cooled down and remained in the glass chamber until they were mounted 
in the experimental setup. This secured the functionalised substrates from contaminations and 
prevented aging processes. 
 
 
The substrates with their two opposing surface features (cf. Chapters 3.3.2 and 3.3.3) were 
treated in the same way to prepare two types of solid-supported model membranes, SLBs and 
SHMs. The substrates were mounted in the method specific reaction chambers, covered with 
Na-citrate buffer (cf. Table 3.16) and the SUV suspension was added in a final concentration 
of at least 0.2 mg lipid material per substrate. The addition of SUV induced their spreading on 
the substrate’s surface. In case of preparations for AFM or fluorescence microscopy the sub-
strates were incubated for a duration of minimum 30 min. The membrane formed in situ dur-
ing RIfS measurements, enabling the control of the formation process in real time. After 
spreading the reaction chambers were rinsed with buffer which composition depended on the 
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continuing experiments (cf. Table 3.14). This rinsing guaranteed the removal of excess and 
attached, non-spread vesicles and facilitates the change to optimal buffer conditions for pro-
tein adsorption. In case of the gel-phase matrix lipid DPPC all preparation steps were per-
formed at 55 °C, thus DPPC containing lipid mixtures were not suitable for RIfS-experiments. 
For all non-RIfS preparations, after changing the buffer conditions the membrane formation 
was controlled via fluorescence microscopy. In case of a homogenous fluorescence intensity 
with only a small number of defects or none at all visible inside the membrane, the volume 
above the preparation was reduced and protein was added to the solution (cProtein ≥ 1 µm) and 
incubated at room temperature for minimal 1 h. Afterwards, imaging of the adsorbed protein 
structures via AFM or determination of the protein’s effect on fluorescence-quality and lipid 
mobility was feasible. 
 
 
A tool to determine the hydrophobic character of a surface is the measurement of static contact 
angles (θ) that appear in sessile water droplets upon 
such surfaces. A water drop that easily spreads on a 
substrate exhibits a small contact angle, which is the an-
gle made up by the liquid-solid interface and the liquid-
gas interface (cf. Figure 3.4). This indicates a high wet-
tability caused by a low hydrophobic character. In con-
trast to that high contact angles are detected on sub-
strates that express a low wettability.135 Therefore, this 
method is a good tool to evaluate the different strategies for substrate functionalisation de-
scribed in Chapter 3.3.3. 
 
Experimental procedure 
A custom-build contact angle goniometer setup, inspired by the one applied by STALDER et 
al.,136 was utilized to determine contact angles of sessile water droplets (5 µL) on top of the 
hydrophobically functionalised SiO2 substrates and on non-functionalised Si-SiO2 wafers. The 
measurements were performed after rising each substrate with ethanol and drying it in a 
stream of nitrogen. The droplets were imaged with a Nikon D600 (Nikon Corporation, Minato, 
Figure 3.4: Scheme of a sessile droplet on a 
solid substrate with the contact angle θ con-
necting the liquid-solid and liquid-gas inter-
faces highlighted. 
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Japan) that was equipped with an AF-S Nikkor 18/300 mm objective (Nikon Corporation, Min-
ato, Japan) and fronted by a custom-made lens (Scientific Precision Instruments GmbH, Oppen-
heim, Germany). Analysis of gathered data was conducted by fitting a YOUNG-LAPLACE equa-
tion to the contour of the droplets using the ImageJ plugin Drop Shape Analysis.136 
 
 
Nowadays direct optical sensors make up an important class of detectors operating without 
invasive components like fluorophores that in many cases alter the activity and structure of 
physiological-relevant target molecules. Therefore, these non-invasive techniques represent 
an interesting tool to examine sensitive biomolecular interactions. The optical detection prin-
ciples of the methods can be partitioned into two classes,137 while the one is based on evanes-
cent fields, like surface plasmon resonance (SPR), other methods among them the reflectomet-
ric interference spectroscopy (RIfS) rely on reflecto- or refractometry. RIfS is based on the re-
flection of white light at interfaces of transparent layers and thereby detects the interference 
pattern resulting from superposition of partially reflected beams.138 The superposition of re-
flected and transmitted partial beams leads to either destructive or constructive interference 
depending on the angle of incidence, the wavelength and the optical thickness of the transpar-
ent layers investigated.139 Therefore, changes in these factors alter the interference pattern fa-
cilitating e.g. the detection of optical thickness changes caused by adsorption processes like 
that of proteins to lipid membranes in real time. 
 
 
The basic principle of reflectometry is described in SNELL’s law (cf. Equation 3.4)140 focussing 
on the relationship between angle of incidence (α) and refraction (β) at interfaces of media with 







𝑛1 sin 𝛼 = 𝑛2 sin 𝛽 3.5 
This fundamental law distinguishes between three different cases depending on the propor-
tion of the refractive indices schematically illustrated in Figure 3.5. 
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Figure 3.5 A clearly shows that incident light is not only reflected by the incident angle α but 
also is transmitted without refraction as α = β when the refractive indices of both media are 
identical. In the cases of media with different refractive indices the transmitted light is either 
refracted towards or away from the normal of their interface for n1 < n2 (cf. Figure 3.5 B) or 
n1 > n2 (cf. Figure 3.5 C), respectively.  
In this work the experimental setup was composed of three different phases separated by two 
interfaces (cf. Figure 3.6). The corresponding media were aqueous buffer solutions with 
n1 = 1.333 (T = 20 °C, 
λ = 589 nm, p = 0.1 MPa)141, a 
silicon dioxide layer with 
n2 = 1.458 (T = 20 °C, 
λ = 589 nm, p = 0.1 MPa)142 and 
an opaque silicon layer. The in-
termediate SiO2 layer has a 
thickness (d) of 5 µm that func-
tioned as the interference me-
dium. This thickness is im-
portant as interference can only 
be detected when the path dif-
ference of the partial beams and consequently the reflecting interfaces are within the coherence 
length of white light with 0.5 to 30 µm.143,144 The employment of such substrates guarantees a 
Figure 3.6: Scheme of the optical path in RIfS. The incident light is partially 
reflected (I1) and transmitted (I2). The later part is refracted by the angle β 
towards the normal of the interface due to the higher refractive index of 
the SiO2-layer. The transmitted partial beam encounters the interface be-
tween SiO2 and the opaque Si where it is reflected and after that gets re-
fracted a second time at the first interface between buffer and SiO2. 
Figure 3.5: Principles described by the law of SNELL. Refraction of incident light with the angle α from a medium 
with a refractive index n1 into a medium with n2 by a refractive angle β. A: In case of identical refractive indices no 
refraction occurs. The incident light is transmitted. B: If n2 is higher than n1 the partial beam in the second medium 
is refracted towards the normal of the interface causing α > β. C: The relation of incident and refractive angles is 
changed to α < β if n1 > n2. 
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detection of monomolecular adsorption processes when the interference layer is extended by 
a biological layer, e.g. a lipid membrane or membrane-bound proteins with a refractive index 
(n = 1.46)145 similar to that of SiO2 (n2). Either way, based on the mentioned refractive indices 
the experimental setup of this work represents the type of interfaces corresponding to Figure 
3.5 B. Therefore, white light that hits the interface to the SiO2 is in one part reflected (I1) in the 
same angle as the incident one while a second part (I2) is transmitted under refraction by the 
angle β as schematically presented in Figure 3.6. After the latter partial beam passes the 
interference layer it encounters the second interface (SiO2-Si) at which it is reflected due to the 
opaque character of silicon. This causes a second refraction when leaving the interference layer 
resulting in a parallel travel direction of both partial beams but with I2 covering a longer 





Under consideration of the refractive index n2 of the interference layer and the distance s the 





This equation can be simplified because of the experimental setup used in this work in which 
light is emitted perpendicular to the substrate altering the incident and refractive angles to 
α = β = 0° and resulting in Equation 3.8. 
Δ𝑠 = 2𝑛2𝑑 3.8 
Caused by the aforementioned difference in path length between I1 and I2 a phase shift (Δφ) is 
present that leads to a mutual displacement of maxima and minima of the partial beams. This 
displacement results during superposition of both waves in a specific interference pattern. The 
extreme case of maximum intensity that arises if the optical path is a multiple (m) of the 
emitted wavelength λ can be described by: 
𝑚𝜆𝑚𝑎𝑥 = 2𝑛2𝑑     with     𝑚 ∈ ℕ 3.9 




) 𝜆𝑚𝑖𝑛 = 2𝑛2𝑑     with     𝑚 ∈ ℕ 3.10 
The phase shift of the two partial beams (I1 and I2) is defined by Equation 3.11 with: 












  3.11 









The optical thickness (OT) is the product of the refractive index n and the physical thickness d 
as stated in Equation 3.12. Therefore, it is a parameter that is affected by adsorption processes 
causing an increase in d or a change of n, thus with Equation 3.12 at hand OT can be tracked 
by the phase shift. 
 
 
All RIfS-measurements are based on the detection of the reflectivity, therefore, the connection 
between this parameter and OT will be highlighted within this paragraph. Prior to all RIfS 
adsorption studies reference spectra were detected for the extreme cases of complete and no 
reflectivity. While the bright spectrum (Ir) was determined under the use of a silver-sputtered 
glass substrate (reflectivity ≥ 98.5 %, Chroma Technology GmbH, Olching, Germany) the dark 
spectrum (Id) was recorded when the light source was deactivated. The reflectivity spectrum 
of each substrate was displayed with Spectra Suite (Ocean Insight, Duiven, Netherlands) in 
consideration of the specific intensity spectrum of the substrate and both reference spectra 





For non-absorbing substances the reflectivity can be described by the reflectivity coefficients 









2 + 2𝑟12𝑟23 cos(2Δ𝜑)
1 + 𝑟12
2 𝑟23
2 + 2𝑟12𝑟23 cos(2Δ𝜑)
 3.15 
Considering the definition of the phase shift and inserting it into Equation 3.15 leads to the 
direct correlation of reflectivity and OT: 

















If this equation is fitted to the reflectivity spectra during RIfS-measurements a temporal 
change in optical thickness (ΔOT) can be determined. The detected changes are for the most 
part cause by variations in the physical thickness d because of the aforementioned very similar 
refractive indices of the interference layer SiO2 and adsorbed biological material, thus being a 
good read-out parameter for surface coverages by those adsorbed substances. 
 
 
The measuring chamber used for RIfS as illustrated in Figure 3.7 is composed of an alumina 
base with an inlet (2 cm x 2 cm, depth: 2 mm) in which the substrates can be placed and an 
acrylic glass top that can be mounted to the base with screws. The top exhibits a milling groove 
exactly fitting the size of a seal ring with dimension of 12 mm in radius and a thickness of 
1 mm, thereby defining the actual reaction volume. Furthermore, the acrylic glass construct 
contains screw threads enabling attachment of tubing for the in- and outflow of solutions. This 
flow was generated by a peristaltic pump (IDEX Health & Science, Wertheim, Germany) with 
a velocity of ca. 0.5 mL/min. On top of the composed measuring chamber an optical fibre is 
placed perpendicular to the substrates surface (cf. Figure 3.7 B), thus guaranteeing the angles 
of incident and reflected light to be 0°, as described in the former chapter. The fibre is made 
up by six light-emitting fibres (e) that circle one detection fibre (d). While the later transmits 
the detected light to a FLAME-S spectrometer (Ocean Insight, Duiven, Netherlands) the other 
Figure 3.7: Scheme of the measuring chamber used in RIfS. A: Illustration of the composed flow-through chamber 
with the acrylic glass top and the alumina base between which the silicon substrate is fixed. The actual reaction 
volume is defined by a sealing ring that is embedded in the top. B: Schematic sideview of the chamber to which the 
optical fibre is attached that consist of six light-emitting fibres (e) around a detection fibre (d). 
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fibres emit light (λ = 360-950 nm) that was generated by a tungsten-halogen light source 
(Ocean Insight, Duiven, Netherlands).  
 
 
After the composition of the measuring chamber and the attachment to the tubing system the 
whole setup was rinsed with ultrapure water to remove all air from inside. Remaining bubbles 
were removed by changing the direction and velocity of flow. Then the system was rinsed and 
equilibrated with the respective Na-citrate buffer. All rinsing processes were conducted in an 
open system configuration while vesicle spreading and some of the adsorption experiments 
took place in a closed one. The recording of change in optical thickness (ΔOT) was performed 
with the software Spectra Suite. After a base line was determined addition of SUV suspension 
(m = 0.2 mg) led to adsorption of lipid material and thus an adlayer formation on the interface. 
It was tracked until a plateau indicated successful membrane formation. Then the system was 
rinsed with the specific buffer (cf. Table 3.14) to remove adhered vesicles and change the buffer 
conditions to an optimum for protein adsorption. After that protein addition followed with 
varying concentrations. Depending on the experimental design either a single protein injection 
or multiple successive additions (referred to as adsorption isotherms) took place as schemati-
cally shown in Figure 3.8 A and B, respectively. 
After another plateau was reached (closed configuration) or the whole protein solution was 
applied (open one) the complete setup was again rinsed with buffer to determine the amount 
of irreversible bound protein to the membrane. When the detection was stopped the tubing 
system was vigorously rinsed with ultrapure water and the acrylic glass tops together with 
Figure 3.8: Schematic illustrations of RIfS-spectra gathered either in a single injection experiment (A) or during 
subsequent increase of protein concentration by multiple injections (B). 
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the seal rings were cleaned three times in an ultrasonic bath for 15 min (1st pass in 5 % Muca-
sol® solution, 2nd and 3rd passes in ultrapure water). 
 
 
The atomic force microscopy (AFM) is another technique in addition to RIfS capable to deter-
mine surface adsorption processes as it detects forces on an atomic level. It was developed in 
1985 by G. BINNIG, C. QUATE and C. GERBER based on the scanning tunnelling microscope 
(STM) to allow high resolutions in all three dimensions not only in x- and y-direction like flu-
orescence microscopy.146 To be precise, its detection is limited to a lateral resolution of 1.0 nm 
while the axial resolution limit is 0.1 nm with the measuring probe being the decisive fac-
tor.147,148 Therefore, in this work AFM aided to characterise the surface roughness of the sub-
strates used as solid support for the model membranes before and after functionalisation with 
HMDS. Furthermore, data on the surface coverage by adsorbed proteins, their lateral organi-
sations and their specific heights on top of the membrane systems were gathered via this tech-
nique making it an essential part of this study. 
 
 
The measuring probe dictating the resolution of the AFM by its radius is attached to a cantile-
ver. The forces that occur either in proximity or in contact of probe and specimen cause a de-
flection of the cantilever that can be detected whereby the topography can be expressed in the 
relation of this deflection to the position on the specimen. The force necessary for cantilever 
manipulation is described by the law of HOOK: 
𝐹 = 𝑘 ∙ 𝑧C 3.17 
Accordingly, the required force F depends on the spring constant k of the cantilever and the 
deflection zC. In addition to the aforementioned atomic forces between probe and specimen 
there are also macroscopic, repulsive and attractive interactions taking place depending in 
various ratios on the distance r between both. In case of close proximity these forces are well 
described by the LENNARD-JONES potential (VLJ) for neutral atoms or molecules: 
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With σ being the finite distance at which the potential between the two molecules is zero, ε 
describing the depth of the potential well whereas r represents the distance between both par-
ticles. Consequently, if two particles move closer together, they first experience attractive van-
der-Waals interactions, though during further distance decrease the electron orbitals start to 
overlap inducing a repulsive force following the principle of PAULI. 
The experimental setup  utilized in this work was a MFP-3D (Asylum Research, Santa Barbara, 
USA), therein the cantilever with the measuring probe is moved by an z-piezo while the spec-
imen inside a reaction chamber can be moved in x- and y-direction via a piezo actuator under-
neath the sample table (cf. Figure 3.9). The actuators enable not only the scanning of the spec-
imen but also allow adjustments of the distance between probe and surface. The later feature 
facilitates measurements either with constant distance or constant force. The vertical and lat-
eral deflection is determined by the displacement of a laser beam that is pointed on the reflec-
tive back of the cantilever and detected via a four-quadrant diode (photodiode, cf. Figure 3.9). 
 
 
In contrast to samples investigated via STM the ones tested with AFM do not need to express 
any conductivity. Furthermore, AFM-imaging is possible not only in air but also in liquids, yet 
it is worthwhile to mention that in aqueous surroundings the imaging is more challenging due 
Figure 3.9: Schematic setup of atomic force microscope. A light beam is reflected from the back of the cantilever 
and detected via a position-sensitive photodiode. Scanning of specimen is possible by movement of the sample 
table in x- and y-direction while the distance between sample surface and cantilever is adjusted by a z-piezo actuator 
in the cantilever holder. 
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to attenuating interaction between cantilever and the liquid itself. Another aspect that neces-
sary to considered when working with AFM is the character of the sample under investigation 
which vary not only in the sense of stability or rigidity but also in adherence and intrinsic 
height differences. Due to these reasons one must choose an imaging mode that suits most the 
given sample characteristics. Therefore, the contact and the intermittent-contact mode were 




The continuous contact of the cantilever with the surface of the specimen during the whole 
scanning cycle is eponymous for this type of imaging. In a static fashion the cantilever can 
either be moved across the surface at a constant height or with an invariable force. Due to this 
features the contact mode is most suitable for rigid probes.147 Furthermore, this mode enables 




The contact mode tends to either manipulated or to destroy softer preparations like cell or 
proteins, whereas in the intermittent-contact or tapping mode the forces induced by the canti-
lever are drastically reduced. This is achieved by a decrease in contact time as the cantilever is 
stimulated in the range of its resonance frequency and thus sinusoidally oscillates with a con-
stant amplitude.149 The determination of the exact resonance frequency is performed for each 
cantilever before the beginning of the experiment by recording the thermal noise. At the min-
imum of the oscillation the cantilever tip touches the sample’s surface and afterwards is re-
moved directly. These dynamics are the reason for the reduction of induced shear forces.  
 
 
For the different substrate types three cantilevers were utilized which varied in their charac-
teristics as shown in Table 3.17. 
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NCH-50 rectangular 250-390 42 125 30 contact 
MSCT triangular 90-160 0.6 85 18 tapping 
MSNL-10 triangular 90-160 0.6 85 18 tapping 
 
The cantilever applied in contact mode was purchased from Nano World (Neuchâtel, Switzer-
land) while the tapping-cantilevers both were produced by Bruker AFM Probes (Camarillo, 
USA).  
At the start of all AFM measurements the cantilever was mounted to a glass prism functioning 
as a holder and fixed with a screw. All time the cantilever was handled with care to avoid any 
damage that might have impeded subsequent surface imaging. The sample of interest, being 
either a plain silicon substrate with or without HMDS functionalisation (cf. Chapters 3.3.2 and 
3.3.3) on air or a solid-supported model membrane in buffer solution before or after incubation 
with protein (cf. Chapter 3.3.4) prepared in a home-build measuring chamber, were placed on 
top of the sample table as schematically shown in Figure 3.9. After that the prism was attached 
to the microscope head and place above the sample. In case of liquid samples, the head was 
lower until the cantilever is just in contact with the liquid whereby inclusion of air underneath 
the cantilever’s tip was avoided. In the liquid the cantilever equilibrated for 30 min. 
Before the tip approached the surface no matter if on air or in solution, the light spot had been 
focussed on the spike of the cantilever directly above the measuring tip to obtain maximum 
signal intensity. Additionally, the deflection was set to zero by adjustment of the reflecting 
mirror to the centre of the position-sensitive diode (PSD). When deflection stayed constant 
after equilibration, the resonance frequency was determined, and the probe approached to the 
sample. In contact the measuring parameters were adjusted using the software Igor – MFP3D. 
The obtained images were processed with Gwyddion 2.49 and analysed in detail with MATLAB 
R2017b and OriginPro 8.5G. To determine the roughness of the substrates the root mean 
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The analyses of surface coverage, lateral protein organisation and protein heights were con-
ducted under the use of a MATLAB script established by DR. INGO MEY. This routine distin-
guished between membrane and adsorbed protein by applying a threshold and identified pro-
tein structures with a 2D-peak detection function marking local maxima. These detected ex-
treme values led to a histogram representing the distribution of their respective heights. To 
these data either a GAUSS-distribution (Equation 3.20) or a logarithmic normal distribution 
(Equation 3.21) was fitted to determine the mean protein height as the maximum value of the 
distribution xc and its error (w = 2·σ). 












𝑦 = 𝑦0 +
𝐴













Fluorescence microscopy is a special form of light microscopy that relies on the ability of spe-
cific molecules, so called fluorophores, to adsorb light at one wavelength and emit it at a dif-
ferent wavelength after a short duration. This wavelength change is based upon a vibronic 
transition of the fluorophore after excitation from an electronic ground state S0 to an excited 
vibrational and electronic one (S1). The relaxation into the vibrational ground state of the ex-
cited electronic state is a fast process caused by collisions with surrounding molecules. Unlike 
this, the lifetime of the excited electronic state is in the range of nanoseconds before the mole-
cule emits a red-shifted photon and thus returns to its ground state. This phenomenon is called 
STOKES shift and is frequently applied in life science to obtain high contrast even when work-
ing with simultaneous excitation and emission.150 Within this work different types of fluores-
cence microscopy setups were used to determine membrane quality and lipid diffusion inside 
the model systems before and after protein adsorption exploiting the presence of fluorescently 
labelled lipids (cf. Chapter 3.1.1.3). The following sections will deal with those setups in more 
detail. 




An epifluorescence microscope is characterised by a straightforward setup design prompting 
light at sample in a straight angle which leads to a maximum in illumination. Due to this fea-
ture it is also referred to as widefield microscopy. In 
general, a high-intensity light source such as a light-
emitting diode (LED) is used emitting a continuous 
light spectrum schematically illustrated in Figure 3.10. 
The eradiated light hits an excitation filter, only passed 
by light of the corresponding excitation wavelength to 
the fluorophore present in the specimen to test. The 
monochromatic beam is reflected by a dichroic mirror 
onto the specimen and excites the fluorophores in a 
wide area. The emitted fluorescence of the sample then 
passes the objective and the dichroic mirror, since the 
mirror functions as a beam splitter only reflecting light 
of shorter wavelengths while irradiation with longer 
wavelengths is transmitted. After that the fluorescence 
is separated from scattered light by an emission filter guaranteeing the detection of the rele-
vant spectral range solely. The resolution of an epifluorescence microscope is limited to half 
of the applied wavelength at best (ABBÉ diffraction limit) due to the optical components of the 
microscope that do not lead to illumination of a single spot in the specimen but a broader area 
as mentioned before. 
Figure 3.10: Schematic drawing of the setup 
of an epifluorescence microscope. 




The confocal laser scanning microscope (CLSM) achieves a better resolution in comparison to 
the epifluorescence microscopy as it reduces the background noise by cutting off scattered 
light before detection. The main difference to widefield microscopy is the application of pin-
holes and the use of a laser eradiating coherent light for fluorophore excitation. Furthermore, 
instead of a complete illumination of the sample 
only a small focal volume is irradiated, reducing 
photo damage and bleaching to a minimum. 
The CLSM technique is based on the principles 
presented in 1955 by MINSKY.151 A scheme of a 
laser scanning microscope is shown in Figure 
3.11. The coherent light is emitted by a laser at a 
specific wavelength and passes a collimator cre-
ating a parallel path of beams towards the di-
chroic mirror. At the mirror the excitation light 
is reflected on the lens inside the objective 
which refracts the light to focus plane resulting 
in light absorption by the fluorophores. When 
the photo-active molecules emit the light of lower wavelength, it afterwards is refracted at the 
lens and transmitted by the beam splitter. It is then separated by the adjustable pinhole from 
the out-of-focus scattered light before detection with a photomultiplier. The resolution of a 
CLSM depends on the width of the opened pinhole and in the extreme event of full opening 
the lateral resolution is similar to that of an epifluorescence microscope. Nonetheless, due to 
the differentiation between focal and scattered light the depth definition is drastically reduced 
and also enables a scanning in z-direction resulting in a 3D-reconstruction of the sample.152 
 
 
The control of model membrane quality after its formation process (cf. Chapter 3.3.4) and prior 
to AFM measurements was performed with a BX 51 epifluorescence microscope (Olympus, 
Hamburg, Germany). On this purpose the specimen was irradiated with green light 
(λ = 580 nm) to excite the TxR-fluorophores in the lipid layers. 
Figure 3.11: Setup of a confocal laser scanning micro-
scope schematically illustrated. 




For detailed characterisation of the prepared model membrane systems by high-resolution im-
aging and fluorescence recovery after photobleaching experiments, a confocal LSM 880 Exam-
iner (Carl Zeiss, Jena, Germany) equipped with a 40 x water immersion objective (W Plan-Ap-
ochromat, NA = 1, Carl Zeiss, Jena, Germany) was utilised. After the formation process of the 
membranes the distribution and the mobility of the employed fluorophores were examined. 
To do this, either TxR or BODIPY®-TMR PtdInsPs were excited using a laser with λ = 561 nm 
of emission. For bleaching of the fluorophores an additional laser (λ = 488 nm) was employed 
to induce a grout amount of energy in a short duration. Although, the detection parameters 
varied, in all recovery experiments the bleach spot was placed in the centre of the detection 
area to guarantee an accurate analysis. This procedure is described in detail in the next chapter. 
 




The method of fluorescence recovery after photobleaching (FRAP) is frequently used to deter-
mine lateral mobilities and binding kinetics of fluorescently labelled molecules inside a solu-
tion or liquid aggregate.153–155 By exposition to high-energy radiation fluorophore molecules 
are destructed (non-filled red circles in Figure 3.12 A to D) in the corresponding area resulting 
(represented by the dashed blue circle in Figure 3.12 A to D). Due to the lack of fluorescent 
molecules the spot referred to as region of interest (ROI) appears dark (Figure 3.12 B) and the 
respective intensity minimum immediately after bleaching is I0. Determinations of the recov-
ery-duration and the regenerated, final fluorescence intensity Ieq enable the characterisation of 
the fluorophore mobility inside the specimen.156 To facilitate exact determinations the initial 
fluorescence intensity Ii of e.g. SLBs and SHMs, like in this work, is measured. The bleached 
area exhibited a circular shape to facilitate analysis with a HANKEL transform.157 All parame-
ters in combination with the time t and the time constant of the fluorescence recovery tF can be 
Figure 3.12: Schematic illustration of a FRAP experiment with the ROI highlighted as a dashed blue circle while 
fluorescently labelled lipid molecules are represented as red circles, unlabelled ones in orange while bleached fluor-
ophores are presented as non-filled red circles. A: Initial fluorescence intensity Ii is detected in the ROI. B: Bleaching 
of fluorophores in the ROI (I0) by inducing a high-energy laser pulse. C: Diffusion of lipid molecules in and out of 
the ROI cause recovery of the fluorescence intensity. D: A new intensity plateau is reached with Ieq when in and 
out diffusion of lipids is in an equilibrium. E: Schematic intensity spectrum correlating to the time series illustrated 
in A to D. 
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used to describe the time dependent fluorescence intensity I(t) as shown in Figure 3.12 E via 
the following equation: 




Between the time constant of the fluorescence recovery and the characteristic diffusion time τD 
a relation exists as shown in Equation 3.23: 
𝜏D = ln(0.5) ∙ (−𝑡F) 3.23 
With known radius of the circular ROI the diffusion time can be used to calculate the diffusion 





In case of solid-supported model membranes there is always an interaction taking place be-
tween lipid molecules and substrate resulting in a proportion of immobilised lipid molecules. 






The detailed analysis of all FRAP experiments to calculate the specific diffusion coefficients 
and immobile fractions was conducted by application of a MATLAB script that was established 
by JÖNSSEN et al.157 
  








This work aimed on the development on an in vitro model system of the GABAAergic postsyn-
aptic receptor organisation machinery to enable characterisation of its constituents and their 
interactions. Different solid-supported membrane systems are envisioned to establish the bot-
tom-up approach. These were prepared on top of silicon dioxide wafers which provided dif-
ferent surface features due to modification with 1,1,1-trimethyl-N-(trimethylsilyl)silanamine 
(HMDS). The functionalisation process together with the characterisation of the obtained sur-
faces and the subsequently prepared model membranes will be the focus of Chapter 4.1. The 
application of two different model membrane systems allowed determination of the leaflet-
dependent PtdIns[4,5]P2 distribution in solid-supported lipid bilayer (SLBs). The adsorption 
of marker proteins, both the N-terminal domain of ezrin (N-ERMAD) and the C-terminal PH 
domain of collybistin 2 (CB2PH), was used to examine the accessibility of the specific receptor 
lipid in SLBs as well as in solid-supported hybrid membranes (SHMs). Having outlined the 
adsorption results and thus the advantages of SHMs in Chapter 4.2, the following section (cf. 
Chapter 4.3) will deal with the adsorption behaviour of the adapter protein collybistin 2 (CB2) 
to this model membrane system. On the account of binding specificity different PtdInsP-spe-
cies have been deployed as receptor lipids and a detailed look on CB2’s topographical features 
will be presented to evaluate their impact on the protein organisation. Afterwards, this char-
acterisation allows the expansion of the in vitro model system by addition of neuroligin 2 
(NL2). The protein-protein (NL2—CB2) interaction is believed to induce the activation of the 
latter under physiological conditions which has been investigated in co-adsorption experi-
ments presented in Chapter 4.4. 
 
 
-Some of the results presented in this Chapter have been published in “Leaflet-Depend-
ent Distribution of PtdIns[4,5]P 2 in Supported Model Membranes” by J.Schäfer et al. , 
Langmuir, 2020, 36, 1320-1328.158- 




The preparation of solid-supported lipid bilayers is a widely distributed and frequently used 
method to obtain a simple model membrane which can be applied to examine protein-lipid 
interactions.159–161 A prerequisite for the material used as solid support is an inert and smooth 
surface with a hydrophilic character. Next to mica these features are presented by silicon sub-
strates with a SiO2 surface. In this work SiO2 wafers with a surface layer thickness of either 
100 nm or 5 µm were used (cf. Chapter 3.5.1). A good model system requires the knowledge 
of all its constituents, therefore a de-
tailed look on the substrate’s surface 
features has been taken. Figure 4.1 A 
presents an exemplary atomic force mi-
crograph of a hydrophilic functional-
ised SiO2 substrate (with a layer thick-
ness of 100 nm, cf. Chapter 3.3.2). The 
image shows a smooth surface with few 
aggregates of small heights on top of it. 
As the surface was imaged in air, these 
deposits might correlate to dust parti-
cles upon the otherwise clean surface. 
The surface roughness was determined 
as root mean square (RMS, cf. Equation 
3.19) by atomic force microscopy 
(AFM) while imaging in intermittent-contact mode (cf. Chapter 3.6). For both hydrophilic sil-
icon substrates (with different SiO2 layer thicknesses of 100 nm and 5 µm) RMS was 
(0.88 ± 0.24) nm, based on eight independent measurements gathered on five different sub-
strates. The results were combined due to an insignificant deviation. 
In addition to roughness determinations also the hydrophilicity of the substrates was studied 
by contact angle measurements of sessile water droplets (cf. Figure 4.1 B). The analysis of the 
contact angle was conducted by the ImageJ plug-in LB-ADSA as demonstrated in Figure 4.1 C 
and described in detail in Chapter 3.4. The mean of the determined angles is (16 ± 6)° with the 
Figure 4.1: A: Atomic force micrograph of an unfunctionalised 
SiO2 wafer surface. Scale bar: 2 µm. B: Exemplary image of a ses-
sile water droplet on top of such a surface. C: Water droplet 
modulation (red) by the LB-ADSA ImageJ plug-in to determine 
the contact angle.
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The functionalisation of the silicon substrates with HMDS as inspired by HERTL and HAIR162 
was performed following three different strategies. The cleaned wafers were either directly 
incubated with HMDS-solution, or exposed to HMDS-plasma for at least 120 seconds or to an 
HMDS-atmosphere at increased temperature und reduced pressure overnight (cf. Chapter 
3.3.3). In analogy to the characterisation of hydrophilic SiO2 surfaces, these substrates were 
also examined according to surface roughness and hydrophilicity. In Figure 4.2 atomic force 
micrographs are presented exemplary for each functionalisation strategy. The corresponding 
contact angle measurements are displayed in the respective inset. 
While the direct incubation of the solid support to HMDS-solution resulted in a very hetero-
genous surface with plenty deposits on top (cf. Figure 4.2 A), the exposure to HMDS plasma 
reduced the amount of deposits on the surface (cf. Figure 4.2 B). However, the hydrophobic 
character of substrates functionalised following the plasma protocol is reduced with a contact 
angle of (61 ± 12)° (n = 12) compared to those directly incubated (69 ± 7)° (n = 8). The substrates 
exposed to the HMDS-vapour (cf. Figure 4.2 C) in turn exhibited the highest hydrophobicity 
with contact angles of (87 ± 1)° (n = 12). Furthermore, there were large discrepancies in the 
roughness of the hydrophobically functionalised surfaces. The direct incubation and plasma 
treatment led to aggregate formation during the deposition process resulting in RMS of 
Figure 4.2: Atomic force micrographs of the functionalised substrate surfaces. A: Silicon dioxide wafer after direct 
incubation with HMDS-solution. B: Surface image after HMDS-plasma treatment (for 120 s). C: Surface imaged 
after exposure to HMDS-vapour overnight under reduced pressure and increased temperature. Scale bars: 2 µm. 
Insets represent the corresponding sessile water droplet experiments to determine the substrate’s hydrophilicity by 
contact angle measurements. 
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(1.97 ± 1.54) nm (n = 13) and (1.18 ± 0.67) nm (n = 8), respectively. Even though, higher rough-
ness might reduce the hydrophilicity of a surface,163 the detected heterogeneities had to be 
avoided. Otherwise, their broad height- and shape-distribution would have perturbed subse-
quent AFM studies of adsorbed proteins. In that scenario a precise distinction between func-
tionalisation deposits and protein aggregates would have been possible only by using specific 
markers for the proteins, like antibodies or previously fused fluorescent labels. Fortunately, 
the strategy of substrate treatment with HMDS-vapour resulted not only in highest hydropho-
bicity but also led to a surface roughness of (0.40 ± 0.07) nm (n = 4). This value is even lower 
than that determined for the untreated SiO2 substrates with (0.88 ± 0.24) nm, as shown in the 
prior Chapter 4.1.1. Additionally, none of the substrates functionalised following this strategy 
exhibited any aggregates. The de-
termined features for the untreated 
silicon dioxide surfaces as refer-
ence were in good agreement with 
those determined for a smooth sili-
con wafer.164 However, the rough-
ness of the untreated substrate is 
vigorously larger than that deter-
mined for a freshly cleaved mica 
sheet, which is atomically 
smooth.165 A model considering the net energy decrease during spreading of a droplet on a 
rough surface,166 describes the well-known trend of very even surfaces to exhibit the highest 
hydrophilicity.163 Yet, the data gathered after vapour deposition contradict this trend when 
compared to the results of the other functionalisation strategies as illustrated in Figure 4.3. 
Moreover, in surface surveys the discrimination between hydrophilic and hydrophobic char-
acteristics is based on contact angles being <90° and >90°, respectively.167 Therefore, the desig-
nation of the HMDS treated substrates as “hydrophobic” is incorrect in its general sense. Due 
to drastic increases in hydrophobicity after HMDS functionalisation this connotation will still 
be maintained. 
The choice of HMDS as reagent for surface functionalisation instead of other substances lead-
ing to a self-assembled monolayer (SAM) was based on its good compatibility with the SiO2 
Figure 4.3: Illustration of the surface characteristics RMS (red) and hy-
drophilicity (contact angle, blue) for the different functionalisation 
techniques compared to an untreated SiO2 substrate. Error bars are 
the standard error of the mean with n ≥ 4. 
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substrates. Examples for SAM formation are on one hand the adsorption of thiols on gold as 
introduced by NUZZO and ALLARA in 1983,168 or on the other hand the functionalisation of 
hydrophilized silicon dioxide by covalent adsorption of trichlorosilanes.169 The first possibility 
was inadequate for the application in RIfS due to the lack of an interference layer (cf. Chapter 
3.5.1), yet, the second options would have been compatible with the deployed techniques as 
shown in former studies.170 CAPEL-SANCHEZ and colleagues discovered in comprehensive ex-
aminations by means of diffuse reflectance infrared Fourier transform (DRIFTS), solid-state 
nuclear magnetic resonance (NMR) and photoelectron spectroscopy that chemically grafting 
of silica with both trimethylsilyl chloride (TMSCl) and HMDS leads to a complete removal of 
terminal and geminal hydroxyl groups on the functionalised substrate, thus causing full sur-
face coverage by hydrophobic methyl groups.171 Furthermore, they found higher hydrophobi-
city for surfaces treated with HMDS, showing its advantage compared to TMSCl. HMDS ex-
hibits a single reaction site for interaction with the silicon dioxide, while other organosilicon 
compounds like the mentioned trichlorosilanes contain more of those sites. Therefore, such 
agents can form SAMs under ideal conditions, yet, other reaction pathways like covalent at-
tachment or vertical polymerisation are possible, too.172 The latter might result in an increased 
surface roughness and therefore was avoided by deploying HMDS to render the silicon diox-
ide substrates hydrophobic. When comparing the obtained surfaces, it becomes obvious that 
the substrate treatment with HMDS-vapour has been the most promising strategy. For this 
reason, subsequent hydrophobic solid supports preparation followed this protocol. 
  




-Some of the RIfS experiments have been performed by Jessica Nehls and Anna Lena 
Toschke as parts of their bachelor theses , and by Lucas Förster as part of his master the-
sis- 
Having determined the surface features of 
the silicon substrates that were applied as 
solid support in this work, it is now reason-
able to examine and compare the two model 
membranes (SLBs and SHMs). Both were 
prepared via spreading of small unilamellar 
vesicles (SUVs) on the two substrate types 
(cf. Chapter 3.3.4). The membrane for-
mation was performed either prior to the 
measurement in case of AFM and fluores-
cence microscopy experiments or in situ 
when working with reflectometric interfer-
ence spectroscopy (RIfS). The latter concedes the characterisation of this process in detail. In 
Figure 4.4 exemplary plots of the change in optical thickness (ΔOT) vs. the time (t) are pre-
sented. These have been recorded during the incubation of both hydrophilic (black) and hy-
drophobic (grey) SiO2 surfaces with POPC : PtdIns[4,5]P2 (99 : 1, n/n) SUVs in a closed circuit. 
While the addition of vesicle suspension (m = 0.2 mg) to the reaction chamber at t = 0 min leads 
to a rapid increase in optical thickness (OT) when working on hydrophilic silicon surfaces 
(black graph), the change induced on hydrophobically functionalised substrates (grey graph) 
is reduced. The maxima recorded in these specific measurements for ΔOT are 6.3 nm and 
2.8 nm for SLB and SHM, respectively. The statistics of ΔOT for the two membrane systems 
are displayed in Figure 4.5. Additional to the matrix- to receptor lipid ratio of 99 : 1 (cf. Figure 
4.4), the ΔOT values with increased receptor lipid concentrations are presented. Thereby, the 
influence of the PtdIns[4,5]P2 content on the resulting membrane thickness was assessed. The 
data represented in Figure 4.5 A correspond to the detected membrane thicknesses of SLBs 
while Figure 4.5 B shows ΔOT caused by SHM formation. 
Figure 4.4: Exemplary plots of the change in optical thick-
ness vs. the time during the process of model membrane 
formation after addition of SUV-suspension 
(POPC : PtdIns[4,5]P2, 99 : 1, n/n) at t = 0 min on either hy-
drophilic (black) or hydrophobic (grey) silicon dioxide sub-
strates. 
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The means of layer thickness for lipid bilayers prepared on hydrophilic SiO2 surfaces varies 
from a lower limit of (6.6 ± 0.5) nm for 3 mol% to (7.3 ± 0.6) nm for 5 mol% PtdIns[4,5]P2. The 
values determined for SHM thickness rank from (2.6 ± 0.2) nm for 6 mol% to a maximum of 
(3.0 ± 0.2) nm for 2 mol% of the bisphosphorylated receptor lipid. These values match the ex-
pectations as the model membrane on hydrophilic substrates is composed of two lipid leaflets 
whereas on hydrophobic ones only one leaflet is formed. Therefore, half the thickness of SLB 
was expected for SHMs. All calculations comprise at least five independent measurements and 
data sets were analysed using an analysis of variance (ANOVA) to determine significant dif-
ferences caused by the increased PtdIns[4,5]P2 content. Though, the rejection of the null hy-
pothesis was not possible as no significant difference between the membrane thicknesses could 
be detected. One can assume that the thickness of the formed lipid layer is independent of the 
amount of PtdIns[4,5]P2.  
According to Equation 3.12 the optical thickness is the product of the refractive index n and 
the physical thickness d. Hence, assuming n = 1.49173–175 the determined changes in OT caused 
by lipid membrane formation correspond to membrane thicknesses d of (1.9 ± 0.3) nm or 
(4.5 ± 0.3) nm for SHMs or SLBs, respectively. This is in good agreement with literature values 
ranging from 4 to 5 nm in case of SLBs.176 In contrast to that, also a thickness of (3.98 ± 0.08) nm 
has been reported for a bilayer investigated by means of small-angle neutron and X-ray scat-
tering.177 Those membranes, in contrast to the ones investigated in this work, were composed 
of POPC only and additionally were examined by techniques requiring other experimental 
Figure 4.5: Box plots of the model membrane thickness of SLB (A) and SHM (B) dependent of the PtdIns[4,5]P2 
content in the small unilamellar vesicles used for membrane formation. The boxes extent from upper and lower 
quartile while the whiskers represent 1st and 99th percentiles. The medians are shown as horizontals inside the boxes 
and the means are represented by red squares within the respective data sets. 
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conditions. A better comparability is given to a study employing SUVs composed of 
POPC : PtdIns[4,5]P2 (92 : 8, n/n) for membrane formation in RIfS-adsorption experiments, 
which found a SLB thickness of 4.2 nm.170 This value not only directly matches to the one de-
termined in this work, it also shows that even higher fractions of PtdIns[4,5]P2 above the ex-
amined range of 0 to 6 mol% do not influence the resulting layer thickness. In case of the SHMs 
the determined values are slightly reduced compared to those found for erythrocyte mem-
brane layers supported by alkanethiol monolayers on gold substrates.178,179 This discrepancy 
is, however, reasonable as the lipid monolayer in the referred studies were prepared from 
erythrocytes and thus were not only composed of lipid molecules but also contained mem-
brane proteins and other constituents which alter the thickness of a lipid membrane. 
It has been shown by LUDOLPHS et al. in adsorption studies to SLBs containing 10 mol% recep-
tor lipid, that collybistin 2 is not only specific for binding to PtdIns[4,5]P2 but is also capable 
of interacting with other phosphoinositide species.113 On this account also solid-supported 
membranes were prepared that were doped with either PtdIns[3]P or PtdIns[3,4,5]P3. They 
were prepared in analogy to those of PtdIns[4,5]P2 containing membranes (cf. Chapter 3.3.4). 
Therefore, it is possible to determine the effect of the phosphorylation degree on the lipid layer 
thickness. Multiple RIfS experiments were 
performed using SUVs composed of 
POPC : PtdIns[x]P (97 : 3, n / n) whose results 
are represented in Figure 4.6. The mean values 
of SHM thickness (red squares) calculated 
were (2.7 ± 0.6) nm for PtdIns[3]P (n = 24), 
(2.8 ± 0.4) nm for PtdIns[4,5]P2 (n = 31) and 
(2.8 ± 0.5) nm for PtdIns[3,4,5]P3 (n = 22). Fur-
thermore, an ANOVA analysis was performed 
detecting no significant difference between the 
hybrid membrane thicknesses caused by vari-
ation of the receptor lipid. Taking these results 
and those represented in Figure 4.5 together, one can state that neither the concentration of 
phosphoinositides nor their phosphorylation degree influence the layer thickness of the model 
systems in an extent detectable by means of RIfS. 
Figure 4.6: Box plots of SHM thicknesses containing 
3 mol% of different phosphoinositides. The boxes ex-
tent from upper to lower quartile while the whiskers 
represent 1st and 99th percentiles. The medians are 
shown as horizontals inside the boxes and the means 
are represented by red squares within the respective 
data sets. 




With the knowledge that the resulting model membrane thicknesses are independent of both 
phosphoinositide species and their concentration, at least in a range from 1-6 mol%, it is im-
portant to examine another relevant feature of the SLBs and SHMs which is the lateral lipid 
mobility. This is a crucial characteristic as a reduced mobility directly affects e.g. the adsorp-
tion process of cytosolic proteins. Each adsorbed protein might cover multiple receptor lipids 
at once due to its specific footprint which leads to a depletion of pinning points in the mem-
brane. To investigate the lipid mobility, fluorescence recovery after photobleaching (FRAP) 
experiments (cf. Chapter 3.7.4) were performed on membranes containing a small fraction 
(1 mol%, equal to 10 % of the total receptor lipid amount) of PtdIns[4,5]P2 labelled with the 
fluorescent dye BODIPY®-TMR (cf. Chapter 3.1.1.3). The experiments were all conducted with 
a confocal LSM 880 Examiner under slightly varying instrumental settings. Nonetheless, the 
time series detected on an SHM as illustrated in Figure 4.7 A is representative for all measure-
ments on both SLBs and SHMs. 
Prior to bleaching with a high intensity laser pulse, the membrane exhibited a homogeneously 
distributed fluorescence (t = -4 s). This indicates that no clusters of PtdIns[4,5]P2 in a detectable 
Figure 4.7: A: Time series exemplary displayed in four characteristic frames (t = -4 s, 0 s, 8 s, 90 s) showing the iden-
tical scanning area with a region of interest (ROI, highlighted with a white circle) during a fluorescence recovery 
after photobleaching experiment of an SHM (POPC : PtdIns[4,5]P2 : BODIPY-TMR-PtdIns[4,5]P2, 90 : 9 : 1, n/n/n) on 
a hydrophobically functionalised SiO2 surface. Scale bar: 10 µm. B: FRAP experiments on either SLB (black) or SHM 
(grey) led to intensity time course as those exemplary shown here. There is a drastic discrepancy in fluorescence 
recovery detectable between the two model membranes. This is expressed in variations of the diffusion coefficient 
D and the mobile fraction γ0, both being displayed in (C). 
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size were present within the membrane. Other studies focused on the receptor lipid distribu-
tion in the plasma membrane of PC12 cells. They determined inner-leaflet PtdIns[4,5]P2 micro-
domains of about 65 nm or 73 nm in size detected either by direct stochastic optical reconsti-
tution microscopy (dSTORM) or stimulated emission depletion (STED) microscopy.180,181 
Though, in both cases it can be assumed that clustering is induced by Ca2+ ions which are 
avoided within the model system applied in this work for this exact reason. Furthermore, the 
fluorescence images in Figure 4.7 A indicate that the duration of preparation did not lead to 
an aging process of the membranes. It would result in a great number of defects which would 
have been detected as areas without fluorescence. The laser pulse causes bleaching of dye mol-
ecules in the region of interest (ROI) in which the fluorescence intensity is detected over the 
whole experimental duration. After a characteristic time fluorescently labelled lipids laterally 
diffuse into while bleached ones leave the ROI causing a recovery of the fluorescence intensity. 
This process is vividly shown in the fluorescence micrographs at t = 8 s and t = 90 s. Exemplary 
background corrected intensity courses within the ROI during a FRAP-experiment for each 
membrane system are shown in Figure 4.7. The direct comparison visualises the presence of 
continuous lipid layers on both substrate functionalisations. But it also indicates a different 
recovery behaviour between SLB (black) and SHM (grey) that affects parameters like the dif-
fusion coefficient D and mobile fraction γ0. These parameters were calculated to be 
DSLB = (2.9 ± 0.2) μm2/s with a mobile fraction of 54 ± 9 % (n = 10) for supported lipid bilayer, 
while the values of SHMs were determined to be DSHM = (1.8 ± 0.5) μm2/s and γ0 = 81 ± 5 % 
(n = 7) (cf. Figure 4.7 C). Both values are larger compared to the diffusion of BODIPY®-TMR 
PtdIns[4,5]P2 in fibroblasts and epithelial cells with an average of D = (0.8 ± 0.2) μm2/s as de-
termined by GOLEBIEWSKA et al. via fluorescence correlation spectroscopy.182 Additionally, 
they examined the PtdIns[4,5]P2 diffusion in Rat1 cells to be D = (2.5 ± 0.8) μm2/s which is in 
the same range as the diffusion determined for SLBs. The reduced diffusion constant within 
the SHM compared to that of the SLB is reasonable under the assumption of a stronger hydro-
phobic interaction between the HMDS-functionalised surface and the hydrophobic fatty acid 
chains of the lipid molecules. Furthermore, the mobile fraction of the lipid bilayer is only about 
50 % and compared to that determined for SHMs considerably smaller. The same tendency 
has been recognised by BRAUNGER et al.,170 who determined a mobile fraction of 64 ± 3 % for 
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SLBs and 98 ± 3 % for SHMs with a different fluorescently labelled PtdIns[4,5]P2 on an alter-
native hydrophobic monolayer. The discrepancy can be explained with the direct interaction 
of the lower (proximal) leaflet in SLBs with the solid support resulting in an immobilisation of 
the PtdIns[4,5]P2 derivative. In case of PtdIns[4,5]P2 BAUMANN et al. assumed that the negative 
charge of the lipid (charge repulsion) and the steric demand of its head group (large hydration 
shell) are possible reasons for the mobility reduction in SLBs.183 They suggested pits in the 
negatively charged substrate as potential wells of suitable dimensions for the receptor lipid 
leading to a reduced diffusion. 
An additional aspect is the used labelled PtdIns[4,5]P2 derivative which was non-natural and 
differed from natural PtdIns[4,5]P2 due to shorter fatty acid chains. Therefore, the results did 
not report quantitative numbers of the latter’s diffusive behaviour, still clearly expressed the 
different diffusion in both membrane systems and additionally are in good agreement with 
diffusive parameters found in similar systems.170 
In conclusion the model membranes prepared on silicon dioxide substrates with two opposing 
surface features have shown to present all prerequisites necessary for detailed adsorption ex-
periments. Furthermore, both SLBs and SHMs provide features which are close to those of in 
vivo systems even though the hybrid membrane is composed of only a single lipid layer and 
thus is in general more far away from physiology. Nonetheless, these models facilitate a closer 
look on the effect of the respective surface on the coating of lipid layers when compared under 
exact same conditions. On this account the accessibility of PtdIns[4,5]P2 was addressed by ad-





-Some of the results presented in this  Chapter have been published in “Leaflet-Depend-
ent Distribution of PtdIns[4,5]P 2 in Supported Model Membranes” by J.Schäfer et al., 
Langmuir, 2020, 36, 1320-1328.158- 
-Some of the RIfS experiments have been performed by Jessica Nehls as part of her bach-
elor thesis- 
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-Atomic force micrographs of the SHMs were taken by Anna Lena Toschke as part of her 
bachelor thesis- 
In Chapter 1.4 the importance of in vitro model systems to characterise crucial physiological 
processes and interactions has already been mentioned. This is equally true for investigations 
focussing on the receptor lipid PtdIns[4,5]P2 which is the most abundant phosphoinositide in 
the plasma membrane.111,184 It is a known source for the second messengers inositol triphos-
phate (IP3) and diacylglycerol (DAG) and contributes to intracellular signalling processes.185 
Furthermore, it has a pivotal role in eukaryotic cell functions such as cytoskeletal dynamics, 
signal transduction, ion channel activation and endo- and exocytosis.97,186–189 In part, these func-
tions are based on the specific interaction of cytosolic proteins with PtdIns[4,5]P2.190–192 Some of 
these interaction partners harbouring protein domains of known and well-conserved struc-
tures like ENTH-, FERM-, FYVE-, PH-, PX-, and Tubby domains, while others bind via rather 
unstructured protein parts.96,193–196 Due to a rather simple preparation protocol (cf. Chapter 
3.3.4) SLBs doped with PtdIns[4,5]P2, which are negatively charged at physiological pH, are 
often produced via spreading of SUV on surfaces providing low surface roughness.105,197 The 
success of membrane formation depends on various factors among which the presence of di-
valent cations especially Ca2+, the ionic strength and pH of the environment, the vesicle size 
and lipid composition are decisive parameters.198–202 If the interplay of all these aspects is ap-
propriate, spontaneous rupturing of absorbed vesicles leads to lipid bilayer formation.203 Nev-
ertheless, it is necessary to keep in mind that some factors directly influence the formed SLB, 
such as the presence of Ca2+ induces aggregation of PtdIns[4,5]P2 in lipid monolayers and ves-
icles.204,205 Unfortunately, the effect of the hydrophilic surface properties of the solid support 
and especially the surface charge density of e.g. SiO2 or mica on the distribution of charged 
lipid molecules in the membrane leaflets has not been considered yet. Therefore, this Chapter 
will focus on the exact portion of accessible PtdIns[4,5]P2 molecules in an SLB. On this purpose 
advantage will be taken of the two model membrane systems characterised before, enabling 
determination of PtdIns[4,5]P2 accessibility via marker protein adsorption. The proteins uti-
lised as markers in this work are the N-terminal domain of ezrin (N-ERMAD) and the C-ter-
minal PH domain of collybistin 2 (CB2) both known to exhibit binding affinity to the phospho-
inositide. They were expressed in a recombinant fashion as described in Chapter 3.2.5, purified 
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with affinity chromatography (cf. Chapter 3.2.7.1) and identified with polyacrylamide gel elec-
trophoresis (PAGE) and Western blots (cf. Chapters 3.2.8 and 3.2.9). The results of this process 
are described in Chapter 4.2.1. The results of marker protein adsorption via RIfS experiments 
will be focus of Chapter 4.2.2, moreover, the examinations of surface coverage via AFM are 




The expression and isolation of the N-terminal domain of ezrin was conducted several times 
in the progress of this work following a protocol well consolidated throughout previous stud-
ies.206–208 After protein expression the target protein was purified via immobilised metal ion 
affinity chromatography (IMAC, cf. Chapter 3.2.7.1) taking advantage of the N-terminally 
fused His6-tag. A combination of sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE) with Western blot was performed to control the success of the target protein iso-
lation. Examples for both, PAGE and blot, are shown in Figure 4.8 A and B, respectively. 
The SDS-PAGE allows a qualitative classification using a mass reference only. In the superna-
tant (SN) after lysate clarification a variety of bands over the whole mass range (10 to 250 kDa) 
was detected. This number of bands was reduced both in quantity and intensity when com-
paring the traces of flow through (FT) and washing fraction 1 (WF1). While in WF2 and the 
early elution fraction (E2) no bands were detected, in each of the other elution fractions (E6 to 
Figure 4.8: A: SDS-PAGE of N-ERMAD with the supernatant after ultra-centrifugation (SN), the flow through (FT) 
and washing fractions (WF), and multiple elution fractions (E) loaded to the polyacrylamide gel. B: Corresponding 
Western blot overlay (of luminescence and marker image) with two early elution fractions of N-ERMAD loaded to 
the gel and a specific primary antibody against the N-terminally fussed His6-tag. 
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E18) a single vigorous band with a mass between 35 and 55 kDa was exclusively visible. This 
band was also present in SN in a prevalent fashion while in FT, WF1 and 2 no correlating signal 
was detected. These results suggest that the incubation of the immobile IMAC phase 
(NTA(Ni2+) agarose) with the clarified lysate led to a specific fixation of the proteins correlating 
with this band. Additionally, the gel shows that none of the other proteins interacted with the 
resin due to their detection in the flow through and WF1. These proteins were completely 
removed from the column as fraction WF2 did not show any signal within its trace. The lack 
of bands within the early elution fractions (represented by E2) can be explained by both the 
dead volume of the column outlet and a short duration of tag cleavage. Another reason for 
this can be accounted for the detection limit of SDS-PAGE, which was proven by an additional 
Western blot as shown in Figure 4.8 B. The WB exhibits an increased sensitivity, achieved 
through use of specific antibody (Anti-His), and is therefore capable of detecting in a lower 
concentration regime than PAGE,209,210 resulting in a predominant signal for a His6-tag carrying 
protein with a mass again ranging between 35 and 55 kDa. Also, bands with reduced intensity 
were detected in the lower molecular regime. These might correspond to not completely ex-
pressed protein fragments as the His6-tag is N-terminally fused and thus expressed first.  
The theoretical mass of N-ERMAD calculated with the PROTPARAM tool211 is Mtheo = 38.75 kDa 
based on the known amino acid sequence (cf. Appendix A.4.1), therefore it is reasonable to 
assume that the most intense band in both SDS-PAGE and WB correlates with the target pro-
tein, even though it appears at slightly higher masses. This tendency is also known for the full-
length protein ezrin and is declared to be caused by the high intrinsic charge of the protein.212 
This can also be transferred to N-ERMAD, which contains 91 charges amino acids among the 
332 in total, leading to an anomalous migration within the electric field during PAGE. Since 
the SDS-PAGE only shows this specific protein band in the elution fractions the isolation was 
successful, notwithstanding the fact that in WB slight contaminations of lower and higher mo-
lecular weights have been detected. Afterwards, the protein was dialysed against E1 buffer (cf. 
Table 3.14) and subsequently stored at 4 °C until further use in adsorption experiments. 
 




The C-terminal PH domain of collybistin 2 (CB2PH, Mtheo = 20.96 kDa) was expressed from E. 
coli cells containing the vector pTYB21. After lysis and ultra-centrifugation, the clarified lysate 
was applied on an affinity chromatography column containing a chitin resin as immobile 
phase. The process and success of this purification steps were controlled via SDS-PAGE as 
exemplary shown in Figure 4.9 A. 
In the exemplary SDS-PAGE multiple bands were detected in all traces of supernatant (SN), 
flow through (FT) and washing fraction 1 (WF1) with diminishing intensities. The fraction of 
the second washing step (WF2) presented no bands, while in all elution fractions (E2 to E8) 
three well separated bands were detected. The intensities of all signals decreased with higher 
fraction numbers suggesting a gradual removal from the chitin resin by elution. The prevalent 
band was located between the 15 and 25 kDa bands of the mass standard in contrast to the 
other two that were visible at higher molecular weights. These results suggest that the domi-
nant band in E2 to E8 correlates with CB2PH based on the known calculated molecular weight. 
The SN clearly indicates that next to CB2PH a larger number of other proteins was expressed. 
The target protein was immobilised and remained on the column while the majority of pro-
teins either directly flow through the column without retention (FT) or was washed from it in 
the first washing fraction (WF1). This assumption is based on the absence of a predominant 
signal within the corresponding mass range between 15 and 25 kDa in both traces. The second 
washing step not only was used to remove further contaminations but also increased the con-
Figure 4.9: A: SDS-PAGE of the collybistin isoform CB2PH after purification via affinity chromatography against a 
chitin resin. The collected fractions of supernatant (SN), flow through (FT), washing (WF) and elution (E) were 
investigated to control the isolation of the target protein. B: Western blot overlay with isolation fractions tested for 
CB2PH under the use of a specific CB2 primary antibody. 
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centration of DTT on the column, thus, inducing the cleavage of the affinity tag from the pro-
tein allowing the elution of the later. Nonetheless, the extra signals needed additional exami-
nation to make sure whether they corresponded to oligomers of the PH domain or other col-
lybistin isoforms. Thus, a Western blot was performed with a specific primary antibody 
against collybistin 2. As clearly shown in Figure 4.9 B the impurities of around 70 kDa were 
also present in the FT and WF1. Yet, they did not correspond to the similar proteins detected 
in the elution fractions of the SDS-PAGE because no such signal was visible in the elution 
fractions of the WB. In the elution fractions examined by WB, however a small contamination 
of 14 kDa was detected. Therefore, the protein corresponding to the signal must contain the 
epitope sequence to the used antibody suggesting the existence of an incomplete PH domain 
fragment. However, it was refrained from a subsequent application to an ion-exchange chro-
matography (IEC) due to no significant improvement in purity as shown in previous work.213 
A size-exclusion chromatography was also discarded as a successful separation of molecules 
with a molecular weight difference of around 6 kDa was unlikely. Accordingly, the protein 
solution was stored at 4 °C until it was transferred into another buffer system (cf. Chapter 
3.2.10.2) directly before use in adsorption experiments which will also be focus of the following 
section. 





The issue of receptor lipid accessibility for marker protein adsorption in SLBs and SHMs as a 
function of different nominal PtdIns[4,5]P2 concentrations in the SUVs was addressed by RIfS 
experiments. This allowed monitoring of the time-resolved change in OT, which is a good 
readout parameter for the amount of bound 
protein. OT is the product of the refractive index 
n and the physical thickness d. With the refrac-
tive indices for silicon dioxide, lipid membranes 
and proteins being in a similar range,145,214,215 de-
tected changes in OT can be correlated to 
changes of the physical layer thickness induced 
by deposition and adsorption in the scanning 
area (1 mm2). While the prepared membranes 
contained different nominal amounts of phos-
phoinositide the concentration of added 
N-ERMAD in solution remained constant. A 
typical graph of such an experiment is pre-
sented in Figure 4.10 A for an SLB prepared via 
SUV (POPC : PtdIns[4,5]P2, 96 : 4, n/n) spread-
ing on hydrophilic SiO2. The arrows in this im-
age indicate from left to right the incubation 
with SUV suspension, followed by rinsing with 
E1-buffer (cf. Table 3.14) and the addition of N-
ERMAD (c = 850 nM). The experimental course was identical for all measurements independ-
ent of the solid support or the receptor lipid concentration resulting in N-ERMAD adsorption 
as exemplary portrayed in Figure 4.10 B on SLBs with increasing PtdIns[4,5]P2 fractions from 
0 to 6 mol%. The adsorption curves firstly show no nonspecific binding of N-ERMAD in the 
absence of PtdIns[4,5]P2 and secondly indicate that with an increasing ratio of receptor lipid 
also the amount of adsorbed protein rose, represented by a higher ΔOT value. Only at higher 
Figure 4.10: A: Exemplary plot of the change in optical 
thickness vs. the time of an adsorption experiment 
with N-ERMAD (850 nM) on an SLB formed via SUV 
(POPC : PtdIns[4,5]P2, 96 : 4, n/n) spreading on a hy-
drophilic SiO2 substrate. The arrows indicate from left 
to right: addition of SUV-suspension, buffer system 
change and incubation with N-ERMAD. B: Examples 
of N-ERMAD (c = 850 nM) adsorption to SLBs with re-
ceptor lipid concentrations from 0 to 6 mol% as indi-
cated. 




tions of 5 and 6 mol% no further 
increase was detected. This 
might hint at maximum surface 
coverage by N-ERMAD. A simi-
lar trend was found for the ezrin 
mutant T567D in RIfS adsorp-
tion experiments.187 By reading 
out the maximum change in op-
tical thickness for the adsorption 
to both SLB and SHM under oth-
erwise exact same conditions 
the amount of bound protein 
was determined as presented in Figure 4.11. The graph shows that incubation with N-ERMAD 
leads to larger changes in OT on hybrid membranes than those detected on lipid bilayers over 
all fractions of PtdIns[4,5]P2. This clearly demonstrates that the concentration of accessible re-
ceptor lipid is higher in SHMs than in SLBs. To estimate a relation factor describing the acces-
sibility discrepancy, the determined ΔOTs for SHMs were divided by the corresponding 
changes on SLBs at each receptor lipid content. The calculated asymmetry factors are summa-
rised in Table 4.1. 
Table 4.1: Asymmetry factors determined for N-ERMAD adsorption at different receptor lipid fractions. 
PtdIns[4,5]P2 1 2 3 4 5 6 
asymmetry factors 21.7 5.7 3.5 3.2 2.8 2.7 
 
The values are evidence for the heterogeneous distribution of PtdIns[4,5]P2 in silicon dioxide 
supported lipid bilayer resulting in an enrichment of the negatively charged lipid in the prox-
imal leaflet. Consequently, a mismatch arises between nominal and accessible receptor lipid 
content. 
 
Figure 4.11: Statistical analysis of the maximum ΔOTs obtained for N-
ERMAD adsorption on SLBs (black) and SHMs (grey), respectively, as a 
function of PtdIns[4,5]P2 in the membrane. Error bars are the standard 
error of the mean with n ≥ 4. 




In addition to the single injection experiments (cf. Figure 3.8 A) on varying PtdIns[4,5]P2 frac-
tions also measurements were performed in which a successive and stepwise increase in pro-
tein concentration took place while the receptor lipid concentration remained constant (cf. Fig-
ure 3.8 B). To rule out that the observed differences shown in Figure 4.11 and Table 4.1 are a 
function of the protein under investigation, two different proteins were used harbouring either 
the FERM domain (N-ERMAD) or a PH domain (CB2PH). In case of N-ERMAD a receptor lipid 
concentration of 1 mol% was chosen to obtain on one hand a good signal to noise ratio but also 
to guarantee that no maximum protein surface coverage was reached. On the other hand, for 
CB2PH a higher phosphoinositide concentration of 10 mol% was employed to ensure a good 
signal to noise ratio and to obtain similar changes in optical thickness for both proteins.113 The 
stepwise concentration increase from either 0 to 1.5 µM for N-ERMAD or from 0 to 3.5 µM for 
CB2PH resulted in adsorption curves like those exemplary shown in Figure 4.12 A or B, respec-
tively. To highlight the adsorption process the established membrane plateaus were set to zero  
(ΔOTSLB = ΔOTSHM 
!
= 0 nm, cf. Figure 3.8 B). The successive protein injections were performed 
in an open system configuration, therefore an adequate volume of protein solution had to be 
applied to ensure the detection of newly reached plateaus simplifying the ΔOT determina-
tions. As shown in Figure 4.12 A the exposure of both membranes doped with 1 mol% 
Figure 4.12: Exemplary plots of the change in optical thickness vs. the time during the adsorption of N-ERMAD (A) 
and CB2PH (B) on either SLBs (black) or SHMs (grey). In case of N-ERMAD the membranes were composed of 
(POPC : PtdIns[4,5]P2, 99 : 1, n/n), while for CB2PH the membrane composition was (POPC : PtdIns[4,5]P2, 9 : 1, n/n). 
The successive protein injections resulted in a stepwise concentration increase as indicated by the red dashed lines 
which also mark the moments of protein addition. The corresponding protein concentration is also indicated in 
each injection frame. 
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PtdIns[4,5]P2 to small N-ERMAD concentration (c < 50 nm) led to no or only slight changes in 
optical thickness in case of SLB or SHM, respectively, indicating a very low amount of ad-
sorbed protein. This is reasonable as the membranes also exhibited only a poor pinning point 
density at this receptor lipid content. Nevertheless, with increasing protein concentration the 
optical thickness is drastically raised on SHM compared to the signal changes on the lipid 
bilayer. These results are in good agreement with the trend detected on increasing 
PtdIns[4,5]P2 concentrations as shown in Figure 4.11. Additionally, the graphs in Figure 4.12 
B prove that the discrepancy in adsorbed protein is not a N-ERMAD specific feature but was 
also detected for CB2PH. This consequently indicates that there is a discrepancy in concentra-
tion of accessible receptor lipid between the solid-supported bilayer and the hybrid mem-
brane. This effect seems to be more pronounced in case of CB2PH as the ΔOTs on the SHM are 
a multiple of those detected on the SLB after protein addition, although the pinning point den-
sity in the model membranes of these experiments was significantly increased. These findings 
are mirrored in the statistics of all multiple injection experiments that are summarised in Fig-
ure 4.13. For N-ERMAD (cf. Figure 4.13 A) each data point is based on at least four independ-
ent measurements, while the data set of CB2PH shown in Figure 4.13 B is composed of at least 
three individual results. 
Again, the graphs indicate a higher amount of adsorbed protein in the hybrid membrane sys-
tem in contrast to that on the SLBs, allowing another determination of asymmetry factors for 
either N-ERMAD (cf. Table 4.2) or CB2PH (cf. Table 4.3). 
Figure 4.13: A: Adsorption isotherms of N-ERMAD on POPC : PtdIns[4,5]P2 (99 : 1, n/n) membranes. Error bars are 
the standard error of the mean with n ≥ 4. B: Adsorption isotherms of CB2PH on POPC/PtdIns[4,5]P2 (9 : 1, n/n) 
membranes. Error bars are the standard error of the mean with n ≥ 3. 
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Table 4.2: Asymmetry factors determined for adsorptions of various N-ERMAD concentrations at a constant re-
ceptor lipid fraction. 
Protein N-ERMAD 
(PtdIns[4,5]P2) / mol% 1 
c(Protein) / µM 0.01 0.025 0.05 0.10 0.25 0.50 0.85 1.50 
Asymmetry factor 7.6 7.9 11.8 5.3 4.0 2.8 2.4 2.0 
 
Table 4.3: Asymmetry factors determined for adsorptions of various CB2PH concentrations at a constant receptor 
lipid fraction of 10 mol%. 
Protein CB2PH 
(PtdIns[4,5]P2) / mol% 10 
c(Protein) / µM 0.25 0.50 0.75 1.00 2.00 3.00 4.00 5.00 
Asymmetry factor 10.0 8.1 8.1 6.8 4.1 3.2 3.0 2.5 
 
The calculated factors first of all support the assumption of a heterogeneous receptor lipid 
distribution inside an SLB. However, it appears that with higher amount of protein available 
the discrepancy is alleviated for both proteins. Whereby this tendency is more pronounced in 
case of N-ERMAD as it became obvious for lower protein concentrations tested than those 
applied during CB2PH examination. 
 
Refocussing on Figure 4.13, it seems that only isotherms detected on lipid monolayers reach a 
saturation. Therefore, these data were used to determine thermodynamic parameters such as 
the affinities of both proteins for PtdIns[4,5]P2. For this type of analysis, the adsorption iso-
therm of LANGMUIR describing the dynamic equilibrium of adsorption and desorption pro-
cesses on interfaces in dependency of temperature and concentration can be deployed. It is 
based on the following assumptions: 
o The adsorption of molecules on an interface leads to a mono molecular layer. 
o The surface quality is uniform, and all pinning points are equal. 
o The amount of pinning points is finite. 
o The adsorption to each pinning point is independent of all other interaction sides. 
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In his theory LANGMUIR not only considered the adsorption process of a ligand L to pinning 
point P but also the transport of ligands to the interface. The concentration of freely diffusing 
ligands cL in the interaction layer is reduced due to binding of L to P. This decrease must be 
compensated by transport of L to the interaction layer and only in case the transport is at least 
ten times faster than the adsorption, the latter is the rate-determining process. The dynamic 
equilibrium of freely diffusing (L) and adsorbed ligand (L-P) is described by: 
Here k+ describes the rate constant of adsorption while k- correlates to the desorption process. 
This leads to the following differential equation for the adsorption speed of L: 
𝑑ΓL−P(𝑡)
𝑑𝑡
= 𝑘+ΓP(𝑡)𝑐L(𝑡) − 𝑘
−ΓL−P(𝑡) 4.1 
In Equation 4.1 cL(t) describes the concentration of free ligand, ΓP(t) and ΓL-P(t) the area concen-
trations of either vacant pinning points or bound L at moment t. When assuming an excess of 
L towards P, cL(t) equals the initial concentration cL,0 at t = 0. Furthermore, the vacant pinning 
points ΓP(t) can be expressed by ΓP,0-ΓL-P(t) with ΓP,0 being the initial concentrations of pinning 
points. Both relations lead to a modification of Equation 4.1 resulting in Equation 4.2: 
𝑑ΓL−P(𝑡)
𝑑𝑡
+ (𝑘+𝑐L,0 + 𝑘
−)ΓL−P(𝑡) = 𝑘
+𝑐L,0ΓP,0 4.2 
When adsorption and desorption rates are equal in equilibrium, the change of occupied pin-
ning points dΓL-P(t)/d(t) is zero which simplifies the equation to: 
𝑘+𝑐L,0(ΓP,0 − ΓL−P) = 𝑘
−ΓL−P 4.3 
In equation ΓL-P depicts the concentration of bound ligand in the equilibrium state. In general, 
the dissociation constant KD is defined by the rate constant for adsorption and desorption by 










Substitutions in Equation 4.3 under consideration of the relation outlined in Equations 4.4 and 
4.5 result in a term for the surface occupancy in the system: 







In this work the surface coverage was determined via RIfS as exemplary shown in Figure 4.13 











From an application of ΔOT against the concentration of ligand, being the concentration of 
injected marker proteins (both N-ERMAD and CB2PH), an adsorption isotherm is obtained. By 
fitting Equation 4.8 to the resulting graph the thermodynamic parameter KD can be deter-
mined. 
This was done for the data of N-ERMAD adsorption to SHMs illustrated in Figure 4.13 result-
ing in a dissociation constant of KD(N-ERMAD) = (72 ± 12) nM. No KD value for N-ERMAD to 
PtdIns[4,5]P2 has been reported so far. Though a former study examined a KD value of 52 nM 
for the full-length protein of ezrin (wild-type) by means of quartz crystal microbalance (QCM) 
experiments which at least is in the same range.216 
The RIfS examinations in total showed that there are effects on hydrophilic silicon dioxide 
substrates present leading to a heterogeneous PtdIns[4,5]P2 distribution inside the two leaflets 
of SLBs. This distribution causes a depletion in accessible receptor lipid concentration in con-
trast to that of an SHM, resulting in a decreased amount of bound marker proteins on the SLB 
surface. But to guarantee that this discovery is a function of bound protein and not induced 
by, for example, an increased number of defects in the membrane owing to the different func-
tionalisation strategies, the surface coverage was independently analysed by AFM. The results 
gathered by this experimental approach will be displayed in the subsequent section. 
 
 
Contrary to RIfS, atomic force microscopy is an invasive technique. It was used to verify the 
findings on protein adsorption discrepancy between solid-supported lipid bilayers and hybrid 
membranes, both on silicon dioxide substrates. Based on the results gathered by means of RIfS, 
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it remained elusive whether the determined trend was caused by heterogeneities, like for ex-
ample membrane defects, in the model membranes. This option can be validated by AFM as a 
direct distinction between membrane surface and adsorbed deposits is possible. However, due 
to the invasive character caused by the direct interaction of the cantilever with the surface of 
the specimens their features had to be adjusted to obtain micrographs of optimum quality. On 
this account, next to POPC also DPPC (cf. Scheme 3.1) was deployed as matrix lipid. The latter 
is in the crystalline phase at room temperature because of the high main transition temperature 
of 41 °C. Thus, the DPPC membranes provide rigid features leading to a reduced lateral mo-
tion of the lipids and consequently of adsorbed proteins in case of N-ERMAD. This feature 
allows imaging at a reduced speed resulting in micrographs with high contrast and sharp res-
olution.217 Two of these micrographs are presented in Figure 4.14 showing an SLB (A) and 
SHM (B) composed of DPPC : PtdIns[4,5]P2 (97 : 3, n/n) before addition of N-ERMAD. 
Both images indicate homogeneous membrane surfaces with only slight fluctuations in height 
without any defects present, that would have been represented by black areas inside the oth-
erwise uniform lipid layers. Based on these results obtained from membranes that were at least 
two hours old due to their preparation process and the subsequent control via fluorescence 
microscopy (cf. Chapter 3.3.4), it can be assumed that the membranes formed in situ during 
RIfS experiments exhibited similar qualities. Furthermore, resulting membrane features 
should be independent of the matrix lipid (DPPC or POPC) if all preparation steps were per-
formed above the corresponding main transition temperature. Only the lipid mobility will be 
reduced in the resulting DPPC membranes. These identical qualities have been proven in var-
ious studies which employed different surface-sensitive technique such as RIFTS, AFM and 
Figure 4.14: Atomic force micrographs of an SLB (A) and SHM (B) composed of DPPC : PtdIns[4,5]P2 (97 : 3, n/n) 
prior to N-ERMAD addition. Scale bars: 500 nm. 
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dissipation-enhanced QCM.218–220 Moreover, LIND et al. were able to show, that the preparation 
of SLBs from DPPC-SUVs is even possible when working below the main transition tempera-
ture.221 
The membranes of proven quality were subsequently exposed to the marker proteins for at 
least one hour at room temperature and then imaged in intermittent-contact mode (cf. Chapter 
3.6.3). Examples of such micrographs presenting higher structures on the membrane surface, 
which were attributed to adsorbed N-ERMAD on either SLB (A) or SHM (B), are illustrated in 
Figure 4.15. 
Both micrographs (upper left) show adsorbed N-ERMAD structures (golden) on top of the 
membrane surfaces (brown). It is obvious that the protein arranges in different shapes on SLB 
and SHM. While the protein deposits on SLBs tend to form reticular structures (cf. Figure 4.15 
A) which has also been observed by SHABARDINA et al.,217 N-ERMAD on SHMs rather forms 
greater aggregates of no specific shape (cf. Figure 4.15 B). Nonetheless, in both cases adsorbed 
protein structures and membrane could be distinguished by applying a threshold. The thresh-
olding process resulted in black and white images of the original data, with white representing 
the surface covered by protein. These are shown as overlays in the lower right half of both 
micrographs in Figure 4.15.  
In analogy to these examinations, topographical experiments on SLBs and SHMs, containing 
a strongly increased amount of receptor lipid (10 mol%), after CB2PH adsorption have also been 
performed. Representative for the gathered results Figure 4.17 displays two micrographs of 
CB2PH on either SLB (A) or SHM (B). 
Figure 4.15: Atomic force micrographs of model membranes composed of DPPC : PtdIns[4,5]P2 (97 : 3, n/n) with 
N-ERMAD adsorbed to an SLB (A) and SHM (B). Scale bars: 1 µm. The micrographs (original data represented in 
the upper left half) were analysed using a threshold to distinguish uncovered membrane (in black) from protein 
deposits (in white) shown as overlays in the lower right half of both micrographs. 
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In contrast to the shape of the N-ERMAD deposits only small CB2PH aggregates were detected 
on both membrane systems. The direct comparison between Figure 4.17 A and B vividly 
demonstrate that the amount of adsorbed protein is increased on SHMs. This trend is better 
visible in the black and white images after thresholding. For both proteins, N-ERMAD and 
CB2PH, the analysed micrographs were used to determine the surface coverage by adsorbed 
protein as shown in Figure 4.16. It is based on the values of 14 ± 3 % surface coverage by N-
ERMAD on the membrane in case of SLBs, whereas the occupancy was larger with 31 ± 6 % 
on SHMs determined from three individual experiments. The same holds true for the values 
calculated for CB2PH being 5.7 ± 1.2 % on SLBs and 31.0 ± 1.3 % on SHMs. Under consideration 
of the AFM data a third asymmetry factor calculation 
was performed whose results are reported in Table 
4.4. 
Consequently, Figure 4.16 also illustrates the drastic 
discrepancy in surface coverage by marker protein be-
tween the lipid bilayer and the hybrid system. These 
findings support the assumption based on the RIfS re-
sults that hydrophilic SiO2 substrate surfaces affect 
the distribution of PtdIns[4,5]P2 within SLBs causing 
a depletion of the receptor lipid in the distal leaflet 
and rendering the majority of these lipid inaccessible 
for specific binding partners. 
Figure 4.17: Atomic force micrographs of model membranes composed of POPC : PtdIns[4,5]P2 (9 : 1, n/n) with 
CB2PH adsorbed to an SLB (A) and SHM (B). Scale bars: 500 nm. The micrographs (original data represented in the 
upper left half) were analysed using a threshold to distinguish uncovered membrane (in black) from protein de-
posits (in white) shown as overlays in the lower right half of both micrographs. 
Figure 4.16: Protein surface coverage on SLBs 
and SHMS for N-ERMAD (DPPC : 
PtdIns[4,5]P2 (97 : 3, n/n)) with (14 ± 3) % on 
SLBs and (31 ± 6) % on SHMs (n = 3) and for 
CB2PH adsorption to 10 mol% PtdIns[4,5]P2 
with (5.7± 1.2) % on SLBs and (31.0± 1.3) % on 
SHMs (n = 5). 
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Table 4.4: Calculated asymmetry factors based on the surface coverages determined via AFM. 
Protein N-ERMAD CB2PH 
(PtdIns[4,5]P2) / mol% 3 10 




Both data gathered by means of RIfS and AFM on the adsorption of marker proteins to 
PtdIns[4,5]P2, indicate an intrinsic heterogeneity in the receptor lipid distribution within solid-
supported lipid bilayers using silicon dioxide surfaces. This is a substantial finding as plenty 
of studies have been based on such SLBs. Among those were protein binding examinations 
from NÖDING et al. who applied SLBs with varying PtdIns[4,5]P2 concentrations to build up a 
minimal actin cortex (MAC) and to correlate the actin architecture with its viscoelastic prop-
erties.187 Apart from this, the complex membrane-binding mechanism of the phosphatase and 
tensin homolog (PTEN) was investigated on the same model membrane system.222 While both 
surveys followed an SLB preparation protocol similar to the one applied in this work, 
DRÜCKER et al. also used a low pH of 4.6, but increased the sodium chloride concentration to 
150 mM to prepare SLBs on SiO2 and subsequently investigated the annexin A2—PtdIns[4,5]P2 
interaction.223 Regardless of the membrane formation conditions, all previous results were in-
terpreted under the premise of a homogeneous PtdIns[4,5]P2 distribution in the model mem-
brane. This was insofar reasonable when considering the results of RICHTER et al. whose QCM-
D experiments proved a homogeneous distribution of the negatively charged lipid DOPS in 
SLBs generated by SUV spreading on SiO2 surfaces.224 However, they also found that spread-
ing of the same vesicles on mica led to SLBs in which the accessible amount of DOPS is reduced 
to the nominal concentration of the negatively charged molecules. In this study they used the 
specific adsorption of prothrombin to DOPS as a readout parameter for accessibility of the 
latter. They concluded that the asymmetry is already produced during the spreading process 
and proposed a lipid transfer across the edges of bilayer patches (10-4 to 1 µm2) that are formed 
during bilayer formation on mica,225 which takes place on short time scales below 1 s. But on 
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silicon dioxide, the spreading process of vesicles follows a different track, starting with adhe-
sion of intact SUVs up to a critical surface concentration followed by wave-like rupturing of 
the lipid spheres which was impressively shown by interferometric scattering microscopy (iS-
CAT) experiments.226 Along this line, BISWAS et al. performed a comprehensive study in which 
they looked in detail at the different vesicle adsorption and spreading pathways. Their results 
indicated that the spreading of negatively charged phospholipid vesicles (DOPC : DOPS, 7 : 3, 
n/n) onto SiO2 surfaces is dictated by interfacial forces (electrostatics and steric hydration 
forces) which they tested by systematically varying the pH and the membrane surface charge 
of the vesicles. Furthermore, they observed that bilayers only are formed within a pH range of 
2 to 6, whereas larger pH values prevent the spreading process. Similar tendencies have been 
found by BRAUNGER et al. who detected that high PtdIns[4,5]P2 concentrations (>4 mol%) pre-
vent spreading on hydrophilic silicon dioxide surfaces if a pH of 7.4 is adjusted.170 A decrease 
in pH of the buffer to 4.8 reduces the net charge of PtdIns[4,5]P2 to -3,227 and thereby facilitates 
the spreading of vesicles containing up to 10 mol% PtdIns[4,5]P2 as shown in a former study 
on CB2 adsorption.113 At pH 4.8 the net charge of POPC : PtdIns[4,5]P2 (9 : 1) SUVs matches 
that of vesicles with a lipid composition of DOPC : DOPS (7 : 3) and both compositions indeed 
spread at low pH. Thus, both examples indicate the strong influence of the vesicles’ negative 
surface charge density on the spreading process, which is even more comprehensible when 
considering that the SiO2 support is negatively charged at this pH due to its isoelectric point 
ranging from 1.0 to 3.7.228,229 However, it remains unknown to what extent the vesicle spread-
ing pathway on SiO2 affects the leaflet distribution of negatively charged lipids. 
In the special case of PtdIns[4,5]P2 containing membranes, another aspect has to be taken into 
account. Not only electrostatic repulsion but also attractive forces can occur due to the capa-
bility of PtdIns[4,5]P2 to form hydrogen bonds,230,231 further influencing the spreading path-
way. This might be another cause for the increased immobility of labelled PtdIns[4,5]P2 with 
only about 50 % in SLBs compared to 80 % in SHMs. 
A third aspect that needs to be discussed is the high steric demand of the headgroup of 
PtdIns[4,5]P2. The inositol ring with its phosphate substituents in 4- and 5-position demands 
an area of 70 Å2 being slightly increased compared to the area occupied by the headgroup of 
phosphatidylserine (65 Å2).232,233 If compared to phosphatidylcholine, the headgroup of 
PtdIns[4,5]P2 is even 40 % lager.234 Furthermore, LI et al. reported an exposed position of the 
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phosphoinositide’s headgroup into the aqueous phase when contained in a POPC lipid bilayer 
based on molecular dynamics (MD) simulations.235 Thus, it is conceivable that owing to the 
large head group there is already an asymmetric PtdIns[4,5]P2 distribution present in SUVs. 
This is supported by the findings of CHIANTIA et al. They showed that the large curvature of a 
vesicle with a radius smaller than 70 nm causes the lipid in the outer leaflet to be further apart 
from each other in contrast to those of the inner leaflet.236 This suggests more available space 
in the outer leaflet for lipids with a high steric demand such as PtdIns[4,5]P2. In the exact same 
direction point the results of SAKUMA et al. who observed an enrichment of cone-shaped lipids 
in the outer leaflet of SUVs.237 Based on the outlined indications a lipid distribution dictated 
by that inside the vesicles could be assumed, yet in that case also the spreading mechanism 
has to be taken into account. The mechanism has been subject of extensive discussions since 
the preparation of solid-supported lipid bilayers via vesicle spreading was introduced by 
MCCONNELL et al. in the 1980s.238,239 The dispute focusses on the question whether the spread-
ing is an inside-up or outside-up process, meaning which lipid leaflet (inside or outside one) 
of the vesicles faces the bulk solution after membrane formation, and thus is accessible for 
potential interaction partners.108,240 Arguments for an outside-up process have been presented 
in two studies deploying transmembrane protein containing liposomes to test either activity 
after proteolytic digestion241 or binding capability.242 In contrast to that, REIMHULT et al. found 
that at best 30 to 40 % of biotinylated lipids face the bulk solution after spreading of vesicles. 
The specific lipids were selectively incorporated in the outer monolayer of those vesicles.243 
They assumed a transient mixing process between inner and outer leaflets during rupturing 
process of the adsorbed vesicles, which accordingly is critically dependent on the bilayer for-
mation rate. Furthermore, a lipid translocation across the established bilayer at a later stage is 
hindered by a high energy barrier composed of the high resistance of the polar headgroups to 
passage through the hydrophobic core and the increasing lateral tension arising in the receiv-
ing leaflet.244 Considering these indications, the presented results hint at an inside-up SLB for-
mation mechanism, however to which extend the PtdIns[4,5]P2 asymmetry is a result of the 
spreading process or is already generated in the highly curved SUVs remains unclear. There-
fore, subsequently further investigations should be conducted in which the surface properties 
of the solid support and the vesicle size will be varied. Notwithstanding these uncertainties, 
the results highlight the usability of SHMs to develop sensor surfaces that can be applied to 
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quantitatively study lipid-protein interactions although these type of model membranes do 
not fully resemble the natural bilayer situation. 
 
 
Based on the marker protein adsorption to both SLBs and SHMs studied by means of RIfS and 
AFM as presented in Chapters 4.2.2 and 4.2.3, respectively, the discrepancy in amount of ad-
sorbed protein was calculated as asymmetry factors. These factors indicated that in case of an 
increase for both receptor lipid fraction and marker protein concentration the discrepancy de-
clined as illustrated in Figure 4.18 A and B. 
This effect was more pronounced in case of ezrin’s N-terminal domain compared to CB2PH and 
might be caused by the tendency of ezrin to laterally interact on the membrane surface. The 
ability results in an adsorption without a direct linkage to the receptor lipid.245,246 This assump-
tion is supported by another set of adsorption 
experiments with a successive increase in N-
ERMAD concentration on SLBs and SHMs 
doped with 3 mol% PtdIns[4,5]P2. The result-
ing adsorption isotherms show that there is no 
difference in the amount of bound protein be-
tween the two model membrane systems (cf. 
Figure 4.19), which has also been tested via a 
STUDENT’s t-test for each protein concentra-
Figure 4.18: Asymmetry factors of N-ERMAD adsorption calculated as ratio of changes in optical thickness on 
SHMs and SLB determined either on POPC model membranes with different PtdIns[4,5]P2 fractions (A) or on mem-
branes composed of POPC : PtdIns[4,5]P2 (99 : 1, n/n) exposed to ascending N-ERMAD concentrations (B). 
Figure 4.19: Adsorption isotherms of N-ERMAD on 
POPC : PtdIns[4,5]P2 (97 : 3, n/n) membranes. Error bars 
are the standard error of the mean with n ≥ 10. 
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tion, detecting no significant difference between the ΔOTs on both membranes. It is, however, 
not possible to quantitatively determine the impact of N-ERMAD’s lateral interaction, there-
fore the exact asymmetry factor remains unidentified. Yet, based on all the results presented 
in the last sections at least a factor of two exists for the concentration differences of accessible 
PtdIns[4,5]P2 in SHMs and SLBs. Therefore, SHMs were selected as the starting point of the 
model system for the organisation machinery of γ-amino butyric acid (GABA) receptors type 
A (GABAAR) in the postsynaptic membrane. However, it was previously shown that CB2 as 
part of the organisation machinery can also interact with other phosphoinositide variants.113 
Thus, it was investigated via CB2PH adsorption experiments to PtdIns[3,4,5]P3 if the heteroge-
neous receptor lipid distribution in SLBs also exists in case of other PtdInsPs. The correspond-
ing results are presented in the next paragraph. 
 
 
Having previously outlined the variety of phosphoinositides due to phosphorylation of the 
inositol ring (cf. Chapter 3.1.1.2) and as the results on membrane formation indicate that nei-
ther receptor lipid concentration nor its phosphorylation degree have an influence on the re-
sulting model membrane thickness (cf. Chapter 4.1.3), it was worth testing if the detected het-
erogeneous PtdIns[4,5]P2 distribution in SLBs is likewise present in case of other phospho-
inositides. That is why, the trisphosphorylated PtdIns[3,4,5]P3 was deployed which functioned 
as another receptor lipid for the PH domain of collybistin 2. In analogy to the PtdIns[4,5]P2 
examinations (cf. Chapter 4.2.2), the model membranes contained 10 mol% PtdIns[3,4,5]P3 and 
were exposed to increased CB2PH concen-
trations ranging from 0-5 µM. The protein 
adsorption was again followed by means 
of RIfS. The adsorption isotherms are de-
picted in Figure 4.20 and are based on at 
least three individual experiments. As in-
dicated by the error bars, representing the 
standard error of the mean, for all protein 
concentrations rather large deviations of 
ΔOT were detected. However, it becomes 
Figure 4.20: Adsorption isotherms of CB2PH on 
POPC : PtdIns[3,4,5]P3 (9 : 1, n/n) membranes. Error bars are 
the standard error of the mean with n ≥ 3. 
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obvious that there is no difference in those values between SLBs and SHMs. This meets the 
results of a STUDENT’s t-test for each protein concentration detecting no significant differences. 
Referring to this data set, the conclusion of a homogeneous PtdIns[3,4,5]P3 distribution seems 
reasonable. The is supported by findings of LUCCHINI et al. who investigated the structural 
effects of phosphatidylinositol trisphosphate on SLBs by means of QCM-D, AFM and Neutron 
Reflectometry (NR).159 Not only did they show that spreading of SUVs containing 10 mol% 
PtdIns[3,4,5]P3 leads to the formation of homogenous lipid bilayers, they also were able to 
detect an inclination of the inositol headgroup towards the layer of POPC headgroups match-
ing the calculated 40° angle of former MD simulations.235 Consequently, the question arises 
which differences between the two phosphoinositides lead to such opposing distribution 
tendencies.  
On one hand the aforementioned simulations indicated that both phosphatidylinositol phos-
phates perturbed a POPC membrane to similar extends, with the ring phosphate in position 4 
(P4) extending ~5.5 Å above the phosphate plane and ~1 Å above the other ring phosphates.235 
This is commensurate with the results for membrane formation gathered by means of RIfS and 
indicates that next to PtdIns[4,5]P2 also PtdIns[3,4,5]P3 can form intermolecular hydrogen 
bonds.230,247,248 Then again, at least both phosphoinositides differ in their net charge due to their 
degree of phosphorylation. While for the bisphosphorylated phosphoinositide charges of -
1.58 ± 0.05 and -1.41 ± 0.05 were detected for P4 and P5, respectively, leading to an overall 
charge (including the charge of the phosphodiester group) of -3.99 ± 0.10 at pH 7.0, 
PtdIns[3,4,5]P3 exhibits a charge of -5.05 ± 0.15 under these conditions.249 Due to the conditions 
applied for SUV spreading within this work the net charge of both was reduced to facilitate 
lipid membrane formation,170,202 however, the charge difference between both phosphoinosi-
tides remains the same. Thus, increased repulsion will occur if a SiO2 surface is exposed to 
vesicles composed of a great fraction of PtdIns[3,4,5]P3 (10 mol%). The repulsion might be able 
to counteract those effects responsible for the enrichment of receptor lipids in the proximal 
SLB leaflet in case of PtdIns[4,5]P2. Eventually, these determinations hint at a unique feature 
of PtdIns[4,5]P2 that needs to be considered when working on SLBs, although, its exact origin 
remains elusive. At the same time these findings represent another reason for the selection of 
SHMs as basis for the model system preparation, because only in this model membrane system 
an equal accessibility for all phosphoinositides under investigation can be guaranteed. Even if 
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the heterogenous leaflet distribution is unique for PtdIns[4,5]P2, it would still affect comparing 




The Dbl-family (diffuse B-cell lymphoma) guanine nucleotide exchange factor collybistin (CB) 
exists in several splice variants which differ in their N- and C-termini (CB1-CB3, cf. Figure 1.6) 
and the presence or absence of an exon encoding a regulatory src homology 3 (SH3) domain.48 
Furthermore, collybistin contains a so-called tandem-domain made up by a DH (Dbl homol-
ogy) and a C-terminal PH (pleckstrin homology) domain. The latter is capable of interacting 
with phosphoinositides like many other members of this specific protein group.250 Based on 
this ability, CB2 is believed to function as an adapter protein connecting the plasma membrane 
with other scaffolding proteins in inhibitory postsynapses.63,251 However, former studies re-
vealed that SH3 domain containing isoforms adopt a closed, autoinhibited conformation that 
prevents the interaction of CB2 with phosphatidylinositol phosphates (PtdInsPs).60 Addition-
ally, a series of recent studies focussed on ARHGEF9, the collybistin encoding gene, and mis-
sense mutations therein. For instance, PAPADOPOULOS et al. investigated the influence of a 
point mutation in position 290 of the Dbl-homology domain on the intramolecular interactions 
within the tandem domain and were able to detect an altered interaction strength and even 
more serious a reduced binding affinity of the PH domain to PtdIns[3]P.252 Another example 
is the work of LONG et al. which concentrated on a family with X-linked intellectual disabil-
ity.253 They were able to identify a point mutation in position 338 causing a change from argi-
nine (R) to tryptophan (W) as the origin of the symptoms. Furthermore, functional assays re-
vealed a deficiency of the PH domain to interact with phosphoinositides for this missense mu-
tation. Both results emphasise the importance of the proper interaction between collybistin’s 
C-terminal domain and phosphoinositides and therefore the adsorption of CB2 to the postsyn-
aptic plasma membrane. To illuminate the process and to gain insights in the behaviour of the 
adsorbed proteins, different isoforms of collybistin 2 were applied in this work. Their recom-
binant expression and purification will be presented in Chapter 4.3.1. The adsorption analysis 
was started with the isolated PH domain (CB2PH) as the minimal prerequisite for CB2-PtdInsP 
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interaction. The experiments with the minimal system were performed to identify ideal exper-
imental conditions and determine binding affinities to solid-supported hybrid membranes 
(SHMs) doped with the three different phosphoinositides mentioned before (PtdIns[3]P, 
PtdIns[4,5]P2 and PtdIns[3,4,5]P3). The gathered data on CB2PH will be focus of Chapter 4.3.2. 
The adsorption behaviour of the full-length protein was studied by deploying a point mutated 
isoform of collybistin 2 (CB2SH3/W24A-E262A) which has already been investigated in former exper-
iments.60,113 Its application is inevitable as the wild-type of collybistin 2 (CB2SH3) is not able to 
interact with phosphoinositides in the plasma membrane due to the reasons mentioned before 
in detail. The results obtained under the use of the mutant will be presented in Chapter 4.3.3. 
Furthermore, the orientation and lateral behaviour of the adsorbed isoforms were investigated 
by means of AFM to determine an influence of the various receptor lipids (cf. Chapter 4.3.4).  
 
 
The isolation of the minimal adsorption fragment (CB2PH) has already been presented in Chap-
ter 4.2.1.2, as the PH domain was also applied as a marker protein to investigate the 
PtdIns[4,5]P2 distribution in the two solid-supported model membrane systems. In contrast to 
that isolation protocol, the full-length proteins CB2SH3 (Mtheo = 55.93 kDa) and CB2SH3/W24A-E262A 
(Mtheo = 55.76 kDa) were heterologously expressed in E. coli cells containing the corresponding 
pTXB1 vectors. After lysis and ultra-centrifugation, the clarified lysate was applied on a French 
press column containing chitin resin as immobile phase. The process and success of the puri-
fication steps were controlled via SDS-PAGE and Western blot analysis. In Figure 4.21 exam-
ples of a gel after electrophoresis (A) and an overlay after immunodetection (B) are presented. 
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The exemplary gel of a CB2SH3 isolation (cf. Figure 4.21 A) after electrophoresis showed a great 
number of bands of the supernatant (SN) after cell lysis, indicating the expression of basal 
proteins along with the target protein. Similar band quantities were present in the flow 
through (FT) and first washing fraction (WF1), which provided reduced intensities. In the sec-
ond washing fraction (WF2) no signals were detected, while in the elution fraction (E2 and E4) 
a single band was visible between the 55 and 70 kDa bands of the mass standard. This specific 
band at around 60 kDa was assumed to correspond with the wild-type of CB2 due to its theo-
retical molecular mass calculated from the amino acid sequence (cf. Appendix A.4.2) via the 
PROTPARAM tool.211 In addition, a similar band was detected in isolations, either recombinant 
or from cellular tissue, as part of former studies.60,213 They also recognised a slight shift to 
higher molecular weights. Yet, the target protein band did not dominate the SN indicating that 
it was not overexpressed. Nonetheless, in FT as well as in WF1 a band was detected in this 
molar regime. This might indicate that the capacity of the chitin resin was exceeded due to a 
high amount of protein with a fused Chitin binding domain (CBD). Another possibility is that 
the band corresponds to a basal protein of similar weight. In this case the corresponding pro-
tein was incapable of interacting with the stationary phase and thus was removed from the 
column. However, the comparison of SN and FT together with WF1 shows that the different 
purification steps led to a reduction of undesired proteins as the number of bands and their 
intensities were successively decreased in these fractions. The purification was optimized to 
such an extent that WF2 did not contain any proteins at all, represented by the absence of band 
signals within the corresponding lane. The introduction of dithiothreitol (DTT) as composite 
Figure 4.21: A: SDS-PAGE of CB2SH3 after purification via affinity chromatography. The collected fractions of su-
pernatant (SN), flow through (FT), washing (WF) and elution (E) were loaded on a polyacrylamide gel control the 
isolation of the collybistin 2 wild-type. B: Western blot overlay with elution fractions tested for CB2SH3 using a CB2 
specific primary antibody. 
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of the second wash buffer (cf. Table 3.8) induced the cleavage of the Intein-tag from the target 
protein and facilitated the elution of the latter. The early elution fractions (E2 and E4) con-
tained the corresponding band but presented a declining signal intensity resulting in complete 
extinction of signal in E6. This hints at a total removal of the target protein from the column. 
The expression and purification of collybistin 2 wild-type can be considered as a success. These 
results indicate that the capacity of the resin was not exceeded. Consequently, the band at 
around 60 kDa in both FT and WF1 most probably corresponds to another protein with similar 
weight lacking the affinity tag. To identify further elution fraction that contained target protein 
also a Western blot was performed (cf. Figure 4.21 B) using a specific primary collybistin anti-
body. In the corresponding overlay all elution fraction (E1, E3 and E5) presented a single broad 
band in the same molecular weight regime as detected via SDS-PAGE. The signal intensities 
have their climax in E3. This indicates a retention of target protein in the beginning of elution 
but also shows that the protein amount on the column is reduced in course of it. Thus, the WB 
confirmed the correlation between the band of the elution fractions and the target protein and 
furthermore showed that it is also contained in later elution fractions. 
The expression and isolation of the collybistin isoform with two point-mutations at positions 
24 and 262 where tryptophan (W) and glutamine (E), respectively, are substituted by alanine 
were conducted following a protocol identical to that of the wild-type. An exemplary 
SDS-PAGE after the purification of CB2SH3/W24-E262A via affinity chromatography is illustrated in 
Figure 4.22 A. 
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The illustrated gel of CB2SH3/W24-E262A highlights some differences to the one obtained from wild-
type isolation (cf. Figure 4.21) as the band intensities in all traces of SN, FT and WF1 were 
reduced in case of the active mutant. Such a comparison is possible as the applied volumes of 
the tested fractions was constant (V = 10 µL) in all electrophoresis runs (cf. Chapter 3.2.8). The 
smaller intensities indicate lower protein amounts that were applied to the gel. This could 
correlate with a decreased expression yield of CB2SH3/W24-E262A. However, the tendency of reduc-
tion in signal quantity and intensity is also apparent. The second washing fraction (WF2) pre-
sented no detectable bands which indicates a complete removal of unbound proteins from the 
stationary column phase. In the early elution fractions tested (E1 and E5) a narrow band was 
recorded which was located between the 55 and 70 kDa bands of the mass standard. Under 
consideration of the amino acid sequence of CB2SH3/W24A-E262A and the resulting molecular 
weight (cf. Appendix A.4.3) the signal in all elution fractions was assumed to correlate with 
the target protein. It was expressed together with basal proteins represented by the great num-
ber of bands in the SN. Yet, also for CB2SH3/W24A-E262A no overexpression was detected and again 
a band was present in the FT corresponding to a protein with a molecular weight of around 
60 kDa. In contrast to the wild-type, the first washing step during the isolation of the mutant 
already contained nearly no proteins. Therefore, also in WF2 no protein bands were visualised. 
Because of the single band in the elution fractions that was assigned to the target protein, the 
isolation of CB2SH3/W24A-E262A was assumed to be successful. Yet again, only small amounts of 
target protein were obtained. This is concluded from the low band intensities for the early 
fractions while the corresponding band vanished in E10. Therefore, a complete cleavage of the 
Figure 4.22: A: SDS-PAGE of CB2SH3/W24A-E262A after purification via affinity chromatography. The collected fractions 
of supernatant (SN), flow through (FT), washing (WF) and elution (E) were loaded on a polyacrylamide gel to 
control the isolation of the target protein. B: Western blot overlay with isolation fractions tested for CB2SH3/W24A-E262A 
using a CB2 specific primary antibody. 
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mutant from the affinity column was presumed. To ensure that no protein fragments in con-
centrations below the detection limit of the SDS-PAGE were present, a Western blot as shown 
in Figure 4.22 B was performed. By applying a specific primary CB2 antibody (cf. Table 3.12) 
FT, WF1 and early elution fractions were tested. While the FT contained both, protein frag-
ments with lower molecular weight and proteins in the higher molecular regime exhibiting 
the specific antigen, in the elution fractions only the specific band was visualised which corre-
sponded to CB2SH3/W24A-E262A. 
In Table 4.5 the average yields (per litre nutrient solution) for the three different isoforms of 
collybistin 2 after heterologous expression in E. coli are summarised based on at least three 
isolations. 
Table 4.5: Averaged yields of the three different CB2 isoforms from heterologous expression in E. coli. 
Protein Yield [mg/mL] Isolations n 
CB2PH 16.4 ± 7.2 8 
CB2SH3 1.8 ± 0.5 3 
CB2SH3/W24A-E262A 4.0 ± 2.3 7 
 
Despite the different yields of target proteins, all isoforms were successfully isolated and thus 
were applicable for subsequent investigations which focussed on their interaction with solid-
supported hybrid membranes containing phosphoinositides as specific receptor lipids. The 
results of such experiments will be presented in the following chapters. 
 




The PH domain is a protein motif composed of approximately 120 amino acid residues that 
lacks primary sequence similarity.254,255 Despite this minimal homology of the PH domain, the 
three-dimensional structures are well conserved and it is found in a great number of pro-
teins.256 Most of them participate either in cell signalling or cytoskeletal regulation. Among this 
quantity also collybistin harbours a PH domain required as the interacting domain with 
PtdInsP in the plasma membrane. This process is crucial for accurate neuronal functions as a 
malfunction can be related to various diseases which has been outlined before (cf. Chapter 
1.3.2). Thus, this work concentrated on the interaction of collybistin’s PH domain (CB2PH) with 
different variants of phosphoinositides that were embedded in SHMs. The protein-lipid inter-
action was investigated by means of reflectometric interference spectroscopy (RIfS). In a first 
set of adsorption experiments on SHMs unspecific interactions of the PH domain with the 
matrix lipid POPC were excluded as no protein adsorption could be detected in absence of 
receptor lipid (cf. Figure 4.23 black spec-
trum). Additionally, it was investigated 
whether protein adsorption is caused by 
electrostatic interactions. On this pur-
pose CB2PH was added to POPC SHMs 
doped with 30 mol% 1-palmitoyl-2-
oleoyl-sn-glycero-3-phospho-L-serine 
(POPS) mimicking the net charge of a 
membrane containing 10 mol% 
PtdIns[4,5]P2 (cf. Figure 4.23 grey 
graph).227 A close look at both plots 
shown in Figure 4.23 reveals that addi-
tion of 1 µM protein (highlighted as point 
II) neither for pure POPC- nor for 
POPC : POPS (7 : 3, n/n) membranes leads to a change in optical thickness. Thus, the adsorp-
tion to PtdInsP doped membranes is exclusively caused by specific interactions with the re-
ceptor lipids. 
Figure 4.23: : Exemplary plots of the change in optical thick-
ness vs. the time of an adsorption experiment with of CB2PH on 
either a pure POPC solid-supported hybrid membrane (black) 
or a POPC SHM doped with 30 mol% POPS (grey). SUV were 
added at t = 0 min which induced their adsorption and spread-
ing to form the differently composed membranes. Subse-
quently the setup was rinsed with HEPES buffer (I). CB2PH in-
jection with a concentration of 1 µM is indicated by II. 
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Parts of the data of CB2PH adsorption to such SHMs doped with 10 mol% of bis- and trisphos-
phorylated forms of PtdInsP have 
already been presented in Chapters 
4.2.2.2 and 4.2.4.2, respectively. In 
addition to those adsorption exper-
iments, the interaction with the 
monophosphorylated PtdIns[3]P 
was quantified by means of reflec-
tometric interference spectroscopy 
(RIfS). The statistics for successive, 
stepwise increase in CB2PH concen-
tration to SHMs doped with one of 
the PtdInsPs at a time is presented 
in Figure 4.24. 
In those experiments the protein concentration was increased from 0-5 µM. Each data point is 
an average of at least three independent measurements and error bars represent the standard 
error of the mean. A Langmuir adsorption isotherm was fit to the data (coloured curves, cf. 
Chapter 4.2.2.2 Equation 4.8) to determine the maximum change in optical thickness (ΔOTmax) 
and the dissociation constant KD of CB2PH to the different phosphoinositides. The determined 
parameters are shown in Figure 4.25. 
Figure 4.24: Adsorption isotherms of CB2PH to POPC SHMs doped 
with 10 mol% of either PtdIns[3]P (blue), PtdIns[4,5]P2 (red) or 
PtdIns[3,4,5]P3 (green). Error bars are the standard error of the mean 
with n ≥ 3. The continuous curves in the corresponding colours rep-
resent the applied LANGMUIR fits. 
Figure 4.25: Determined ΔOTmax (A) and KD values (B) of CB2PH on POPC SHMs doped with 10 mol% of either 
PtdIns[3]P (blue), PtdIns[4,5]P2 (red) or PtdIns[3,4,5]P3 (green). Error bars are the standard error of the mean with 
n ≥ 3. 
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Both, Figure 4.24 and Figure 4.25 indicate a diverse adsorption behaviour of the C-terminal PH 
domain to the three PtdInsPs. While the adsorption to PtdIns[3]P and PtdIns[3,4,5]P3 doped 
SHMs resulted in ΔOTmax values of (1.9 ± 0.1) nm and (1.5 ± 0.1) nm, respectively, the CB2PH 
layer thickness was calculated to be (3.7 ± 0.2) nm on PtdIns[4,5]P2 doped membranes. Thus, 
the difference in adsorbed protein layer thickness varies with a factor of around two and re-
flects the different binding capacities of the membranes. Furthermore, the determined adsorp-
tion isotherms led to different affinities of the PH domain to the phosphoinositides (cf. Figure 
4.25 B). These are independent of the calculated maximum layer thicknesses. CB2PH exhibits 
the highest affinity to PtdIns[3]P with a KD of (1.0 ± 0.1) µM. The dissociation constants for 
PtdIns[3,4,5]P3 and PtdIns[4,5]P2 were determined to be (2.8 ± 0.1) µM and (1.8 ± 0.3) µM, re-
spectively. 
Due to the well conserved structure within the PH domain protein motif, a comparison of the 
determined values to those recognised for other representatives is reasonable. The determined 
affinity to PtdIns[4,5]P2 is in accordance with the dissociation constant of phospholipase C-δ1 
(PLC-δ1) as determined by LEMMON et al.257 They were able to detect an average KD of the iso-
lated PH domain to PtdIns[4,5]P2 of (1.66 ± 0.80) µM by means of isothermal titration calorim-
etry (ITC). This finding was supported by another study that investigated the amount of 
bound isolated PH domain (PLC-δ1) to large unilamellar vesicles (LUVs) containing 
PtdIns[4,5]P2 after ultracentrifugation via bicinchoninic acid (BCA) assays.258 In contrast to 
that, the isolated N-terminal PH domain of pleckstrin investigated by HARLAN et al. exhibits a 
KD of around 30 µM to PtdIns[4,5]P2,96 hence, showed lower affinity to the bisphosphorylated 
phosphoinositide. A third representative is Num1p which is one of the 33 proteins in baker’s 
yeast (S. cerevisiae) harbouring this protein modulus.259 For its isolated GST/Num1p-PH fusion 
form an equal affinity to PtdIns[4,5]P2 has been measured as that detected for PLC-δ1. 
Affinities to PtdIns[3]P and PtdIns[3,4,5]P3 for other PH domain containing proteins have also 
been determined. While the dissociation constants to the later range from 27 nM to ~1 µM,260,261 
showing high affinities and selectivity, those determined for the monophosphorylated phos-
phoinositide are reduced. For instance, KDs calculated for the tandem domain (DH and PH 
domain) of the guanine nucleotide exchange factor (GEF) Tiam1 are 5 µM to inositol 1,3-
bisphosphate (Ins[1,3]P2), which is the head group of PtdIns[3]P, or 10 µM to PtdIns[3]P it-
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self.262 Only the vacuolar protein-sorting-associated protein 36 (Vps36) as part of the endoso-
mal sorting complexes required for transport II (ESCRT-II) contains a PtdIns[3]P-specific bind-
ing motif , the GLUE (GRAM-like ubiquitin-binding in EAP45) domain, that expresses a high 
affinity of 0.1 µM to the monophosphorylated phosphoinositide within the full-length pro-
tein.263 Though, this domain has been reported to be a “split” PH domain that interacts with 
PtdIns[3]P in a distinct manner than that determined for PtdIns[4,5]P2- and PtdIns[3,4,5]P3-
specific interactions.261,263,264  
This selection of affinities and selectivity expressed by different PH domains already indicates 
their broad distributions. Thus, it qualifies the calculated KD values of CB2PH to be consistent 
for all three phosphoinositides under investigation. Such a behaviour is also known for other 
proteins like those of the Osh1 and Osh2 (oxysterol-binding protein homologue) families 
found in yeast, who express affinities in the range of 1.1 to 6.2 µM to PtdIns[3]P and 
PtdIns[4,5]P2.259 They are characterised as proteins with moderate binding affinities yet low 
selectivity which can also be considered being true for the PH domain of collybistin 2 based 
on the adsorption behaviour detected within this work. Some of the related studies suggested 
that the interaction of PH domain and receptor lipid is affected when the whole protein is 
adsorbed instead of the isolated binding motif. Therefore, it was necessary to have a closer 
look on the adsorption process of the full-length protein which was achieved by using the 
active mutant CB2SH3/W24A-E262A. Those results are in focus of the following section. 
 
 
Already in 2000 when KINS et al. identified collybistin as a “brain-specific GEF”, they were able 
to show, that splice variants containing the N-terminal SH3 domain were redistributed in the 
presence of gephyrin to cytoplasmic regions enriched with this scaffolding protein.90 Apart 
from that, they detected sub-membraneous collybistin-gephyrin cluster formation for SH3-
deficient collybistin in human embryonic kidney (HEK) 293 cells. This feature was also deter-
mined for subsequently identified collybistin isoforms generated by alternative splicing.48 The 
results gathered in this work for the wild-type of collybistin 2 (CB2SH3) are in accordance with 
the former findings, i.e., the addition of CB2SH3 to SHMs doped with one of the tested phos-
phoinositides did not lead to a detectable adsorption signal during RIfS measurements. 
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One time course of such adsorption experi-
ments of CB2 wild-type is presented in Fig-
ure 4.26 showing the addition of CB2SH3 to a 
PtdIns[3]P doped solid-supported hybrid 
membrane (POPC : PtdIns[3]P, 9 : 1, n/n). 
The removal of excess lipid material by 
rinsing with HEPES buffer (cf. Table 3.14, 
highlighted by I) was followed by injection 
of CB2SH3 (c = 1 µM, indicated by II). After 
protein addition a small rise in change of op-
tical thickness (ΔOT) was recorded which 
was almost undetectable because of the sig-
nal noise. If protein molecules would have 
been adsorbed to the membrane surface, a large ΔOT would have been recorded. Thus, this 
result can be interpreted as no protein adsorption as the small fluctuation can originate from 
changes of the refractive index induced by protein addition. This result matches with the ex-
pectation of an inactive CB2 wildtype that is unable to interact with phosphoinositides in 
membranes because of an intramolecular interaction of its terminal domains.28 Therefore, an 
active mutant was required to enable the investigation of the full-length protein adsorption. A 
possible option would have been the collybistin 2 isoform lacking the N-terminal SH3 domain 
(cf. Figure 1.6) which was proven to be active by HARVEY et al. who detected the aforemen-
tioned sub-membraneous collybistin-gephyrin clusters.48 However, they also mentioned its 
very rare character, which is the reason why the protein is untraceable in mouse brain tissue.60 
To circumvent problems with this CB2 isoform, a double point-mutated one (CB2SH3/W24A-E262A), 
being intrinsically active, was applied for the adsorption experiments of the full-length protein 
in analogy to those performed with the minimal adsorption system (CB2PH, cf. Chapter 4.3.2). 
An exemplary plot of ΔOT vs. the time for an adsorption experiment of CB2SH3/W24A-E262A is il-
lustrated in Figure 4.27. 
 
 
Figure 4.26: Exemplary plot of the change in optical thick-
ness vs. the time of a CB2SH3 adsorption experiment on a 
POPC solid-supported hybrid membrane doped with 
10 mol% PtdIns[3]P. The model membrane was prepared 
via SUV spreading at t = 0 min and subsequently rinsed 
with HEPES buffer (I). CB2SH3 injection with a concentra-
tion of 1 µM is indicated by II. 
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During the course of the experiment the protein concentration on the solid-supported hybrid 
membrane (POPC : PtdIns[4,5]P2, 9 : 1, n/n) 
was increased in 1 µM-steps (starting at 
t = 0 min) to record an adsorption isotherm. 
The addition of CB2SH3/W24A-E262A in the lower 
concentration regime (c ≤ 3 µM) resulted in 
relatively large ΔOT values. At higher pro-
tein concentrations (c > 3 µM) the rise of 
ΔOT was attenuated until the last protein 
injection (c = 5 µM) caused only a small in-
crease in ΔOT (cf. Figure 4.27). 
This indicates the saturation of accessible 
receptor lipids in the SHM and thus maxi-
mum surface coverage by the adsorbed protein. However, in the statistics of all adsorption 
isotherms recorded on PtdIns[4,5]P2 containing SHMs a mitigation in ΔOT increase but no 
saturation is evident (cf. Figure 4.28 red curve). In contrast to that, when adsorbed to mem-
branes doped with PtdIns[3]P and PtdIns[3,4,5]P3 CB2SH3/W24A-E262A reached complete surface 
coverage at lower concentrations (cf. Figure 4.28 blue and green curves). To be precise, the 
fitted LANGMUIR adsorption iso-
therms (solid lines in Figure 4.28) 
indicate that complete surface cov-
erage with the active mutant has 
been reached already at c ≥ 3 µM. 
For all phosphoinositides under in-
vestigation at least four independ-
ent experiments were performed. 
The data points are the correspond-
ing mean values while the error 
bars represent the error of the mean. 
In virtue of a lack of measurements 
with higher protein concentrations, 
Figure 4.28: Adsorption isotherms of CB2SH3/W24A-E262A to POPC SHMs 
doped with 10 mol% of either PtdIns[3]P (blue), PtdIns[4,5]P2 (red) 
or PtdIns[3,4,5]P3 (green). Error bars are the standard error of the 
mean with n ≥ 4. The continuous curves in the corresponding colours 
represent the applied LANGMUIR fits. 
Figure 4.27: Exemplary plot of ΔOT vs. the time during an 
adsorption experiment of CB2SH3/W24A-E262A to an SHM com-
posed of POPC : PtdIns[4,5]P2 (9 . 1, n:n). The protein con-
centration was subsequently increased in 1 µM-steps (start-
ing at t = 0 min, indicated by arrows) from 0-5 µM. 
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the adsorption isotherms only consider the range from 0 to max. 4 µM. This was owed to the 
low yield obtained from the heterologous expression (cf. Table 4.5). Furthermore, data gather-
ing in the low concentration range (c > 1 µM) due to the signal-noise ratio of RIfS and challeng-
ing concentration adjustments. Nevertheless, the statistics were used to obtain the protein spe-
cific parameters ΔOTmax and the dissociation constant KD which are illustrated in Figure 4.29. 
The afore mentioned tendency of CB2SH3/W24A-E262A to induce maximum change in optical thick-
ness already at concentrations of around 3 µM is also represented in the calculated ΔOTmax 
values (cf. Figure 4.29 A) with (1.2 ± 0.1) nm and (0.9 ± 0.1) nm for PtdIns[3]P and 
PtdIns[3,4,5]P3, respectively. The maximum signal intensity on PtdIns[4,5]P2 (ΔOT-
max = (3.9 ± 0.3) nm) was by a factor of four larger than that determined for the trisphosphory-
lated PtdInsP. These calculations indicate an increased binding capacity for hybrid membranes 
doped with PtdIns[4,5]P2. Furthermore, when compared to the values calculated for CB2PH 
with (1.9 ± 0.1) nm and (1.5 ± 0.1) nm on PtdIns[3]P and PtdIns[3,4,5]P3, respectively, the ΔOT-
max values of the active mutant suggest a reduced membrane binding capacity for SHMs con-
taining the mono- and trisphosphorylated PtdInsP. Yet, no such impact was detected for 
PtdIns[4,5]P2. Another difference in adsorption of the two collybistin 2 isoforms to phospho-
inositide doped hybrid membranes is represented by the different affinities. While CB2PH ex-
hibits highest affinity to the monophosphorylated PtdIns[3]P, the KD of (0.7 ± 0.1) µM for 
PtdIns[3,4,5]P3 depicts the strongest binding in case of CB2SH3/W24A-E262A adsorption (cf. Figure 
4.29 B). The dissociation constants determined for either PtdIns[3]P or PtdIns[4,5]P2 were 
(1.3 ± 0.1) µM or (5.4 ± 0.6) µM, respectively. Thus, the latter is the only combination of protein 
Figure 4.29: Determined ΔOTmax (A) and KD values (B) of CB2SH3/W24A-E262A on POPC SHMs doped with 10 mol% of 
either PtdIns[3]P (blue), PtdIns[4,5]P2 (red) or PtdIns[3,4,5]P3 (green). Error bars are the standard error of the mean 
with n ≥ 3. 
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and receptor lipid that can be described as a low affinity interaction when following the gen-
eral categorisation.259,260 A STUDENT’s t-test was performed for the KD values expressed by both 
isoforms (CB2PH and CB2SH3/W24A-E262A) to each phosphoinositide and showed that all were sig-
nificantly different. However, when reconsidering the great margin of affinities expressed by 
various PH domains to phosphoinositides (cf. Chapter 4.3.2) the values determined in this 
work do lie in a narrow range. Exclusively, the values of CB2SH3/W24A-E262A adsorption to 
PtdIns[4,5]P2 do not match with the others. This mismatch might be caused by the heteroge-
neity in the detected adsorption signals leading to the error. Despite this, the calculated protein 
characteristics are considered to correspond well, as related fluctuations have also been shown 
for other isolated PH domains and their respective full-length proteins.257 
One interesting aspect calls for precise investigation. When considering size or better say the 
molecular weights of the two proteins, the active mutant is by a factor of ~2.6 larger than the 
C-terminal PH domain. This difference must also be reflected in the dimensions of the proteins. 
Therefore, adsorption of the full-length protein should lead to a larger change in optical thick-
ness assuming identical surface coverage. However, this is not the case contemplating the cal-
culated ΔOTmax values. While the ones determined for adsorption of both isoforms to 
PtdIns[4,5]P2 were similar, the ΔOTmax values of CB2SH3/W24A-E262A on PtdIns[3]P and 
PtdIns[3,4,5]P3 doped SHMs were smaller than those calculated for CB2PH on the respective 
phosphoinositides. The tendencies of the adsorbed protein layers might originate from a 
smaller surface coverage or could be traced to a special protein organisation on the surface. 
This however could not be examined by means of RIfS. Hence the organisation of the adsorbed 
collybistin 2 isoforms was investigated by means of atomic force microscopy (AFM). The re-
sults gathered with this surface-sensitive technique are described within the next chapter. 
  




-Some of the AFM experiments were performed by Anna Lena Toschke                          
as part of her bachelor thesis- 
For the characterisation of processes taking place at surfaces reflectometric interference spec-
troscopy (RIfS) is a valued technique to examine inter alia adsorption and deposition pro-
cesses, such like those presented earlier. But as a consequence of its experimental setup (cf. 
Chapter 3.5.3), the spectroscope detects changes in a scanning area of around 1 mm². There-
fore, the detected changes in reflectivity and consequently in optical thickness (ΔOT) are av-
eraged over this zone. That is why the information gathered by means of RIfS can be used as 
an indicator for e.g. the amount of bound protein or other deposits. Yet, further details such 
as physical thickness (d) of the adlayer can only be determined in case of complete surface 
coverage by the adsorbate. In addition the prepared hybrid membranes were examined by 
means of atomic force microscopy (AFM, cf. Chapter 3.6) after addition of one of the collybistin 
2 isoforms and incubation for at least one hour to obtain spatially resolved information. Imag-
ing of the surface was conducted in intermittent-contact mode to reduce forces induced by the 
cantilever to a minimum. It is important to emphasise that after protein injection and incuba-
tion the preparations were not rinsed with buffer. In Figure 4.30 three exemplary micrographs 
are illustrated, showing the C-terminal PH domain of collybistin 2 (CB2PH) adsorbed to solid-
supported hybrid membranes (SHMs) composed of POPC and one of the three phosphoinosi-
tides (9 : 1, n/n) under investigation in this work. 
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In all three micrographs high structures were presented in gold while brown areas provide a 
height equal to that of the membrane surface. Thus, on all SHMs containing the different 
PtdInsPs adsorbed structures, defined as CB2PH, are visible. Additionally, in all micrographs 
red and green lines highlight cross sections along which height profiles have been detected. 
These profiles are shown in graphs below the corresponding micrograph. In all cross sections, 
adsorbates with heights between 3-4 nm were detected independent of the phosphoinositide 
deployed as receptor lipid. 
This homogeneity in height of the adsorbed structures is also reflected in the histograms illus-
trating the height distribution (cf. Figure 4.31) of the detected local maxima (cf. Chapter 3.6.3). 
In case of PtdIns[4,5]P2 a very narrow distribution was recorded (cf. Figure 4.31 B), while for 
the two other phosphoinositides broader scatterings were determined with extended shoul-
ders to higher values (cf. Figure 4.31 A and C). 
  
Figure 4.30: Atomic force micrographs of CB2PH (c ≥ 1 µM) on POPC SHMs doped with either PtdIns[3]P (A), 
PtdIns[4,5]P2 (B) or PtdIns[3,4,5]P3 (C) (9 : 1, n/n) with the corresponding line scans below. The latter graphs pre-
sent the height profile along the cross sections highlighted with red and green lines in the micrographs. Scale bars: 
2 µm. 
4 RESULTS & DISCUSSION 
113 
 
To all data sets distribution-functions were adjusted to determine the mean height of the ad-
sorbed aggregates. For PtdIns[3]P and PtdIns[3,4,5]P3 log-normal distributions were adapted 
whilst a normal distribution was fitted to the data gathered for CB2PH on PtdIns[4,5]P2. Based 
on this analysis an average protein height of CB2PH was determined on each of the three phos-
phoinositides, which are summarised in Table 4.6. 
The height of the PH domain varies between 3.3 and 3.6 nm which is a very narrow range. 
Based on these results the height of adsorbed CB2PH can be assumed to be independent of the 
deployed phosphoinositide. When reconsidering the RIfS results such equality was not deter-
mined for ΔOTmax (cf. Figure 4.25 A). Yet, both findings are consistent when considering aver-
aging effect in detection during RIfS experiments and the difference in surface coverage by 
CB2PH dependent on the deployed receptor lipid. This difference in surface occupancy is in-
stantly evident when comparing the presented micrographs of the adsorbed C-terminal do-
main (cf. Figure 4.30). The variation in surface coverage was quantified by calculating the sur-
face area ratio covered by protein via analysis of binary versions of the micrographs that dis-
tinguished between adsorbate and membrane surface via thresholding. The obtained occu-
pancies are summarised in Table 4.6. 
  
Figure 4.31: Histograms of the detected local maxima and their corresponding heights for CB2PH (c ≥ 1 µM) adsorbed 
to POPC solid-supported hybrid membranes doped with 10 mol% of either PtdIns[3]P (A), PtdIns[4,5]P2 (B) or 
PtdIns[3,4,5]P3 (C). Either normal or log-normal functions were fitted to the data indicated by the solid red lines to 
determine the average height. 
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Table 4.6: Calculated heights of and surface coverages by CB2PH (c ≥ 1 µM) adsorbed to SHMs doped with 10 mol% 
phosphoinositide with the corresponding statistics. For comparative reasons, the determined ΔOTmax values are 
also included. 
Receptor lipid PtdIns[3]P PtdIns[4,5]P2 PtdIns[3,4,5]P3 
CB2PH height / nm 3.40 ± 0.04 3.58 ± 0.04 3.34 ± 0.13 
nImage 8 8 9 
NPreparations 2 3 2 
Distribution log-norm Normal log-norm 
Surface coverage / % 20.0 ± 3.8 31.0 ± 1.3 2.6 ± 1.1 
ΔOTmax / nm 1.9 ± 0.1 3.7 ± 0.2 1.5 ± 0.1 
 
The relative amount of surface covered by CB2PH is maximum on PtdIns[4,5]P2 doped SHMs 
(cf. Chapter 4.2.3). In case of PtdIns[3]P and PtdIns[3,4,5]P3 containing membranes the occu-
pancy by protein is lower. These values are in good agreement with the trend determined for 
ΔOTmax. But the rather high occupancy difference between the mono- and trisphosphorylated 
phosphoinositide is not reflected in the RIfS results. This can be explained by the affinity of 
CB2PH to the latter, being the lowest for all PtdInsPs tested within this work. The weaker inter-
action and the application of external forces by the cantilever might lead to the removal of a 
large amount of protein from the PtdIns[3,4,5]P3 containing membrane surface and thus re-
sulting in a reduced surface coverage. Higher fluctuation in SHMs doped with PtdIns[3,4,5]P3 
might be another explanation for the reduced occupancy, as imaging of adsorbed proteins 
would not be possible in a more dynamic system. 
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With this supporting and explanatory results for the RIfS data on CB2PH at hand, it is now 
necessary to have a closer look on the behaviour of the adsorbed active mutant to illuminate 
the discrepancy detected for CB2PH and CB2SH3/W24A-E262A adsorption via RIfS (cf. Chapters 4.3.2 
and 4.3.3). In analogy to the experiments performed with CB2PH, also the active mutant of col-
lybistin 2 was imaged after its adsorption to SHMs containing 10 mol% phosphoinositide. Rep-
resentative micrographs are shown in Figure 4.32. 
Extra to the micrographs, height profiles of the adsorbed structures are displayed below the 
corresponding images. The respective line scans are visualised by red and green lines in the 
original surface images. Again, all profiles demonstrate deposits on top of the SHMs with 
height ranging between 2.5 and 4 nm independent of the deployed receptor lipid. 
Figure 4.32: Atomic force micrographs of CB2SH3/W24A-E262A (c ≥ 1 µM) on POPC SHMs doped with either PtdIns[3]P 
(A), PtdIns[4,5]P2 (B) or PtdIns[3,4,5]P3 (C) (9 : 1, n/n) with the corresponding line scans below. The latter graphs 
present the height profile along the cross sections highlighted with red and green lines in the micrographs. Scale 
bars: 2 µm. 
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This uniformity is also evident in the histograms (cf. Figure 4.33) that represent all detected 
local maxima and their corresponding heights of the absorbed active mutant to PtdIns[3]P, 
PtdIns[4,5]P2 and PtdIns[3,4,5]P3. A log-normal distribution-function was fitted to the data sets 
of the histograms to determine the height of adsorbed CB2SH3/W24A-E262A. The results of the fits 
together with the underlying statistics are summarised in Table 4.7. 
Like the findings on CB2PH, also the height of the adsorbed active CB2 mutant is indifferent for 
SHMs doped with the three phosphoinositides. Surprisingly, the calculated heights for the 
latter match those determined for the PH domain as vividly illustrated in Figure 4.34. This 
finding was unexpected as the minimal adsorption fragment provides a molecular weight just 
slightly above a third of the mutant’s mass, hence calls for further consideration. Yet, for the 
moment refocussing of the presented micrographs is more reasonable as also in case of 
CB2SH3/W24A-E262A heterogeneous amounts of ad-
sorbed protein have been detected on the SHMs. 
This becomes obvious when comparing the quan-
tity of golden structures on top of the membrane 
surfaces (represented in light brown) in Figure 
4.32 A to C. Consequently, the surface occupancy 
by CB2SH3/W24A-E262A is also affected by the receptor 
lipids, as well as it is the case for CB2PH. The cal-
culated ratios of area occupied with CB2SH3/W24A-
E262A to vacant membrane surface are summed up 
in Table 4.7. 
Figure 4.34: Protein heights of the collybistin 2 
isoforms CB2PH (solid grey bars) and CB2SH3/W24A-
E262A (shaded bars) on 10 mol% phosphoinositides 
containing POPC SHMs determined by AFM. Error 
bars indicate the standard deviations (σ) of the fit-
ted distribution functions. 
Figure 4.33: Histograms of the detected local maxima and their corresponding heights for CB2SH3/W24A-E262A (c ≥ 1 µM) 
adsorbed to POPC solid-supported hybrid membranes doped with 10 mol% of either PtdIns[3]P (A), PtdIns[4,5]P2 
(B) or PtdIns[3,4,5]P3 (C). Either normal or log-normal functions were fitted to the data indicated by the solid red 
lines to determine the average height. 
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Table 4.7: Calculated heights of and surface coverages by CB2SH3/W24A-E262A (c ≥ 1 µM) adsorbed to SHMs doped with 
10 mol% phosphoinositide with the corresponding statistics. For comparative reasons, the determined ΔOTmax val-
ues are also included. 
Receptor lipid PtdIns[3]P PtdIns[4,5]P2 PtdIns[3,4,5]P3 
CB2SH3/W24A-E262A height / nm 3.40 ± 0.03 3.50 ± 0.04 3.39 ± 0.06 
nImage 6 10 9 
NPreparations 2 3 4 
Distribution normal log-norm log-norm 
Surface coverage / % 1.1 ± 0.4 1.2 ± 0.8 3.0 ± 1.3 
ΔOTmax / nm 1.2 ± 0.1 3.9 ± 0.3 0.9 ± 0.1 
 
The occupancies in case of PtdIns[3]P and PtdIns[4,5]P2 are an order of magnitude smaller 
than those determined for CB2PH under identical conditions. Only for PtdIns[3,4,5]P3 no sig-
nificant difference was detected between the two collybistin 2 isoforms. When compared to 
the RIfS data on CB2SH3/W24A-E262A, it becomes obvious that the occupancy variation matches the 
determined affinities (cf. Chapter 4.3.3). At the same time the high fluctuations in ΔOTmax (cf. 
Figure 4.29 A and Table 4.7) cannot entirely be explained by the calculated coverages. While 
for PtdIns[3]P and PtdIns[3,4,5]P3 the findings are in good accordance, there is a mismatch in 
case of the bisphosphorylated PtdIns[4,5]P2. Such an effect might be explained with the low 
affinity of the active mutant to PtdIns[4,5]P2 (cf. Figure 4.29 B) causing a wide spread of ΔOT 
induced by CB2SH3/W24A-E262A adsorption. This in turn affects the determination of ΔOTmax ren-
dering it imprecise.  
The identical height of CB2PH and the full-length active mutant with a 2.6 times higher molec-
ular weight is remarkable and will be discussed below. To better understand the organisation 
of the proteins, CD (circular dichroism) spectroscopy or crystal structure analysis can be per-
formed with the latter being the technique of choice to gain detailed structural information. 
However, neither for the PH domain nor for CB2 itself these data are available, whilst CB1 
was characterised in detail by means of small angle X-ray scattering (SAXS).60 The crystal struc-
ture in various orientations (PDB ID: 4MT6, turned around the z-axis) are illustrated in Figure 
4.35. 
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The dimensions of the protein structure become obvious when placed inside a box of corre-
sponding side lengths (cf. Figure 4.35 B). These dimensions can also be attributed to CB2 in a 
good approximation as both proteins share an overall amino acid sequence homology of 
95.5 %. To be more precise, 450 amino acids exhibit an overlap with a unity of 99.1 % when 
both sequences (for CB2 cf. Appendix A.4.3) are compared excluding the terminal domains.60 
The determined heights for both adsorbed CB2 isoforms range around 3.4 nm which fits to the 
smallest extension determined for CB1. The flat character of the structure in one dimension is 
evident in the complete rotation visualised in 
Figure 4.35 A. Therefore, only an adsorption be-
haviour for the full-length protein is possible in 
which the other subdomains (SH3 and DH) are 
arranged next to the PtdInsP-binding PH do-
main. This would be equal to a deposition of the 
“boxed” protein alongside the (8.66 x 5.94) 
plane which is schematically illustrated in Fig-
ure 4.36. 
Figure 4.35: Crystal structure of the active collybistin 1 isoform (PDB ID: 4MT6) determined by means of SAXS at 
a resolution of 5.501 Å² by SOYKAN et al.54 The PH domain is coloured in yellow, orange and red, while green and 
blue code the DH domain. A: 360° rotation of the structure around its z-axis. B: Visualisation of the protein dimen-
sions by placement of the structure inside a box. 
Figure 4.36: Scheme of the hypothised full-length col-
lybistin orientation when adsorbed to PtdInsP con-
taining solid-supported hybrid membranes. 
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This arrangement can be supported when considering structural similarities with other 
PtdInsP-interacting proteins. The PH domains usually share a low sequence identity. How-
ever, all possess a β-sandwich fold that is capped at one end with a C-terminal α-helix.262 This 
motif is also present in the PH domains of both phospholipase C-δ1 (PLC-δ1) and CB1 as shown 
in Figure 4.37.60,265 Focussing the structure of PLC-δ1, it becomes obvious that the headgroup 
of PtdIns[4,5]P2, Ins[1,4,5]P3, is embedded in the 
mentioned cavity in a specific manner. This em-
bedment would only allow the protein to be ad-
sorbed to a PtdIns[4,5]P2 doped membrane in the 
fashion previously suggested for CB based on the 
determined protein heights. In Figure 4.37 B the 
CB1 crystal structure is shown in an orientation 
that matches that of PLC-δ1 and highlights its own 
PtdInsP binding site (red sphere). Thus, the de-
tected protein heights for CB2PH and CB2SH3/W24A-
E262A are confirmed by exact structure determina-
tions of related proteins. One might argue on the 
incomparability of PLC-δ1 and CB, due to the pre-
viously determined unspecific binding character 
for collybistin in contrast to the specificity of 
PLC-δ1 to PtdIns[4,5]P2. But this can be neglect as it has been shown by BARALDI et al. that the 
binding site for PtdIns[3,4,5]P3 in the PH domain of Bruton’s tyrosine kinase (Btk) is identical 
to that for PtdIns[4,5]P2 in PLC-δ1’s pleckstrin homology domain.264 Based on their results it is 
reasonable to consider the protein orientation on the model membranes independent of the 
used phosphoinositide, which is consistent with the results of this work. Thus, the presented 
crystal structure of CB provides a good explanation for the determined heights, however, also 
other explanations might be possible. It might be possible that the structure of CB is more 
flexible and therefore capable arranging in different conformations while bound to phospho-
inositides on top of membranes. In a recent study CHIOU et al. were able to model the arrange-
ment of CB in a PtdIns[3]P bound state with molecular dynamics (MD) simulations.266 They 
detected different conformations for the wild-type of collybistin 1, among which an elongated 
Figure 4.37: A: Boxed crystal structure of PLC-δ1 
with a zoom-in on the Ins[1,4,5]P3 binding site 
(PDB ID: 1DJX).249 B: Boxed CB1 in a similar orien-
tation to highlight the PtdInsP binding site (red 
sphere).54 
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one was predominant with 68 %. The second most frequent conformation, which they referred 
to as an “open clam”, was evident in 32 % of the cases. Both states diverged from the deter-
mined crystal structure (cf. Figure 4.35 B) thereby implying that structural flexibility might be 
possible. 
Finally, the independency of the protein height from the used phosphoinositide allows inves-
tigations of other features that might be dependent on the receptor lipids like the lateral or-
ganisation of the adsorbed proteins. This becomes obvious when comparing the micrographs 
presented for both CB2PH and CB2SH3/W24A-E262A (cf. Figure 4.30 and Figure 4.32). It appears that 
the deposits were not only dependent on the deployed PtdInsP but were characteristic for the 
added collybistin isoform. To analyse this indications in detail, the available binary images of 
the original micrographs (cf. Chapters 3.6.3 and 4.2.3) have been deployed. The resulting size 
distributions of the deposits for both PH domain and CB2SH3/W24A-E262A were determined as viv-
idly shown in Figure 4.38. 
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Log-normal distribution functions were adjusted to the presented probability density distri-
butions enabling the determination of the corresponding medians. The fit functions are repre-
sented by red lines and the medians are summarised in Table 4.8. 
  
Figure 4.38: Histograms of the deposit diameters determined for CB2PH (left) and CB2SH3/W24A-E262 (right) on top of 
SHMs composed of POPC and 10 mol% of either PtdIns[3]P (blue), PtdIns[4,5]P2 (red) or PtdIns[3,4,5]P3 (green). To 
each data set a log-normal distribution function was adjusted represented by red curves. 
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Table 4.8: Overview of the determined CB2PH and CB2SH3/W24A-E262A aggregate sizes determined on SHMs doped 
with the different phosphoinositides. 
 Deposit diameter / nm 
Receptor lipid PtdIns[3]P PtdIns[4,5]P2 PtdIns[3,4,5]P3 
CB2PH 73 ± 1 72 ± 1 89 ± 1 
CB2SH3/W24A-E262A 92 ± 1 42 ± 2 84 ± 1 
 
It becomes clear that the defined clusters of CB2PH are uniform in size when the mono- and 
bisphosphorylated phosphoinositides function as receptor lipids. Solely, in case of 
PtdIns[3,4,5]P3 the size is slightly increased to (89 ± 1) nm. This might originate from the dif-
ferent affinities determined for CB2PH to the phosphoinositides (cf. Figure 4.25). Because of 
weaker interactions, smaller aggregates might be removed from the membrane surface during 
imaging. In contrast to that larger aggregates that are composed of an increased number of 
protein molecules can interact with a greater number of receptor lipid molecules. The deposits 
with higher pinning-point quantity, hence, can resist the induced forces and are detected 
whilst the smaller ones are removed. This would also explain the drastically declined surface 
occupancy of 2.6 % (cf. Table 4.6 and Table 4.7). In addition, this is also supported by the fact 
that no clusters were detected with a diameter below 50 nm (cf. Figure 4.38). Another expla-
nation might be a varying mobility of the adsorbed protein clusters. While large structures are 
more rigid, the smaller aggregates might diffuse on the membrane surface and thus would be 
indetectable by AFM. 
In case of aggregates composed of full-length protein, the cluster size exhibits a wider range. 
The tendencies on the different PtdInsPs, however, do not show a correlation with the previ-
ous determined protein characteristics like affinity or binding capability of the SHMs (cf. Fig-
ure 4.29). A reason for this can be seen in the very low surface coverage by adsorbed protein 
that ranged between 1.1 and 3.0 % (cf. Table 4.7). 
Nevertheless, the results presented within this chapter identified both isoforms of CB2, CB2PH 
and CB2SH3/W24A-E262A, as unspecific interaction partners of phosphoinositides with moderate af-
finities. Furthermore, no specific lateral protein-protein interactions were detected in contrast 
to e.g. N-ERMAD (cf. Figure 4.15) or the full-length protein of ezrin.217 A detailed analysis of 
the interaction between the adapter protein collybistin 2 and different variants of phospho-
inositides was presented. Thereby, a firm foundation was established upon which the planned 
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in vitro model system for the post synaptic GABAAergic receptor machinery can be build. On 
this purpose, an additional receptor lipid was introduced to the model membrane. This lipid 
was used as a specific receptor for a protein construct mimicking the intracellular domain of 
neuroligin 2. This expansion allows a detailed characterisation of the interaction between the 
adaptor protein collybistin 2 and the cell adhesion protein neuroligin 2, which is believed to 
be a prerequisite for the activation of CB2 under physiological conditions. The results obtained 




-The RIfS data presented in this section contain results determined by                      
Lucas Förster as part of his master thesis- 
The adapter protein collybistin 2 is one of the constituents of the GABAAergic receptor organ-
isation machinery and therein responsible for the interaction of the protein complex with the 
post synaptic plasma membrane. This interaction induces the accumulation of GABAA recep-
tors in the postsynaptic specialisations and thus its fixation in direct apposition to the presyn-
aptic terminals. Yet, in analogy to the findings on the homologous APC-stimulated guanine 
nucleotide exchange factors (Asef) 1 and 2,267,268 also the SH3 domain of collybistin 2 forms an 
intramolecular interaction with the C-terminal PH domain. This renders the protein incapable 
of membrane binding as a closed conformation is exhibited. The consequences of such behav-
iour have been detected in coexpression experiments within HEK 293 cells in which CB1 (SH3 
domain containing isoform) was redistributed to gephyrin-rich cytoplasmic regions, while 
CB2 (lacking the SH3 domain) induces sub-membraneous gephyrin clustering.90 In contrast to 
that, both collybistin isoforms redistributed gephyrin into synaptic clusters in transfected cor-
tical neurons.48 These findings suggest a specific local activation of CB1 via a SH3-interacting 
partner. In 2009, neuroligin 2 (NL2) was identified by POULOPOULOS et al. to perform such an 
interaction and thereby inducing gephyrin in a neuron-specific manner.30 Its short intracellular 
domain contains various motifs assumed to be necessary for the scaffolding process of 
postsynaptic components.269,270 Among these, a gephyrin-specific binding side and poly-pro-
line sections are found. The latter are missing in the CB-binding-deficient neuroligins 1 and 3, 
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hence the interaction of CB2 and NL2 is believed to be a typical SH3/poly-proline mode.60 All 
known studies, focussing on this specific interaction in order to determine collybistin activa-
tion, were performed in vivo. Thus, other effectors cannot be ruled out completely. With the 
solid-supported hybrid membrane (SHM) system and its highlighted advantages (cf. Chapters 
4.1 and 4.2) an isolated observation of the interaction process is possible. To allow the adsorp-
tion of both CB2 and NL2 to the SHM, the in-depth characterised system (cf. Chapter 4.3) had 
to be expanded with a second receptor lipid 
specific for neuroligin. The lipid of choice for 
this purpose was 1,2-dioleoyl-sn-glycero-3-
{[N-(5-amino-1-carboxypentyl)iminodiacetic 
acid]succinyl} nickel salt (DGS, cf. Scheme 
3.3) as the cell adhesion molecule (CAM) NL2 
was mimicked by a protein construct that 
contained a N-terminally fused His6-tag 
(His-cytNL2). The pursued modelling strat-
egy is schematically illustrated in Figure 4.39. 
In this scheme PtdInsPs are represented by li-
pid molecules with red headgroups while those with blue ones correspond to DGS. The effects 
of the latter, which introduces a positive charge to the model system, on the membrane for-
mation and its features will be focus of subsection 4.4.1 while in 4.4.2 the results on His-cytNL2 
isolation and introduction are presented. Conclusively, the impact of NL2 on the adsorption 
behaviour of collybistin 2 will be highlighted in section 4.4.3. 
 
Figure 4.39: Scheme of the expanded model system con-
taining both PtdInsP (red headgroup) and DGS (blue 
headgroup) in the solid-supported hybrid membrane to 
allow the simultaneous adsorption of NL2 and CB2. 




The preparation of solid-supported model membrane systems is either based on a combination 
of the LANGMUIR-BLODGETT and LANGMUIR-SCHÄFER techniques or on the adsorption and 
spreading of vesicles from aqueous solution to the substrate surface. The latter was the method 
applied within this work using hydrophobically functionalised silicon dioxide substrates. Ob-
tained hybrid membranes containing different variants of phosphoinositides and changing 
concentrations thereof have been analysed extensively (cf. Chapter 4.1.3). These experiments 
showed no influence of either the PtdInsP amount nor the phosphorylation pattern of the 
phosphoinositide on the formation of SHMs or its layer thickness. To enable isolated exami-
nation of the interaction of NL2 with CB2 and the expected activation of the later, a second 
receptor lipid (DGS) was added to the system as schematically shown in Figure 4.39. Conse-
quently, a detailed look has been taken at its influence on the hybrid membrane formation as 
DGS introduced a positive charge to the lipid layer which might have altered the membrane 
features because of electrostatic interactions with the negatively charged PtdInsPs. This was 
done by means of reflectometric interference spectroscopy (RIfS) enabling the in situ determi-
nation of the vesicle adsorption, spreading 
and membrane formation process. Further-
more, it had to be guaranteed that both re-
ceptor lipids were accessible in a sufficient 
amount to allow selective adsorption of both 
proteins even in case of consecutively injec-
tions. Therefore, POPC films, used for small 
unilamellar vesicle (SUV) preparation, con-
tained 3 mol% of DGS with or without addi-
tional 3 mol% of PtdInsPs. The resulting hy-
brid membrane thicknesses are summarised 
in Figure 4.40. The calculated mean values of 
SHM thickness (represented by red squares) 
were (2.7 ± 0.3) nm for DGS/PtdIns[3]P 
(n = 38). Equally, the spreading of DGS and 
Figure 4.40: Box plots of the model membrane thickness 
of SHMs dependent on the receptor lipids in the small 
unilamellar vesicles used for membrane formation. The 
boxes extent from upper and lower quartile while the 
whiskers represent 1st and 99th percentiles. The medians 
are shown as horizontals inside the boxes and the means 
are represented by red squares within the respective data 
sets. A statistical ANOVA calculation determined no sig-
nificant differences (ns) for SHMs containing combina-
tions of DGS with PtdInsPs, while ΔOT of DGS doped 
SHMs is significantly different with *p = 0.1. 
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PtdIns[4,5]P2 (n = 45) or 
PtdIns[3,4,5]P3 (n = 32) contain-
ing SUVs resulted in similar val-
ues, which was proven by an 
analysis of variance (ANOVA) 
that determined no significant 
differences among the 
DGS/PtdInsP containing SHMs. 
Then again, for membranes 
doped only with DGS a signifi-
cant increase in resulting layer 
thickness was determined with 
a mean value of (3.0 ± 0.4) nm 
(n = 19, cf. Figure 4.40).  
Furthermore, the obtained val-
ues for DGS/PtdInsP doped SHMs were compared to the ones for membranes containing only 
PtdInsPs (cf. Figure 4.41). Also, for this comparison an ANOVA determined no significant dif-
ferences in the change of optical thickness correlating to the established hybrid membranes 
system. For this reason, it is assumed that DGS does not alter the membrane formation process.  
Even though the additional receptor lipid does not affect the resulting membrane thickness, it 
might still have an influence on its characteristics. In contrast to in vivo experiments supported 
membranes exhibit a reduced mobility of the lipids (cf. Chapter 4.1.4). This feature is com-
monly known; however, it might be affected due to the introduced positive charge by addition 
of DGS. Both receptor lipids provide opposing charges and might interact. Therefore, it was 
necessary to illuminate the resulting lipid mobility in presence of DGS. The mobility for 
BODIPY®-TMR labelled PtdIns[4,5]P2 has already been determined the SHM and SLB as de-
scribed in Chapter 4.1.4. Here, additional fluorescence recovery after photo bleaching (FRAP) 
experiments were performed with small fractions of the phosphoinositides being substituted 
by their BODIPY®-TMR labelled forms in presence and absence of DGS. Fluorescence images 
of SHMs composed of POPC : DGS : PtdInsP : BODIPY®-TMR PtdInsP (94.0 : 3.0 : 2.7 : 0.3, 
n/n/n/n) are shown in Figure 4.42. 
Figure 4.41: Box plots of the SHM thickness dependent on the presence 
or absence of DGS in PtdInsP containing SUVs used for membrane for-
mation. The boxes extent from upper and lower quartile while the whisk-
ers represent 1st and 99th percentiles. The medians are shown as horizon-
tals inside the boxes and the means are represented by red squares within 
the respective data sets. A statistical ANOVA calculation determined no 
significant differences in ΔOT of the resulting SHMs. 
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The presented images are exemplary for hybrid membranes that contained the respective 
phosphoinositides in combination with DGS. In all preparations a homogenous fluorescence 
intensity distribution was detected while the quantity of defects (areas without fluorescence, 
black) remained low. Areas with higher intensities correlated are interpreted as adsorbed, un-
spread lipid material which was proven by FRAP experiments. As the bright spots did not 
recovery it is concluded that they were not connected to the continuous lipid monolayer. The 
determined diffusion coefficients (D) and mobile fractions (γ0) are summarised in Figure 4.43. 
The calculated diffusion coefficients of the different labelled phosphoinositides do not show a 
significant difference as tested by ANOVA in case of either absence (solid bars) or presence of 
DGS (shaded bars, cf. Figure 4.43 A). This was expected because of identical fatty acid chains 
in all labelled PtdInsP-forms deployed in this work as exemplary shown in Scheme 3.5 for 
BODIPY®-TMR PtdIns[4,5]P2. 
Figure 4.43: Overview on the effect of DGS absence in POPC/PtdInsP SHMs (97  : 3, n/n; solid bars) or its presence 
in POPC/DGS/PtdInsP SHMs (94  : 3 : 3, n/n/n, shaded bars) on the diffusion coefficients (A) and mobile fractions 
(B) of BODIPY®-TMR labelled phosphoinositides with 1 % of the corresponding PtdInsP being labelled. Scale bars 
represent the standard error of the mean with n ≥ 5. 
Figure 4.42: Exemplary fluorescence images obtained on solid-supported hybrid membranes composed of 
POPC : DGS : PtdInsP : BODIPY®-TMR PtdInsP (94.0 : 3.0 : 2.7 : 0.3, n/n/n/n). Scale bars: 20 µm. 
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However, when specifically considering the effect of DGS on the lateral motion of each phos-
phoinositide, it becomes obvious that the diffusion coefficients significantly declined (tested 
by ANOVA) in all three cases. For PtdIns[3]P D has been reduced from (2.4 ± 0.6) µm²s-1 with-
out DGS to (1.2 ± 0.4) µm²s-1 in its presence. A similar trend was detected for PtdIns[4,5]P2 and 
PtdIns[3,4,5]P3 with a decrease in D from (1.8 ± 0.5) µm²s-1 to (0.9 ± 0.6) µm²s-1 and from 
(2.1 ± 0.4) µm²s-1 to (1.0 ± 0.2) µm²s-1, respectively. Thus, the addition of DGS is accompanied 
by a bisection of lateral mobility of all phosphoinositides. This might be based on electrostatic 
interactions as DGS contains a divalent nickel cation (Ni2+) in its headgroup which induces 
attractive forces on the phosphoinositides that present a high negative charge. However, no 
formation of PtdInsP-clusters within the confocal laser scanning microscope’s (CLSM) resolu-
tion range was detectable, although it is common knowledge that divalent cations induce such 
processes especially in PtdIns[4,5]P2 containing membranes.204,205 It seems like the “caging” ef-
fect of the nitrilotriacetic acid (NTA) prevents such behaviour. In contrast to the diffusion co-
efficients, the presence of DGS does not influence the mobile fractions of the hybrid mem-
branes that ranges around 80 % (cf. Figure 4.43 B). The independence of the mobile fractions 
of DGS can be understood as an additional prove for the absence of cluster, even of those with 
sizes beyond the detection limit. The presented effects of DGS on the model membrane system 
were considered admissible. Therefore, first adsorption experiments were performed with the 
well characterised protein collybistin 2 to determine the effect of the second receptor lipid on 
the interaction of the adapter protein with the phosphoinositides. 
 
 
The developed model system in this work aims on the imitation of the GABAAergic receptor 
(GABAAR) organisation process. The involved proteins are anchored to specialisations in the 
postsynaptic plasma membrane by the adaptor protein collybistin. Therefore, it is necessary 
to ensure an unaffected adsorption of CB2 to its specific receptor lipid even if a further com-
ponent is introduced to the model. On this purpose additional adsorption studies have been 
performed with full-length isoforms, CB2SH3 and CB2SH3/W24A-E262A. Even though the wild-type 
of CB2 (CB2SH3) was already characterised as incapable of adsorption to phosphoinositides in 
the hybrid membranes of this work (cf. Figure 4.26 in Chapter 4.3.3), additional tests were 
required to eliminate unspecific interactions to the second receptor lipid DGS. The same holds 
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true for the point-mutated isoform CB2SH3/W24A-E262A as shown to be in a permanently opened 
conformation. For each of the full-length proteins an exemplary plot of the change in optical 
thickness (ΔOT) vs. the time during their adsorption to an SHM (POPC : PtdIns[3,4,5]P3 : DGS, 
94 : 3 : 3, n/n/n) determined by means RIfS is shown in Figure 4.44. 
The incubation of the hydrophobically functionalised silicon dioxide substrates with suspen-
sions of small unilamellar vesicles (SUV, t = 0 min) in Na-citrate buffer (cf. Table 3.16) at a pH 
of 4.8 caused a change in optical thickness (ΔOT) of around 2.5 to 3 nm in both measurements. 
This was correlated to solid-supported hybrid membrane formation in agreement with the 
previously determine layer thicknesses of various SHMs (cf. Chapters 4.1.3 and 4.4.1). Ad-
sorbed, yet non-spread lipid material was removed from the SHMs by rinsing with HEPES-A 
buffer (highlighted by timepoint I, cf. Table 3.14) which affected ΔOT only to a minor extent. 
While the subsequent injection of CB2SH3/W24A-E262A (1 µM, represented by timepoint II) led to an 
increase in ΔOT, no such tendency was detected for collybistin wild-type (cf. Figure 4.44 A). 
This again illustrates the behavioural differences between CB2SH3 exhibiting a closed, inactive 
conformation, and the point-mutated isoform that is open and capable of phosphoinositide 
interaction. In analogy to the presented adsorption experiments to PtdIns[3,4,5]P3/DGS doped 
SHMs also measurements on other lipid compositions were conducted. The averaged ΔOTs 
relative to the established membrane level (as illustrated in Figure 4.44 B) are shown as a func-
tion of the corresponding receptor lipids in Figure 4.45. 
Figure 4.44: Exemplary plots of the change in optical thickness vs. the time during adsorption experiments of either 
CB2SH3 (A) or CB2SH3/W24A-E262A (B) on POPC hybrid membranes doped with 3 mol% of each PtdIns[3,4,5]P3 and DGS. 
The model membranes were prepared via SUV spreading at t = 0 min and subsequently rinsed with HEPES-A 
buffer (I). Protein injection with a concentration of 1 µM for both isoforms is indicated by II. 
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Likewise, in case of the other phosphoinositides and their combinations with DGS the injection 
of CB2SH3 resulted in only small changes of ΔOT which were considered as indication of no 
protein adsorption. This is feasible because already slight fluctuations in the refractive index 
n as induced by e.g. change in buffer solution or addition of protein within the detection area 
might alter ΔOT. Furthermore, it is evident, that all spectra present a background noise in the 
range of around 0.1 nm (cf. for example Figure 4.10, Figure 4.26 and Figure 4.44) which im-
pedes the identification of a change in signal intensity with a similar amplitude as induced by 
protein adsorption. Opposing behaviour was detected for CB2SH3/W24A-E262A which induced in-
creases in ΔOT when injected. This can be correlated to specific interactions with the phospho-
inositides as no sufficient change in signal intensity was detected on SHMs doped with DGS 
alone. The detected trends for the adsorption of the active mutant to the different PtdInsPs is 
consistent to the previously determined protein specific parameters ΔOTmax and KD (cf. Chap-
ter 4.3.3), identifying the highest affinity for PtdIns[3,4,5]P3. This, however, was unaffected by 
the presence of DGS. Therefore, the addition of DGS as a second receptor lipid to the existing 
model membrane system seems to be unproblematic. It represents the first step to the intro-
duction of a further constituent, the cell adhesion molecule neuroligin 2, of the GABAAR or-
ganisation machinery to the in vitro model complex of the later. 
Figure 4.45: Change in ΔOT relative to the established membrane level (broken line) induced by adsorption of 
either CB2SH3 (black) or CB2SH3/W24A-E262A (red) each at a concentration of 1 µM to SHMs containing the respective 
receptor lipids or combinations thereof. 




The cell adhesion molecule (CAM) neuroligin 2 (NL2) is responsible for the direct apposition 
of the post synaptic specialisations to the presynaptic release sites. This is accomplished by its 
interaction with neurexins inside the axon of the signal transmitting neuronal cell. Via this 
interaction the synaptic cleft is bridged by the extracellular domains of both CAM species. 
Additional to this part, NL2 consists of a single transmembrane region and an intrinsically 
disordered cytoplasmic tail. Its trans-membraneous character is, however, problematic for the 
application due to a challenging reconstitution process and the necessity of aqueous compart-
ments on both sides of the model membrane missing in the system used in this work. There-
fore, a protein construct was employed to mimic the intracellular domain of NL2. It was com-
posed of all cytoplasmic amino acid residues of NL2 to which a hexa-histidine (His6) tag was 
N-terminally fused, hence, it is referred to as His-cytNL2 in this work. 
 
 
The expression and isolation of the protein construct mimicking the cytoplasmic part of the 
transmembrane protein neuroligin 2 (His-cytNL2) was conducted several times in the progress 
of this work. The protocol followed during this process was inspired by the isolations of 
N-ERMAD and collybistin 2 as described before (cf. Chapter 3.2.5). Additionally, previous 
work of DR. BODO SANDER was referred to for orientation.271 The protein expression was per-
formed in E. coli cells of the BL21(DE3) Rosetta strain. Afterwards target protein purification 
was achieved via immobilised metal ion affinity chromatography (IMAC, cf. Chapter 3.2.7.1) 
taking advantage of the N-terminally fused His6-tag. Its success was controlled by SDS-PAGE 
in combination with Western blot. Examples for both, PAGE and blot, are shown in Figure 
4.46. 
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The theoretical mass of His-cytNL2 was calculated to Mtheo = 17.31 kDa. Its calculation was 
based on the amino acid sequence (cf. Appendix A.4.5) determined via plasmid sequencing 
(cf. Chapter 3.2.4). The obtained sequence was in accordance to previous results.271 While the 
trace for the supernatant (SN) and the flow through (FT) did not show a difference in the gel 
of the SDS-PAGE (cf. Figure 4.46 A), a drastic reduction of bands was evident in the fraction 
of the first washing step (WF1). The intensity decline was even more enhanced in the second 
washing step (WF2). The indifference between SN and FT indicated that most proteins ex-
pressed, did not interact with the solid phase of the column und thus were flushed through it. 
The small number of signals with only light intensities within the washing fractions confirms 
this and shows that nearly no proteins were hold back via unspecific interactions with the 
NTA(Ni2+) agarose. However, all elution fractions (E1 to E5) present a dominant band located 
between the 15 and 25 kDa ones of the applied mass reference. The mass of this specific band 
was estimated to around 20 kDa and thus considered to correlate with the target protein. The 
shift to higher masses can be explained by the poly-proline section in the amino acid sequence, 
providing a rigidity that results in an increased retention within the polyacrylamide gel. Even 
though, the target protein was eluted successfully the isolation cannot be considered as a suc-
cess. The reason for this is the co-elution of other unknown proteins that correspond to bands 
Figure 4.46: SDS-PAGE of His-cytNL2 after purification via affinity chromatography against NTA(Ni2+) agarose. 
The collected fractions of supernatant (SN), flow through (FT), washing (WF) and elution (E) were investigated to 
determine the distribution of the target protein (A). Western blot overlay with a concentration gradient (simple to 
tripled protein amount) of E1 using a specific primary antibody for the intracellular domain of NL2 (B). Western 
blot overlay of the early elution fractions (E1-E5) tested for His-cytNL2 with a specific primary antibody against the 
N-terminally fussed His6-tag (C). 
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detected over the whole separation range of the PAGE. To elucidate the character of the con-
taminations additional Western blots (WBs) of the elution fractions have been performed. 
While one was conducted using a primary antibody that was specific for the intracellular do-
main of neuroligin (cf. Figure 4.46 B), the second WB identified His6-tag harbouring proteins 
via a primary antibody being specific for poly-histidine motifs in amino acid sequences (cf. 
Figure 4.46 C). In both cases and for all fractions tested a double band was detected in the 
molecular range of His-cytNL2. This might either indicate an incompletely expressed protein 
fragment that contains a His6-tag and is sufficient as epitope to the NL-specific antibody. An-
other more probable explanation for this band duplication is a defective reduction process 
prior to PAGE analysis. A fraction of all proteins may have been re-oxidised during or might 
not have been reduced at all in the denaturation process due to a deficiency in DTT.272 This 
effect would result in doubling of all detected protein bands which was the case in both WBs 
presented in Figure 4.46 B and C. Therefore, the double bands were ignored and both overlays 
of the WBs showed intensive bands that were correlated to the target protein. Based on these 
results, the contained impurities were neglected, as only His-cytNL2 exhibited the poly-histi-




After the elution of the protein construct and its transfer into HEPES-A buffer via dialysis (cf. 
Chapter 3.2.10.1), its adsorption behaviour was analysed by means of RIfS to elucidate its in-
teraction with the different receptor lipids inside the SHM (cf. Chapter 4.4.1). In addition to 
the receptor lipids PtdInsP and DGS, adsorption on POPC : POPS (94 : 6, n/n) SHMs was also 
analysed to identify potential non-specific, electrostatic interaction of His-cytNL2. Exemplary 
time courses of the adsorption process to the hybrid membranes containing various receptor 
lipids are shown in Figure 4.47. 
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As expected, the injection of His-cytNL2 to POPC : DGS (97 : 3, n/n, cf. Figure 4.47 A, light grey 
spectrum) SHMs led to a significant change in signal intensity (ΔOT) as the protein is adsorbed 
to the membrane via the interaction of its N-terminal His6-tag with DGS. Additionally, no un-
specific interaction was detected with the matrix lipid POPC (represented by the black spec-
trum in Figure 4.47 A). However, also adsorption of the protein construct to membranes con-
taining 6 mol% POPS was detected as vividly illustrated in Figure 4.47 A by the grey spectrum. 
A similar trend was monitored for SHMs doped with 3 mol% of phosphoinositide (cf. Figure 
4.47 B). The change in ΔOT on PtdIns[3]P, PtdIns[4,5]P2 and PtdIns[3,4,5]P3 doped SHMs (rep-
resented by the blue, red and green curve, respectively) also indicated adsorption of His-
cytNL2. However, the changes in optical thickness did not correlated with the net charges of 
the membrane systems as a higher number of protein (expressed by a larger signal intensity 
change) was adsorbed to PtdIns[3]P and PtdIns[4,5]P2 containing membranes than to ones 
doped with the trisphosphorylated PtdInsP. Even though the latter exhibits the highest net 
charge with each PtdIns[3,4,5]P3 molecule being highly negatively charged (-7) at pH 8.235 This 
suggests that the adsorption to phosphoinositides is not only based on electrostatic interac-
tions. Nonetheless, also in presence of those receptor lipids the interaction of His-cytNL2 with 
DGS still results in raises of the signal intensity. In such SHMs the tendency against the phos-
phoinositides mentioned before is evident, although at higher intensity levels due to the strong 
interactions with DGS. 
Consequently, expansion of the established model membrane system in combination with 
His-cytNL2 in the presented form is not feasible, as a specific interaction of the protein con-
Figure 4.47: Exemplary plots of the change in optical thickness vs. the time during adsorption experiments of His-
cytNL2 (c = 1.36 µM, t = 0 min) on either pure POPC SHMs or on those doped with DGS and POPS (A), and POPC 
SHMs containing 3 mol% PtdInsP or DGS-PtdInsP (each 3 mol%) in combination (B). 
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struct with DGS only is needed to guarantee vacant phosphoinositides which function as pin-
ning-points for collybistin 2. Therefore, a subsequent purification step was applied to increase 
the purity of the His-cytNL2 protein solution.  
 
 
The protein construct mimicking the intracellular domain of neuroligin 2 (His-cytNL2) was 
eluted together with various contaminations after IMAC (cf. Figure 4.46 A). The addition of 
this protein mixture to hybrid membranes containing phosphoinositide and DGS led to ad-
sorbed proteins that were caused by unspecific interaction as shown in the prior sections. 
Thus, it was necessary to elucidate whether this behaviour was caused by His-cytNL2 itself or 
might be a result from deposited contaminations. To do so, the protein mixture obtained from 
the IMAC elution fractions was applied to an anion exchange chromatography (IEC) column 
to separate the target protein from all contaminations. As this purification technique is based 
on electrostatic interactions, a NaCl-gradient was applied during the process in which the ion 
concentration in the buffer solution was stepwise, ranging from 0 to 2 M.271 Simultaneously 
fractions were collected and then analysed by SDS-PAGE. The corresponding gel is shown in 
Figure 4.48 A. 
Figure 4.48: A: Examplary gel of a SDS-PAGE after anion exchange chromatography of His-cytNL2 at a Mono Q 
5/50 in an ÄKTA purification system. Together with the mass standard the flow through (FT) gathered during 
protein application to the column, and the elution fractions (E) collected during rinsing with a gradient of increasing 
NaCl concentration up to 2 M were applied. B: SDS-PAGE after repetition of the purification step yet without a 
gradual NaCl concentration increase. Elution fractions of the IMAC (E) as references were loaded to the gel together 
with the collected fractions of flow through (FT) and washing fractions (WF) of the Mono Q 5/50. 
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In the elution fractions (E3-E7) a great variety of bands was visible among which the band 
corresponding to His-cytNL2 was detected in slight amounts, too. In contrast to that, the flow 
through (FT) fractions contained only minor quantity of bands. In these fractions the band 
corresponding to His-cytNL2 with Mtheo = 17.31 kDa was dominant. Therefore, a second run of 
the anion exchange chromatography was performed without the elution process and conse-
quently the NaCl-gradient. The corresponding gel of the SDS-PAGE is presented in Figure 4.48 
B. Additional, to the FT fractions also elution fractions from IMAC (E1 and E2, cf. Figure 4.46 
A) as references and washing fractions (WF1-4) of the Mono Q column cleaning were applied. 
While the elution fraction contained the previously described band pattern (cf. Chapter 
4.4.2.1), in the FT fractions only a single band of a molecular weight around 20 kDa was de-
tected. On the other hand, all higher molecular bands were present in one of the washing frac-
tions (WF3). Based on the presented gel it becomes clear, that the ion exchange column func-
tioned as a filter, hindering the flow through of contaminations while the His-cytNL2 was 
eluted without retention. Hence, the resulting protein solution contained the pure neuroligin 
2 construct (cf. Figure 4.48 B, FT1 and FT2). 
Furthermore, the specificity of the N-terminally fused His6-tag had to be tested. To do that, the 
obtained pure His-cytNL2 (after IEC) was treated with tobacco etch virus (TEV) to cleave the 
affinity tag and end up with the intracellular domain of neuroligin 2 (cytNL2) alone. The sep-
aration of cleaved protein construct and His6-tag harbouring one was again conducted using 
IMAC. The results are illustrated in 
Figure 4.49. 
In contrast to the His-cytNL2 solu-
tion after anion exchange chroma-
tography (represented by the trace 
labelled with prior), the trace of the 
immobile phase (agarose) and the 
elution fractions showed dominant 
bands with a molecular weight of 
around 15 kDa. These are assigned 
to bare cytNL2 as the fragment 
cleavable by TEV has a theoretical 
Figure 4.49: SDS-PAGE of His-cytNL2 after the cleavage reaction with 
TEV to remove the N-terminal His6-tag. As references the etching vi-
rus (TEV), the immobile phase of the IMAC (agarose) and the un-
treated elution fraction (prior) were of loaded to the gel together with 
various elution fraction (E1-E6). 
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weight of Mtheo = 2.76 kDa. The cleavage of the N-terminal His6-tag was successful and the 
cleaved intracellular domain of neuroligin 2 was effectively isolated. 
With these pure protein fragments (His-cytNL2 and cytNL2) at hand, once again adsorption 
experiments by means of RIfS have been per-
formed. The adsorption behaviour of all 
three neuroligin 2 constructs (His-cytNL2 af-
ter IMAC, His-cytNL2 after IEC and cytNL2) 
are summarised in Figure 4.50. While the 
bare intracellular domain of neuroligin 2 
(cytNL2) has not been adsorbed to any of the 
receptor lipids, the His6-tag containing pure 
His-cytNL2 (after IEC) showed only a spe-
cific interaction with DGS. Thus, an interac-
tion of the tag with the phosphoinositides 
can be neglected indicating that the detected 
changes in optical thickness (cf. Figure 4.47) were results of impurity deposition on top of the 
SHMs. Hence, a selective protein adsorption of NL2 and CB2 can only be guaranteed when 
using His-cytNL2 (after IEC) in the expanded model system. 
 
 
Having proven selective binding of His-cytNL2 to DGS (cf. Chapter 4.4.2.3), the focus was 
switched to its interaction with the full-length isoforms of collybistin 2. On this purpose, the 
adsorption of both, the CB2 wild-type (CB2SH3) and its active mutant (CB2SH3/W24A-E262A), was 
investigated by means of reflectometric interference spectroscopy (RIfS) to hybrid membrane 
systems containing DGS and one of the phosphoinositides (PtdIns[3]P, PtdIns[4,5]P2 or 
PtdIns[3,4,5]P3). Prior to collybistin adsorption, His-cytNL2 was added to the system and fixed 
to the membrane via its N-terminal His6-tag. For both isoforms exemplary time courses of ad-
sorption experiments are portrayed in Figure 4.51. 
Figure 4.50: Change in optical thickness induced by the 
adsorption of the different neuroligin 2 constructs (im-
pure His-cytNL2: black; pure His-cytNL2: red; cytNL2: 
blue) each at a concentration of 1.36 µM to SHMs doped 
with different receptor lipids. 
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After the formation of the lipid hybrid membrane (beginning at t = 0 min) on top of the hydro-
phobically functionalised silicon dioxide substrates, excess lipid material was removed by 
rinsing with HEPES-A buffer (cf. Table 3.14). This also adjusted the conditions (pH) to an op-
timum for the protein adsorption process. Afterwards His-cytNL2 (c = 1.36 µM) was injected 
(timepoint Ia). When a new level in ΔOT was reached (timepoint Ib) the system was rinsed 
with HEPES-A buffer for a second time. The resulting level was referred to as NL2 level. It 
functioned as reference for subsequent determinations of signal intensity changes. These 
changes were caused by the adsorption of CB2 (in form of CB2SH3 and CB2SH3/W24A-E262A) that was 
added to the system in concentrations of 1 µM (at timepoint II). The injection of CB2 wild-type 
led to a significant increase in signal intensity of ΔOT = 0.3 nm on the SHM after His-cytNL2 
adsorption (cf. Figure 4.51 A). This is a striking observation when compared to the determined 
incapability of CB2SH3 to interact with DGS/PtdIns[3,4,5]P3 containing SHMs (cf. Figure 4.44 
A). On the other hand, the adsorption of CB2SH3/W24A-E262A as illustrated in Figure 4.51 B, was not 
or only to a small extend affected by the presence of His-cytNL2 if compared to Figure 4.44 B. 
Figure 4.51: Exemplary plots of the change in optical thickness vs. the time during adsorption of either CB2SH3 (A) 
or CB2SH3/W24A-E262A (B) on POPC hybrid membranes doped with PtdIns[3,4,5]P3 and DGS (94 : 3 : 3, n/n/n). The 
model membranes were prepared via SUV spreading at t = 0 min and subsequently rinsed with buffer. Then His-
cytNL2 (c = 1.36 µM) was injected at timepoint Ia and unbound protein construct was removed by rinsing with 
HEPES-A buffer (Ib). CB2 injection with a concentration of 1 µM for both isoforms is indicated by timepoint II. The 
change in optical thickness caused by CB2 adsorption was determined relative to the established NL2 level (dotted 
line). 
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In analogy to these experiments also the adsorption of both CB2 isoforms to the remaining two 
phosphoinositides in combination with DGS was examined. For each lipid composition at least 
four independent experiments were performed. The mean changes in ΔOT (relative to the 
NL2-level) are summarised in Figure 4.52 and compared to those  induced by CB2 adsorption 
in absence of His-cytNL2 (relative to the membrane-level). 
The comparison of ΔOT caused by adsorption of CB2SH3 to SHMs doped with both DGS and 
phosphoinositides with or without the intracellular domain of NL2 as presented in Figure 4.52 
A hints at an interesting behaviour. While in case of PtdIns[3]P and PtdIns[4,5]P2 containing 
SHMs no significant effect of His-cytNL2 was detected, its presence affected the interaction of 
the wild-type with the tris-phosphorylated PtdInsP in a drastic fashion. After NL2 deposition 
a significant quantity of protein was adsorbed to PtdIns[3,4,5]P3 doped model membranes. 
This indicates an opening of the autoinhibited conformation of CB2SH3. The opening must be 
induced by the interaction with NL2 that renders the adapter protein capable of PtdIns[3,4,5]P3 
binding. Thus, this result supports the previously postulated activation of CB2 via intermolec-
ular interactions with NL2.60 
The preceding NL2 adsorption influences CB2SH3/W24A-E262A in a different way. While on 
DGS/PtdIns[3,4,5]P3 doped membranes no significant difference was monitored, His-cytNL2 
altered the adsorption behaviour of CB2SH3/W24A-E262A to SHMs containing PtdIns[3]P and 
PtdIns[4,5]P2. In both cases the quantity of adsorbed protein was declined when the active 
Figure 4.52: Overview on the induced changes in ΔOT by adsorption of CB2SH3 (A) and CB2SH3/W24A-E262A (B) to POPC 
SHMs containing DGS and one of the phosphoinositides (94 : 3 : 3, n/n/n). While the data in absence of His-cytNL2 
(black, n(CB2SH3) ≥ 3 and n(CB2SH3/W24A-E262A) ≥ 7) was determined relative to the membrane-level, the changes in ΔOT 
after adsorption of 1.36 µM His-cytNL2 (red, n(CB2SH3) ≥ 7 and n(CB2SH3/W24A-E262A) ≥ 5) were calculated relative to 
the NL2-level. The injected CB2 concentration for both isoforms was 1 µM. 
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mutant induced rather large ΔOT changes in the absence of the NL2 construct (cf. Figure 4.52 
B). This hints at an inhibiting effect of His-cytNL2, as PtdInsPs in direct vicinity to DGS-lipids 
might be blocked by the protein construct. In such a case, the phosphoinositides would be 
occupied without a specific interaction. Nonetheless, the amount of accessible, vacant phos-
phoinositides as pinning-points for collybistin 2 would be reduced. Thus, such an effect would 
also be present in the adsorption process of CB2SH3 in case of a similar unspecific interaction 
behaviour. Either way, because of its intrinsically disordered character,51 a size determination 
of the cytoplasmic part of NL2 is not possi-
ble due to the lack of a crystal structure. 
Consequently, an evaluation of the ratio of 
potentially blocked PtdInsP is unconverti-
ble. 
To simplify the comparison of CB2SH3 and 
CB2SH3/W24A-E262A Figure 4.53 presents the 
RIfS data on CB2 adsorption depending on 
the presence of NL2 in another way. The 
addition of CB2SH3 after adsorption His-
cytNL2 often resulted in similar ΔOT val-
ues as those recorded for CB2SH3/W24A-E262A 
with and without prior NL2 adsorption (cf. Figure 4.53). This indicates a related amount of 
adsorbed protein for both isoforms. It might also suggest a similar arrangement of the acti-
vated wild-type on the membrane surface (cf. Chapter 4.3.4). Though, this hypothesis cannot 
be proven by the RIfS results alone and requires further investigations. The combination of 
atomic force microscopy (AFM) with fluorescence labelling would be a promising way of ex-
amination as a differentiation of the adsorbed structures between His-cytNL2 and CB2SH3 
would be impossible by simple AFM-studies. 
Yet, it remains elusive whether the activated CB2 wild-type can also interact with the other 
phosphoinositides. Based only on the comparison of its adsorption influenced by NL2 (cf. Fig-
ure 4.52 A) CB2SH3 could by classified as specific to PtdIns[3,4,5]P3. Both CB2 isoforms exhibit 
identical adsorption behaviour on SHMs (cf. Figure 4.53), therefore, it is feasible to use 
CB2SH3/W24A-E262A as a benchmark. The ΔOTs induced by CB2SH3 adsorption can be related to 
Figure 4.53: A: Comparison of the ΔOT values caused by 
adsorption of CB2SH3 (dark grey) and CB2SH3/W24A-E262A (light 
grey) to SHMs in absence of His-cytNL2 (solid bars) or its 
presence (dashed bars). The error bars indicate the standard 
error of the mean. 
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those determined for CB2SH3/W24A-E262A to 
exclude any impact of the reference layer 
(membrane- or NL2-level). The relative 
ΔOT of CB2SH3 (ΔOTwild-type) correlated to 
ΔOTmutant was calculated as shown in Fig-
ure 4.54. 
In this form of presentation an increase in 
signal intensity on all receptor lipid com-
binations caused by the preceding His-
cytNL2 adsorption is evident. Thus, the 
activated CB2SH3 can interact with all 
phosphoinositides. However, a qualified estimation of its PtdInsP-binding specificity cannot 
be made. This would have been an interesting piece of information as former studies presented 
different behaviour between the wild-type and point-mutated forms of collybistin. REDDY-
ALLA et al. showed by variation of the amino acid residues 232 and 233 of CB2 that inhibition 
of the guanine nucleotide exchange factor (GEF) activity towards the small rat sarcoma hom-
ologue (Rho) GTPases Cdc42 occurred, while the phosphoinositide interaction was not af-
fected.93 On the other hand changes of amino acid residues in the PH domain abolished 
gephyrin recruitment to synaptic sites indicating their requirement for PtdInsP binding. This 
is supported by the finding that alterations in the DH domain (R290H and R338W)252,253 of CB2 
indirectly affect the interaction of its PH domain with the receptor lipids in the post synaptic 
membrane. 
Another aspect that needs consideration is the fact that neuroligins in vivo tend to form ho-
modimers.58 In 2012, POULOPOULOS et al. focussed on the dimerisation of all neuroligin 
isoforms and were able to identify a transmembrane asparagine residue to be crucial for the 
dimer formation and thus the accumulation of neuroligin at synaptic site.57 However, as the 
model setup established in course of this work only contains the C-terminal cytoplasmic do-
main of NL2 dimerisation is not possible. Nonetheless, the results gathered for CB2SH3 after 
His-cytNL2 adsorption (cf. Figure 4.54) suggest an activation by the NL2 construct proving the 
dispensability of NL2 dimerisation for this process. For this reason, it can be assumed that the 
Figure 4.54: Change in optical thickness induced by CB2SH3 ad-
sorption to SHMs correlated to ΔOT caused by CB2SH3/W24A-E262A 
under similar conditions. 
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dimerisation is more relevant for the intercellular communication process with the presynaptic 
neurexins. 
In order to test whether the activation of CB2 is based on its interaction with the poly-proline 
sequences inside the intracellular domain of NL2, it would be an interesting experiment to 
substitute His-cytNL2 by a peptide that harbours at least one poly-proline sequence. The pep-
tide could also be equipped with an accessible cysteine to allow coupling reactions to malei-
mide containing artificial lipids. This would provide the opportunity to renounce the use of 
DGS and thus the reduction of potential lateral lipid-lipid interactions.  
In conclusion, the investigations performed during this work represent the establishing pro-
cess of an in vitro model for the fundamental protein machinery responsible for GABAAR or-
ganisation in the inhibitory postsynaptic membrane. The results showed the advantages of a 
solid-supported hybrid membrane (SHM) system prepared on hydrophobically functionalised 
silicon dioxide substrates. Furthermore, it was proven that a combination of the receptor lipids 
DGS and various phosphoinositides inside such a model membrane is possible without de-
tectable adverse effects except for a slight reductions of diffusion coefficients. Moreover, it was 
possible to selectively bind two constituents of the organisation machinery to the SHM. For 
this purpose, a protein construct (His-cytNL2) mimicking the intracellular part of NL2 was 
isolated and specifically adsorbed to DGS. After its preceding adsorption it was possible to 
monitor an interaction of the usually inactive collybistin 2 wild-type with phosphoinositides. 
Thereby, proof of the activating interaction between NL2 and CB2 was generated in the ab-
sence of other proteins. While the active mutant (CB2SH3/W24A-E262A) and the isolated PH domain 
(CB2PH) were characterised as non-specific interaction partners for the three phosphoinosi-
tides, no qualified statement on the binding specificity of CB2SH3 was possible. 
Based on the accomplishments of this work it is the logical consequence to introduce a third 
protein, the scaffolding protein gephyrin, to the model system. Thereby the presumed protein 
machinery underlying GABAAR organisation would be complete. Already at its current state 
the model system is suitable for drug testing to examine the influence of chemical agents either 
on the adsorption of CB2 to the membrane or on the protein-protein interaction between NL2 
and CB2. Furthermore, the in vitro system can be used to test the consequences of mutations 
within the respective proteins and thereby identify potential origins of diseases which hitherto 
had to be done in neuronal tissue or animal tests. 




The communication at chemical synapses is based on the release and uptake of neurotrans-
mitters. In the mammalian brain, inhibitory signal transduction relies on the neurotransmitter 
γ-amino butyric acid (GABA) which is recognised by specific receptors (GABAARs) in the post 
synaptic plasma membrane. Their accumulation in direct opposition to presynaptic active sites 
is required to facilitate fast communication. The cell adhesion protein neuroligin 2 (NL2), the 
scaffolding protein gephyrin and the adaptor protein collybistin 2 (CB2) are assumed to be 
part of this organisation process. CB2 interacts with phosphoinositides (PtdInsPs) in the 
plasma membrane and functions as an anchor for the protein complex. In this thesis an in vitro 
model system of the GABAAergic postsynaptic receptor organisation machinery was devel-
oped. The model system was based on solid-supported hybrid membranes (SHMs) that were 
prepared via spreading of small unilamellar vesicles (SUVs) on top of hydrophobically func-
tionalised substrates. The surface features were modified by treating SiO2 wafers with 1,1,1-
trimethyl-N-(trimethylsilyl) silanamine (HMDS). Among other strategies, the functionalisa-
tion under reduced pressure and increased temperature was identified as most effective to 
obtain smooth hydrophobic surfaces with a root mean square (RMS) of (0.40 ± 1) nm and a 
mean contact angle of (87 ± 1)°. Besides these substrates hydrophilic functionalised ones were 
used to prepare solid-supported lipid bilayer (SLBs). This allowed the comparison of the phos-
phatidylinositol-4,5-bisphosphate (PtdIns[4,5]P2) distribution in both membrane systems in-
fluenced by the solid support. Via adsorption experiments of marker proteins by means of 
reflectometric interference spectroscopy (RIfS) and atomic force microscopy (AFM) a reduced 
accessibility of PtdIns[4,5]P2 with an asymmetry factor of at least two was identified in SLBs. 
The enrichment of the receptor lipid in the substrate facing leaflet is believed to be caused by 
electrostatic interactions with the SiO2 surface in combination with a pre-organisation of 
PtdIns[4,5]P2 in the SUVs. 
This heterogeneity was identified to be unique for PtdIns[4,5]P2, therefore, the adsorption 
studies of CB2 to membranes containing one of three phosphoinositide variants (PtdIns[3]P, 
PtdIns[4,5]P2 and PtdIns[3,4,5]P3) were performed on SHMs. The adsorption of three different 
CB2 isoforms was examined. The isolated PH domain (CB2PH) and the conformationally active 




with moderate affinities in the range of 0.7-5.6 µM for all three PtdInsPs. No adsorption of the 
CB2 wild type (CB2SH3) was monitored, supporting the general assumption of a closed, inactive 
conformation. AFM imaging of the adsorbed protein structures (CB2PH and CB2SH3/W24A-E262A) 
identified the C-terminal PH domain as height dictating part of CB2 with around 3.4 nm. Ad-
ditional to the protein height, the size of the defined protein structures was characterised to be 
independent of the deployed phosphoinositide. 
Subsequently, NL2 was added to the model system as a further constituent of the protein ma-
chinery. 1,2-dioleoyl-sn-glycero-3-{[N-(5-amino-1-carboxypentyl)iminodiacetic acid]succinyl} 
nickel salt (DGS) functioned as specific receptor lipid for a protein construct mimicking its 
intracellular domain (His-cytNL2). The addition of DGS to PtdInsP containing membranes did 
not affect their formation processes nor the resulting layer thickness (ΔOTSHM = 2.7 nm) but 
caused a reduction in diffusion coefficients by 50 % for labelled PtdInsPs. However, no influ-
ence of DGS was detected on the CB2—PtdInsP interaction. The purified His-cytNL2 did not 
interact with phosphoinositides and thus was adsorbed to DGS/PtdInsP containing SHMs 
prior to injection of either CB2SH3 or CB2SH3/W24A-E262A. While the latter was unaffected by the 
presence of NL2, a drastically increased adsorption of CB2SH3 was monitored after preceding 
His-cytNL2 addition. 
In conclusion, it was shown that the use of SHMs is beneficial to avoid undesired substrate 
influences. Deploying this system, the CB2—PtdInsP interaction was characterised in detail 
and CB2PH was identified as the height dictating protein part. Furthermore, the established 
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YSEYC NNHLD ACMEL SKLMK DSRYQ HFFEA CRLLQ QMIDI AIDGF LLTPV 
QKICK YPLQL AALLK YTAQD HSDYR YVAAA LAVMR NVTQQ INERK RRLEN 
IDKIA QWQAS VLDWE GDDIL DRSSE LIYTG EMAWI YQPYG RNQQR VFFLF 
DHQMV LCKKD LIRRD ILYYK GRIDM DKYEV IDIED GRDDD FNVSM KNAFK 
LHNKE TEEVH LFFAK KLEEK IRWLR AFREE RKMVQ EDEKI GFEIS ENQKR 










MNIDK IAQWQ ASVLD WEGDD ILDRS SELIY TGEMA WIYQP YGRNQ QRVFF 
LFDHQ MVLCK KDLIR RDILY YKGRI DMDKY EVIDI EDGRD DDFNV SMKNA 
FKLHN KETEE VHLFF AKKLE EKIRW LRAFR EERKM VQEDE KIGFE ISENQ 







MKHHH HHHPM SDYDI PTTEN LYFQG AMAYK RDRRQ ELRCR RLSPP GGSGS 
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Anti CB Monoclonal mouse purified 
IgG 
Synaptic Systems GmbH, Göttingen, Germany 
Anti NL Monoclonal mouse purified 
IgG 
Synaptic Systems GmbH, Göttingen, Germany 
Anti-6X His tag® Abcam, Cambridge, UK 
APS Sigma-Aldrich, Taufkirchen, Germany 
Argon Air Liquide Deutschland GmbH, Düsseldorf, Germany 
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TEMED Sigma-Aldrich, Taufkirchen, Germany 
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Tryptone Carl Roth GmbH, Karlsruhe, Germany 
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TxR-DHPE Sigma-Aldrich, Taufkirchen, Germany 
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Ultrapure H2O Millipore, Billerica, USA 
Vivaspin® 500 Sartorius GmbH, Göttingen, Germany 
Yeast extract Carl Roth GmbH, Karlsruhe, Germany 
β-mercaptoethanol Carl Roth GmbH, Karlsruhe, Germany 
 
Atomic Force Microscopy (AFM) 
MFP-3D classic Asylum Research, Santa Barbara, USA 
MFP-3D infinity Asylum Research, Santa Barbara, USA 
 
Confocal Laser Scanning Microscopy (CLSM) 
LSM 710 Examiner Carls Zeiss Microscopy GmbH, Oberkochen, Germany 
LSM 880 Examiner Carls Zeiss Microscopy GmbH, Oberkochen, Germany 
FluoView 1200 Olympus, Tokyo, Japan 
 
Epifluorescence Microscopy 
Olympus BX 51 Olympus, Tokyo, Japan 
 
Reflectometric Interference Spectroscopy (RIfS) 
Flame Spectrometer Ocean Optics GmbH, Ostfildern, Germany 
NanoCalc, SD2000 Spectrometer Ocean Optics GmbH, Ostfildern, Germany 
Silver Mirror Chroma Technology GmbH, Olching, Germany 
ADC1000-USB, A/D Converter Ocean Optics GmbH, Ostfildern, Germany 
Dichotomous light fibre Ocean Optics GmbH, Ostfildern, Germany 
Ismatec 795C peristaltic pump IDEX Health & Science, Wertheim, Germany 
HL-2000-LL Light source Ocean Optics GmbH, Ostfildern, Germany 
 
Other devices 
Äkta purification system GE Healthcare, Little Chalfont, UK 
Allegra™ X-22R Beckman Coulter, Brea, USA 
Centricon T-1065, ultracentrifuge Kontron, Eching, Germany 




Galaxy Mini, Minicentrifuge VWR International, Darmstadt, Germany 
Heraeus Fresco 17, table centrifuge Thermo Fisher Scientific, Darmstadt, Germany 
Innova® 44 incubator shaker New Brunswick Scientific, Ensfield, USA 
Microfluidizer™ LM10 Microfluidics, Westwood, USA 
Mini-PROTEAN® Tetra Cell, PAGE 
apparatus 
Bio-Rad Laboratories Inc., Hercules, USA 
MonoQ 5/50 GE Healthcare, Little Chalfont, UK 
MR 3001 K, magnetic stirrer Heidolph, Schwabach, Germany 
NanoDrop2000c Thermo Fischer Scientific GmbH, Dreieich, Germany 
pH-Meter Calimatic 766 Knick, Berlin, Germany 
Thermo mixer compact Eppendorf, Hamburg, Germany 
Tip sonifier Sonoplus HD2070 Bandelin, Berlin, Germany 
Transblo SD Semi Dry Transfer Cell Bio-Rad Laboratories Inc., Hercules, USA 
Ultrapure Water System, MiliQ Gra-
dient A10 
Merck Millipore, Darmstadt, Germany 
Ultrasonic bath Sonorex RK 255H Bandelin, Berlin, Germany 
Vacuum drying oven VD23 Binder GmbH, Tuttlingen, Germany 
Varian Cary Scan 50, Spectrometer Agilent Technologies, Santa Clara, USA 
Varioklav 135S Thermo Fischer Scientific GmbH, Dreieich, Germany 
Vortexer Heidolph, Schwabach, Germany 
Water bath E38 Dinkelberg Labortechnik, Neu-Ulm, Germany 
Zepto LF PC 




Fiji, ImageJ 1.50i http://www.fiji.sc 
Gwyddion 2.49 http://gwyddion.net 
MATLAB 2017b MathWorks, Natick, USA 
Origin Pro 8.5G OrigonLab Corp., Northhampton, USA 
Spectra Suite Ocean Optics GmbH, Ostfildern, Germany 
Zen black 2.3 SP1 Carls Zeiss Microscopy GmbH, Oberkochen, Germany 



















    ImageAnalyse=imread(Files(k).name); 
    ImageAnalyse=im2bw(ImageAnalyse(:,:,1),0.5); 
    Waterimage=bwconncomp(ImageAnalyse,4); 
    %         Waterimage=watershed(ImageAnalyse,4); 
    for m=1:Waterimage.NumObjects 
        if numel(Waterimage.PixelIdxList{m})>10 
            Counter=Counter+1; 
            diameter(Counter)=sqrt(4*numel(Waterimage.PixelIdxList{m})/pi); 
        end 
    end 
    Pixelgroesse=input('geben sie manuell die Pixelgröße ihres Bildes ein 
[nm]: '); 








%  Initializes the GUI and creates one panel to the left and two panels to 
%  the right 
  















leftPanel = uipanel('bordertype','etchedin',... 
    'Position', [0.05*500/750 0.05 0.8*500/750 0.9],... 
    'Backgroundcolor','default','Visible','on',... 
    'Parent',f); 
rightTopPanel = uipanel('bordertype','etchedin',... 
    'Position', [0.9*500/750 0.375 1-0.85*500/750-0.1*500/750 0.575],... 
    'Backgroundcolor','default','Visible','on',... 
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    'Parent',f); 
rightBottomPanel = uipanel('bordertype','etchedin',... 
    'Position', [0.9*500/750 0.125 1-0.85*500/750-0.1*500/750 0.225],... 
    'Backgroundcolor','default','Visible','on',... 
    'Parent',f); 
  
% Constructs the components in the gui 
sh=uicontrol(leftPanel,'Style','slider',... 
    'Max',100,'Min',1,'Value',1,'Visible','off',... 
    'SliderStep',[1/(100-1) 5/(100-1)],'Units','normalized',... 
    'Position',[0 0 1 (1-0.8/0.9)/2],... 
    'Callback',{@sh_Callback}); 
txt_frm=uicontrol(leftPanel,'Style','text',... 
    'String','Frame:','Units','normalized','Visible','off',... 
    'Position',[0 1-(1-0.8/0.9)/2 1 (1-0.8/0.9)/2],'FontSize',10,... 




    'Units','normalized','FontSize',10,'HorizontalAlignment','left',... 
    'Position',[0.05,0.91,0.5,0.06]); 
edit_pre1=uicontrol(rightTopPanel,'Style','edit','String','1','Units','nor-
malized',... 
    'Position',[0.6,0.91,0.15,0.06],'FontSize',10,'HorizontalAlign-
ment','center'); 
uicontrol(rightTopPanel,'Style','pushbutton','Units','normalized',... 
    'String','Get','Position',[0.8,0.91,0.15,0.06],... 
    'Callback',{@btn_pre1_Callback}); 
uicontrol(rightTopPanel,'Style','text','String','Last pre-bleach 
frame:',... 
    'Units','normalized','FontSize',10,'HorizontalAlignment','left',... 
    'Position',[0.05,0.84,0.5,0.06]); 
edit_pre2=uicontrol(rightTopPanel,'Style','edit','String','2','Units','nor-
malized',... 




    'String','Get','Position',[0.8,0.84,0.15,0.06],... 
    'Callback',{@btn_pre2_Callback}); 
uicontrol(rightTopPanel,'Style','text','String','Dark count value:',... 
    'Units','normalized','FontSize',10,'HorizontalAlignment','left',... 
    'Position',[0.05,0.77,0.5,0.06]); 
edit_dc=uicontrol(rightTopPanel,'Style','edit','String','','Units','normal-
ized',... 
    'Position',[0.6,0.77,0.15,0.06],'FontSize',10,'HorizontalAlign-
ment','center',... 
    'Callback',{@edit_dc_Callback}); 
uicontrol(rightTopPanel,'Style','pushbutton','Units','normalized',... 
    'String','Get','Position',[0.8,0.77,0.15,0.06],... 
    'Callback',{@btn_dc_Callback}); 
uicontrol(rightTopPanel,'Style','text','String','First post-bleach 
frame:',... 
    'Units','normalized','FontSize',10,'HorizontalAlignment','left',... 
    'Position',[0.05,0.7,0.52,0.06]); 
edit_pb1=uicontrol(rightTopPanel,'Style','edit','String','4','Units','nor-
malized',... 
    'Position',[0.6,0.7,0.15,0.06],'FontSize',10,'HorizontalAlign-
ment','center'); 
uicontrol(rightTopPanel,'Style','pushbutton','Units','normalized',... 




    'Callback',{@btn_pb1_Callback}); 
uicontrol(rightTopPanel,'Style','text','String','Last post-bleach 
frame:',... 
    'Units','normalized','FontSize',10,'HorizontalAlignment','left',... 
    'Position',[0.05,0.63,0.52,0.06]); 
edit_pb2=uicontrol(rightTopPanel,'Style','edit','String','','Units','nor-
malized',... 
    'Position',[0.6,0.63,0.15,0.06],'FontSize',10,'HorizontalAlign-
ment','center'); 
uicontrol(rightTopPanel,'Style','pushbutton','Units','normalized',... 
    'String','Get','Position',[0.8,0.63,0.15,0.06],... 
    'Callback',{@btn_pb2_Callback}); 
uicontrol(rightTopPanel,'Style','text','String','Omit frame(s):',... 
    'Units','normalized','FontSize',10,'HorizontalAlignment','left',... 
    'Position',[0.05,0.56,0.32,0.06]); 
edit_omit=uicontrol(rightTopPanel,'Style','edit','String','','Units','nor-
malized',... 
    'Position',[0.4,0.56,0.35,0.06],'FontSize',10,'HorizontalAlign-
ment','left'); 
uicontrol(rightTopPanel,'Style','pushbutton','Units','normalized',... 
    'String','Get','Position',[0.8,0.56,0.15,0.06],... 
    'Callback',{@btn_omit_Callback}); 
uicontrol(rightTopPanel,'Style','text','String','r_max [pixels]:',... 
    'Units','normalized','FontSize',10,'HorizontalAlignment','left',... 
    'Position',[0.05,0.49,0.32,0.06]); 
edit_rmax=uicontrol(rightTopPanel,'Style','edit','String','','Units','nor-
malized',... 
    'Position',[0.4,0.49,0.35,0.06],'FontSize',10,'HorizontalAlign-
ment','center'); 
uicontrol(rightTopPanel,'Style','pushbutton','Units','normalized',... 
    'String','Get','Position',[0.8,0.49,0.15,0.06],... 
    'Callback',{@btn_rmax_Callback}); 
uicontrol(rightTopPanel,'Style','text','String','Pixelwidth [um]:',... 
    'Units','normalized','FontSize',10,'HorizontalAlignment','left',... 
    'Position',[0.05,0.37,0.7,0.06]); 
edit_dx=uicontrol(rightTop-
Panel,'Style','edit','String','0.267','Units','normalized',... 
    'Position',[0.65,0.37,0.3,0.06],'FontSize',10,'HorizontalAlign-
ment','center'); 
txt_dt=uicontrol(rightTopPanel,'Style','text','String','Time between frames 
[s]:',... 
    'Units','normalized','FontSize',10,'HorizontalAlignment','left',... 
    'Position',[0.05,0.30,0.7,0.06]); 
edit_dt=uicontrol(rightTopPanel,'Style','edit','String','2','Units','nor-
malized',... 
    'Position',[0.65,0.30,0.3,0.06],'FontSize',10,'HorizontalAlign-
ment','center'); 
cbx_pre=uicontrol(rightTopPanel,'Style','checkbox',... 
    'String','  Use pre-bleach frame','Units','normalized',... 
    'FontSize',10,'HorizontalAlignment','left',... 
    'Value',1,'Position',[0.05 0.18 0.8 
0.06],'Callback',{@cbx_pre_Callback}); 
cbx_times=uicontrol(rightTopPanel,'Style','checkbox',... 
    'String','  Define individual time points','Units','normalized',... 
    'FontSize',10,'HorizontalAlignment','left',... 
    'Value',0,'Position',[0.05 0.11 0.8 
0.06],'Callback',{@cbx_times_Callback}); 
cbx_trc=uicontrol(rightTopPanel,'Style','checkbox',... 
    'String','  Track the center of mass','Units','normalized',... 
    'FontSize',10,'HorizontalAlignment','left',... 
    'Value',0,'Position',[0.05 0.04 0.8 0.06]); 




txt_imin=uicontrol(rightBottomPanel,'Style','text','String','Imin = 1',... 
    'Units','normalized','FontSize',10,'HorizontalAlignment','left',... 
    'Position',[0.05,0.72,0.35,0.175]); 
sh_imin=uicontrol(rightBottomPanel,'Style','slider',... 
    'Max',100,'Min',1,'Value',1,'Visible','on',... 
    'SliderStep',[1/(100-1) 5/(100-1)],'Units','normalized',... 
    'Position',[0.45 0.72 0.5 0.175],... 
    'Callback',{@sh_imin_Callback}); 
txt_imax=uicontrol(rightBottomPanel,'Style','text','String','Imax = 
10000',... 
    'Units','normalized','FontSize',10,'HorizontalAlignment','left',... 
    'Position',[0.05,0.44,0.35,0.175]); 
sh_imax=uicontrol(rightBottomPanel,'Style','slider',... 
    'Max',100,'Min',1,'Value',100,'Visible','on',... 
    'SliderStep',[1/(100-1) 5/(100-1)],'Units','normalized',... 
    'Position',[0.45 0.44 0.5 0.175],... 
    'Callback',{@sh_imax_Callback}); 
uicontrol(rightBottomPanel,'Style','pushbutton','Units','normalized',... 
    'String','Auto','Position',[0.75,0.12,0.2,0.2],... 
    'FontSize',10,'Callback',{@btn_Iauto_Callback}); 
  
uicontrol(f,'Style','pushbutton','Units','normalized',... 
    'String','Start','Position',[0.73,0.05,0.1,0.05],... 
    'FontSize',10,'Callback',{@btn_start_Callback}); 
  




    'Accelerator','O'); 
uimenu(menu_file,'Label','Exit','Callback',{@menu_Exit_Callback},... 
    'Separator','on','Accelerator','Q'); 
  




% Moves the GUI to the center of the screen. 
movegui(f,'center') 
  
% Makes the GUI visible. 
set(f,'Visible','on'); 
  
% Creates axes to the images to appear in 
ax_f=axes('Units','pixels','Parent',leftPanel,'Units','normalized',... 
    'Position',[0 (1-0.80/0.9)/2 1 0.80/0.9],'Visible','off'); 
  
% Defines variables 
FileName='';    % the name of the image file    
file_in=[];     % the filename + directory of the image stack 
api=[];         % API associated with the line handle used to determine 
rmax 
frm_max=1;      % the length of the image stack 
I=[];           % matrix consisting of the current image 
ib_min=[];      % min intensity in the images 
ib_max=[];      % max intensity in the images 
Idark=[];       % dark count intensity 
Ipb=[]; 





    % btn_pre1_Callback - gets the first pre-bleach frame from the frame 
number 
    %   of the currently displayed image 
    function btn_pre1_Callback(source,eventdata) 
        if ~isempty(file_in) 
            if get(cbx_pre,'Value')==0 
                % the pre-bleach intensity is determined within the region 
                % Bpb 
                Bpb=roipoly; 
                Ipb=mean(I(Bpb)); 
                set(edit_pre1,'String',num2str(round(Ipb))); 
            else 
                set(edit_pre1,'String',num2str(get(sh,'Value'))); 
                Ipb=[]; 
            end 
        end 
    end 
  
    % btn_pre2_Callback - gets the last pre-bleach frame from the frame 
number 
    %   of the currently displayed image 
    function btn_pre2_Callback(source,eventdata) 
        if ~isempty(file_in) 
            set(edit_pre2,'String',num2str(get(sh,'Value'))); 
        end 
    end 
  
    % btn_dc_Callback - determines the value of the dark count intensity 
    function btn_dc_Callback(source,eventdata) 
        if ~isempty(file_in) 
            % the dark count intensity is determined within the region Bdc 
            Bdc=roipoly;  
            Idark=mean(I(Bdc)); 
            set(edit_dc,'String',num2str(round(Idark))); 
        end 
    end 
  
    % btn_pb1_Callback - gets the first post-bleach frame from the frame 
number 
    %   of the currently displayed image 
    function btn_pb1_Callback(source,eventdata) 
        if ~isempty(file_in) 
            set(edit_pb1,'String',num2str(get(sh,'Value'))); 
        end 
    end 
  
    % btn_pb2_Callback - gets the last post-bleach frame from the frame 
number 
    %   of the currently displayed image. Left unassigned makes the last 
    %   image in the stack being also the last image in the analyzed stack. 
    function btn_pb2_Callback(source,eventdata) 
        if ~isempty(file_in) 
            set(edit_pb2,'String',num2str(get(sh,'Value'))); 
        end 
    end 
  
    % btn_rmax_Callback - determines the maximum radial distance to be used 
    %   in the analysis 
    function btn_rmax_Callback(source,eventdata) 
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        if ~isempty(file_in) 
            if isempty(api) 
                iml=imline(ax_f,[255 255],[255 255]); 
                api=iptgetapi(iml); 
            end 
            rp=api.getPosition(); 
            Rp_max=sqrt((rp(2,1)-rp(1,1))^2+(rp(2,2)-rp(1,2))^2); 
            set(edit_rmax,'String',num2str(Rp_max)) 
        end 
    end 
  
    % btn_omit_Callback - determines which frames to omit from the analysis 
    function btn_omit_Callback(source,eventdata) 
        if ~isempty(file_in) 
            str_omit=get(edit_omit,'String'); 
            if isempty(str_omit) 
                set(edit_omit,'String',num2str(get(sh,'Value'))); 
            else 
                set(edit_omit,'String',[str_omit,',',num2str(get(sh,'Val-
ue'))]); 
            end 
        end 
    end 
  
    % edit_dc_Callback - uppdates the value of I_dc 
    function edit_dc_Callback(source,eventdata) 
        str_Idc=get(edit_dc,'String'); 
        if isempty(str_Idc) 
            Idark=[]; 
        else 
            Idark=str2double(str_Idc); 
        end 
    end 
  
    % btn_start_Callback - calls the routine calc_frap which does the 
    %   analysis of the FRAP images to determine the diffusion parameters 
    function btn_start_Callback(source,eventdata) 
        if ~isempty(file_in) 
            dx=str2double(get(edit_dx,'String')); 
             
            if isempty(Idark) 
                Idark2=0; 
            else 
                Idark2=Idark; 
            end 
  
            if get(cbx_pre,'Value')==0 
                Ipre=ones(size(I))*Ipb-Idark2; 
            else 
                % A single pre-bleach image is obtained by averaging the 
pre-bleach images 
                % between the first and last pre-bleach frame selected. 
                ipb1=str2double(get(edit_pre1,'String')); 
                ipb2=str2double(get(edit_pre2,'String')); 
                Ipre=double(imread(file_in,ipb1))-Idark2; 
                for i=ipb1+1:ipb2 
                    Ipre=Ipre+double(imread(file_in,i))-Idark2; 
                end 
                Ipre=Ipre/(ipb2-ipb1+1);             




            Ipre(Ipre==0)=1; 
             
            istart=str2double(get(edit_pb1,'String')); 
            iend=get(edit_pb2,'String'); 
            if isempty(iend) 
                iend=length(imfinfo(file_in)); 
            else 
                iend=str2double(iend); 
            end 
             
            nbr_frames=iend-istart+1;   % Number of post-bleach frames used 
            if (istart+nbr_frames-1)>length(imfinfo(file_in)) 
                nbr_frames=length(imfinfo(file_in))-istart+1; 
            end 
             
            % t = frame times 
            if get(cbx_times,'Value')==1 
                t=str2num(get(edit_dt,'String')); 
                t=t-t(1);   % automatically sets the first time to zero 
                if length(t)~=nbr_frames 
                    return 
                end 
            else 
                dt=str2double(get(edit_dt,'String'));               
                t=(0:1:nbr_frames-1)*dt; 
            end 
             
            if get(cbx_trc,'Value')==1 
                trc='y'; 
            else 
                trc='n'; 
            end 
             
            Rp_max=get(edit_rmax,'String'); 
            if ~isempty(Rp_max) 
                Rp_max=str2double(Rp_max); 
            else 
                Rp_max=[]; 
            end 
  
            nr=ones(size(t)); 
            omit_fr=get(edit_omit,'String'); 
            if ~isempty(omit_fr) 
                omit_fr=str2num(omit_fr); 
                for i=1:length(omit_fr) 
                    nr(omit_fr(i)-istart+1)=0; 
                end 
            end 
            calc_frap(file_in,dx,Ipre,Idark2,istart,t,trc,Rp_max,nr); 
        end 
    end 
  
    % sh_Callback - determines which image to show 
    function sh_Callback(source,eventdata) 
        if ~isempty(file_in) 
            frm=get(sh,'Value'); 
            set(sh,'Value',round(frm)); 
            frm=round(frm); 
            I=double(imread(file_in,frm)); 
            imshow_frap(I,[ib_min,ib_max],ax_f); 
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            set(txt_frm,'String',[FileName,' - ',num2str(frm)]) 
        end 
        api=[]; 
    end 
  
    % sh_imin_Callback - updates the min intensity settings for the images 
    %   (coupled to the imin slider) 
    function sh_imin_Callback(source,eventdata) 
        ib_min=round(get(sh_imin,'Value')); 
        if ib_min>ib_max 
            ib_min=ib_max-1; 
            set(sh_imin,'Value',ib_min); 
        end 
        set(txt_imin,'String',['Imin = ',num2str(ib_min)]); 
        if ~isempty(file_in) 
            imshow_frap(I,[ib_min,ib_max],ax_f); 
        end 
    end 
  
    % sh_imax_Callback - updates the max intensity settings for the images 
    %   (coupled to the imax slider) 
    function sh_imax_Callback(source,eventdata) 
        ib_max=round(get(sh_imax,'Value')); 
        if ib_max<ib_min 
            ib_max=ib_min+1; 
            set(sh_imax,'Value',ib_max); 
        end 
        set(txt_imax,'String',['Imax = ',num2str(ib_max)]); 
        if ~isempty(file_in) 
            imshow_frap(I,[ib_min,ib_max],ax_f); 
        end 
    end 
  
    % btn_Iauto_Callback - automatically sets the min and max intensities 
    % to those in the current image 
    function btn_Iauto_Callback(source,eventdata) 
        if ~isempty(file_in) 
            ib_min=min(I(:)); 
            ib_max=max(I(:)); 
            set(txt_imin,'String',['Imin = ',num2str(ib_min)]); 
            set(txt_imax,'String',['Imax = ',num2str(ib_max)]); 
            set(sh_imin,'Value',ib_min); 
            set(sh_imax,'Value',ib_max); 
            imshow_frap(I,[ib_min,ib_max],ax_f); 
        end 
    end 
  
    % cbx_pre_Callback - determines whether to use a pre-bleach frame to 
    % compensate for uneven illumination or to assume a flat illumination  
    % with a user specified pre-bleach intensity 
    function cbx_pre_Callback(source,eventdata) 
        if get(cbx_pre,'Value')==0 
            set(txt_pre1,'String','Pre-bleach intensity:'); 
            set(edit_pre2,'Enable','off'); 
            set(btn_pre2,'Enable','off'); 
        else 
            set(txt_pre1,'String','First pre-bleach frame:'); 
            set(edit_pre2,'Enable','on'); 
            set(btn_pre2,'Enable','on'); 
        end 





    % cbx_times_Callback - determines whether to use individual values of 
    % the times for all frames or just the time between frames 
    function cbx_times_Callback(source,eventdata) 
        if get(cbx_times,'Value')==0 
            set(txt_dt,'String','Time between frames [s]:'); 
            set(edit_dt,'Position',[0.65,0.3,0.3,0.06],'HorizontalAlign-
ment','center'); 
        else 
            set(txt_dt,'String','Frame times [s]:') 
            set(edit_dt,'Position',[0.45,0.3,0.5,0.06],'HorizontalAlign-
ment','left','String',''); 
        end 
    end 
  
    % menu_Open_Callback - chooses the image stack to analyze 
    function menu_Open_Callback(source,eventdata) 
        % Displays a dialog box from where to choose the images to be ana-
lyzed 
        [FileName,PathName] = uigetfile('*.tif','Select the image-file',de-
fault_dir); 
        if FileName==0 
            return 
        end 
         
        default_dir=PathName; 
        file_in=strcat(PathName,FileName); 
         
        if length(imfinfo(file_in))==1 
            error('The FRAP data should be a TIF-stack containing atleast 2 
frames') 
            return 
        end 
         
        set(txt_frm,'String',[FileName,' - 1'],'Visible','on') 
        I=double(imread(file_in,1)); 
        set(sh,'Value',1,'Visible','on'); 
  
        fw=500/750*size(I,2)/size(I,1); 
        set(leftPanel,'Position',... 
            [0.05*fw 0.05 0.8*fw 0.9],... 
            'Visible','on'); 
        set(ax_f,'Visible','on') 
  
        frm_max=length(imfinfo(file_in)); 
        set(sh,'Max',frm_max,'Min',1,... 
            'SliderStep',[1/(frm_max-1) 10/(frm_max-1)]); 
        axis off  
         
        set(sh_imin,'Max',max(2^14,max(I(:))),'Min',0,... 
            'SliderStep',[1/max(2^14,max(I(:))) 10/max(2^14,max(I(:)))],... 
            'Value',min(I(:)),'SliderStep',[1/max(2^14,max(I(:))) 
50/max(2^14,max(I(:)))]); 
        set(sh_imax,'Max',max(2^14,max(I(:))),'Min',0,... 
            'SliderStep',[1/max(2^14,max(I(:))) 10/max(2^14,max(I(:)))],... 
            'Value',max(I(:)),'SliderStep',[1/max(2^14,max(I(:))) 
50/max(2^14,max(I(:)))]); 
         
        ib_min=round(get(sh_imin,'Value')); 
        set(txt_imin,'String',['Imin = ',num2str(ib_min)]); 
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        ib_max=round(get(sh_imax,'Value')); 
        set(txt_imax,'String',['Imax = ',num2str(ib_max)]); 
        imshow_frap(I,[ib_min,ib_max],ax_f); 
        api=[]; 
    end 
  
    % menu_Exit_Callback - ends the program 
    function menu_Exit_Callback(source,eventdata) 
         
        % closes the figures 
        close(f) 
        close(figure(98)) 
        close(figure(1)) 
        close(figure(2)) 
        close(figure(3)) 
        close(figure(4)) 
        close(figure(5)) 
        close(figure(6)) 
        close(figure(7)) 
        close(figure(8)) 
  
























 switch choice  
     case {'m'} 
         baseh=input('Give Baseheight:', 's') 
         baseh=str2num(baseh) 
         disp('manual case, baseheight: ') 
         baseheight=baseh*65535./diffh 
     case {'a'}          
         %plot (xh, counts) 
         [Val,Ind]=max(counts); 
         baseh=xh(Ind) 
         disp('automatic case, baseheight: ') 




















    heightline=double(im_corr(i,:))./65535.*diffh; 
    im_height=[im_height;heightline]; 
    % Threshold peakdet(xxxx, THRESHOLD 
    [MAXTAB, MINTAB] = peakdet(heightline,1.5e-9); 
    if isempty(MAXTAB)==0 
        im_mark(i,MAXTAB(:,1))=1; 
        peakind=MAXTAB(:,1); 
        height_abs=[height_abs;MAXTAB(:,2)]; 
        t=plot(pixel,heightline); 
        plot(pixel(peakind),heightline(peakind),'r*')   
    else 
        im_mark(i,:)=0; 
    end     
       
end 
  
xlabel('distance / pixel'); 
ylabel('height / m'); 
























save height_abs.txt height_abs -ascii 



































    Threshold=input('Geben Sie manuell den Threshold an oder bei OK 
Enter'); 
    if isempty(Threshold) 
        break 
    end 
    speicherThreshold=Threshold; 
    figure(3) 
    Thresimage=im2bw(Tiffimage,Threshold./65535); 
    imshow(Thresimage) 
    figure(2) 
    hist(double(Tiffimage(:)),1000); 
    hold on 
    achsen=axis; 
    plot([Threshold,Threshold],[achsen(3),achsen(4)],'r-') 
    hold off 
    Oberflaechenbelegung=sum(Thresimage(:))/numel(Thresimage) 
     
end 
  
imwrite(Thresimage,[Tiffimage(1:end-4) '_Threshold_' num2str(speicher-
Threshold) '.png'],'png') 
